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ABSTRACT 
Nanoparticles attract vast international research interest for medical applications due 
to their ability to be manipulated via the incorporation of various ligands and 
ligands. These ligands enable the regulation of a diverse range of biomedical 
processes which take place at a nanometer scale. Two approaches are commonly 
used to co-functionalize AuNPs, these methods include synthesizing either a mixed 
monolayer or by using a bifunctional Polyethylene glycol (PEG) linker. This Thesis 
directly compares the two approaches by incorporating the use of an internalization 
and endosomal escape peptide to compare the two arrangements for stability, cell 
viability, internalization and radio sensitization. An extensive research effort 
employed to confirm peptide arrangement has revealed that difficulties arise due to 
the higher binding affinity of thiolated ligands to gold in comparison to amine 
terminated ligands which are commonly used to synthesize a linker surface 
arrangement. It is shown that the successful synthesis using a bifunctional linker is 
heavily dependent on the method of attachment coupled with the solvents used. 
Inductively coupled plasma mass spectrometry (ICP-MS) has indicated a statistical 
difference for internalization, demonstrating that the linker has elicited a higher 
internalization response for both cell lines with an overall F value of 181.8 and a P 
value of 0.0095 (P < 0.05 statistically significant) for the DU145 cell lines resulting 
in over 3 times the amount of gold within the cells. Stability studies and cell viability 
studies have also indicated enhanced stability for the linker samples and preliminary 
data obtained from a clonogenic survival assay has indicated enhanced 
radiosensitivity, with an SER 1.36 for the linker, which represents a 36% increase in 
radiosensitivity for the samples in comparison to the untreated control.  Concurrent 
attachment studies have identified that cysteine binding efficiency can be optimized 
by altering the pH of an AuNP suspension to  ̴ 8, while extensive collaboration 
efforts have established that the solvents used to attach the peptide and/or ligands is 
paramount to a successful, stable covalent attachment, and an essential criteria for 
successful synthesis using a linker using a pre-synthesized NHS ester. 
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1. INTRODUCTION 
 Introduction 
Nanotechnology has vast opportunities for advancing medical science and disease 
treatment. Gold nanoparticles, in particular, have become of significant clinical 
interest due to their unique optical, chemical and biological properties; with cancer 
research becoming one of the most predominant areas of interest. Gold nanoparticles 
are non-toxic, and thermally stable; these properties can be manipulated ‘to provide 
an effective and selective platform to obtain a targeted intracellular release’ of a 
therapeutic drug, dye or other payload. [1] This is of particular interest to biomedical 
engineering as the surface functionalization with different peptides, ligands and/or 
other ligands has the potential to allow for the synthesis of a ‘golden bullet’ which 
may target and destroy cancer cells as a result of external irradiation via a range of 
methods (some of which are illustrated in Figure 1-1). AuNPs offer the sensitization 
of tumors to radiation through utilization of their high atomic number (Gold (Z 
=  79)). This approach can maximize the differential response between tumors and 
normal tissue known as the therapeutic ratio through the introduction of the high-
atomic number (Z) material into the target tissue. The mass energy of the coefficient 
of gold is 100-150 times greater than that of soft tissue in the keV energy range. This 
may overcome current issues with selectivity for radiotherapy, as both cancerous and 
healthy tissue have similar mass energy absorption profiles. Due to the high Z-
average of the AuNPs, introduction of the AuNPs to cancerous tissue offers a stark 
contrast between the tissue types for enhanced selectivity improving tumor control, 
reducing side effects and increasing survival when compared to radiotherapy alone. 
[2]  
Another approach of using AuNP properties to aid the treatment of cancerous tissue 
is by utilization of the Surface Plasmon Resonance (SPR) properties of AuNPs at 
nanoscale. Photo thermal therapy (PTT) involves the conversion of photon energy 
into thermal energy to kill cancer cells. Due to the SPR of AuNPs, AuNPs absorb 
light strongly in the visible range, and convert light into heat upon irradiation.  Upon 
irradiation to electromagnetic radiation, surface electrons are excited resulting in 
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strong surface fields. The relaxation of these electrons result in strong localized heat 
emission. In noble metal nanoparticles, adsorption and scattering efficiencies are 
strongly enhanced due to the SPR, the absorption and scattering are at least 1000 
times stronger than other organic dye molecules otherwise used in PTT. Changing 
the shape of these nanoparticles can allow for fine tuning of these properties to near 
infrared (NIR) region, where light penetration for tissue is optimal. For this reason, 
NIR-absorbing gold-based nanoparticles have received considerable attention in 
plasmonic photo thermal therapy, with gold nanoshells, gold nanorods and gold 
nanocages leading the literature, with silica based gold nanoshells experimented by 
Halas and co-workers in 1988, Au nanorods investigated due to their precise and 
readily controllable NIR properties by Wang, Murphy and El-Sayed groups and Au 
nanocages being developed as a NIR-absorbing structure by the Xia group.  [3–11] 
To further enhance the therapeutic abilities of AuNPs, various ligands can be 
tethered to the AuNP surface to elicit a biological response. Multi functionality is the 
key feature of nanoparticle-based agents. Production via the Turkevich method 
permits the synthesis of citrate capped particles with a zeta potential of 
approximately -20 - -40 mV. The citrate capping is loosely bound on the AuNP 
enabling it to be easily displaced with other functional groups.  Targeting ligands, 
thiol linkers and other functionalities can all be integrated to allow for targeted 
cancer therapy.  The interaction of AuNP with thiols in particular; is of specific 
interest as this can provide an effective and selective means of controlled 
intracellular release via an external stimulus, release of the payload at the required 
Figure 1-1 Schematic of the potential applications of gold 
nanoparticles 
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site can be achieved using photoexcitation or by means of intracellular glutathione 
levels. The intracellular concentration of glutathione is 1–10 mM, whereas 
extracellular levels are 2 µM, which can be used to break the thiol linker, releasing 
the payload inside the cell. [12,13] The main focus of this research is AuNP 
functionalization as it could potentially allow for a drug delivery system that can 
target a specific tumor cell and overcome natural physiological barriers that manifest 
in several distinct ways. For intravascular delivery of NPs, the barrier manifests in 
the form of: (i) immune clearance in the liver and spleen, (ii) permeation across the 
endothelium into target tissues, (iii) penetration through the tissue interstitium, (iv) 
endocytosis in target cells, (v) diffusion through cytoplasm and (vi) eventually entry 
into the nucleus, if required. [14] The thiol-terminated polyethylene glycol (PEG) is 
commonly used to functionalize the surface of the AuNP as PEG improves colloidal 
stability in vivo and prevents uptake by the reticular endothelial system, however it 
limits the overall uptake into the target cancer cell.  As illustrated in Figure 1-2, the 
goal of this Thesis is to firstly identify the surface arrangement to be used, which 
gives the best biological response, then optimize the attachment of the ligands to the 
AuNPs which will be chosen based on their potential to enhance radiosensitization.  
 Aims and Objectives 
1.2.1 Aims 
The ultimate aim of this Thesis is to determine whether the method of co-
functionalization would directly affect the colloidal stability, and biological response 
of a gold nanoparticle conjugate. To achieve this, this research effort involved the 
synthesis and characterization of both a mixed monolayer surface arrangement, and 
compared the conjugate to a AuNP co-functionalized using a bifunctional PEG 
linker. A range of comparative colloidal stability and biological studies were 
performed, with the outcome to be the identification of whether one method of co-
functionalization would initiate cellular internalization and enhanced radiosensitivity 
to a higher degree than the latter. To achieve an ideal complex, the scope also 
involved the optimization of peptide attachment to the AuNP surface through pH and 
the application of this optimized model in a range of in vitro studies. 
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1.2.2 Objectives 
1. To synthesize AuNPs and PEGylate their surface for enhanced colloidal 
stability, followed by co-functionalization of the AuNP surface with various 
peptides 
2. To co-functionalize the AuNPs using peptides to synthesize a mixed 
monolayer and utilize a PEG linker, then conduct an in-depth 
characterization profile of the conjugates 
3. Conduct a range of comparative studies, including, but not limited to, a range 
of in depth characterizations (using spectroscopy and dynamic light 
scattering) followed by in vitro colloidal stability studies and non-specific 
protein adsorption studies to determine if one co-functionalization 
methodology can enhance colloidal stability over the other 
4. Complete a range of cellular internalization and radiosensitization studies to 
identify if one arrangement offers an increase in intracellular concentration – 
and consequently an improved radiotherapy response - in comparison to the 
other 
5. Identify novel agents for AuNP functionalization  
6. Optimize AuNP and peptide binding efficiency through alteration of pH 
Figure 1-2 Illustration of the Thesis aims and objectives 
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2. LITERATURE REVIEW 
 Cancer Origin, Significance, Outcome and Current 
Diagnostics/Therapeutics 
Cancer is a term used for diseases in which abnormal cells undergo uncontrolled 
growth as a result of gene malfunctions and are subsequently able to invade their 
surrounding tissues. In this state, the imbalance of cell division leads to the 
formation of a malignant tumor (Figure 2-1) where cells can spread to other parts of 
the body via utilization of the blood and lymphatic systems. [15]  
 
The overall health of the human body is maintained by the constant division of cells, 
occasionally the genetic material DNA of these cells may become damaged, thus 
producing mutations which affect the healthy cell growth process. Consequently, 
Figure 2-1 Schematic of tumor formation 
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these mutations result in the cessation of cell apoptosis, ensuing in the continuation 
of cell generation when they are not required. A tumor is therefore an abundance of 
these cells. [15] 
In 2014 the National Cancer Institute estimated 233,000 new cases and 29,480 
deaths from prostate cancer in the United States (U.S) alone. Approximately 15% of 
men will be diagnosed with prostate cancer during their lifetime and in 2016 there 
was an estimated 3.3million with a history of prostate cancer living in the U.S. and 
an estimated additional 180,890 men which will be diagnosed in 2016. [16–18] Cancer 
is currently being diagnosed with pathological testing such as blood and biopsy. 
Treatment usually follows the mechanism of surgery, radiation therapies, 
chemotherapy, immunotherapy and the utilization of anti-cancer drugs. These drugs 
are commonly injected directly into the tumor site, administered intravenously for 
general systematic distribution via anti-cancer therapy drug implants or electro 
chemotherapy. The drugs used are predominantly dependent on both the tumor 
location and severity and are currently only administered in order to induce a period 
of partial or complete remission (remission for 5+ years without reoccurrence) or for 
palliative purposes. [19] 
Cancer mortality is still primarily linked with the development of metastatic disease. 
Current curative treatment schedules are typically limited to localized/primary 
disease within clearly defined tumor boundaries; therefore, effective treatment 
options remain limited for disseminated disease. Therapeutic drugs are administered 
intravenously leading to general systemic distribution, this results in detrimental 
side-effects as the drugs attack healthy tissues in addition to tumor cells. As the 
drugs also impact healthy cells, treatment doses must be bound within established 
margins to avoid the risk of drug induced adverse effects. Targeting technologies 
utilizing suitable tumor specific antigens can therefore be applied to help reduce 
systemic toxicity by conferring more selective targeting. [20–23] 
It should be noted that other routes of administration are available, however they too 
have their limitations. Oral ingestion, for example, is lacking due to the inability to 
overcome the acidity of the stomach. [24] Research is therefore focused on the 
development of a method to selectively target the tumor cell to elicit controlled drug 
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delivery with sustained release over a specific time period while avoiding non-
specific interactions with plasma proteins (opsonization), remain stable in 
physiological conditions in a wide array of pH and evade uptake via the 
reticuloendothelial system.[24]  
 Nanoparticles  
Nanoparticles are particles between 1 and 100 nanometers in size with a surrounding 
interfacial layer. The interfacial layer is an integral part of nanoscale matter, 
fundamentally affecting all of its properties.[25] Nanotechnology is linked to Richard 
Feynman in 1959 whom first described the concept of being able to arrange atoms 
‘one by one, just as we want them’ and has since attracted vast international interest 
over the past several decades resulting in the development of various potential 
biomedical applications. Biological applications range from drug, protein or peptide 
delivery, imaging, tumor targeting - with the biggest areas of growth revolving 
around detection of molecules associated with diseases such as diabetes, mellitus 
neurodegenerative diseases and cancer.  [26–28]  
 Nanomaterials for Drug Delivery 
Metal nanoparticles have long been considered to exhibit unique physical and 
chemical properties which are different from those in their bulk state. The unusual 
property of small crystals that arise from confinement of electrons to small regions 
of space designates the quantum size effect.  The quantum size effect describes the 
physics of electron properties in solids with a great reduction in size. It can dominate 
the comportment of matter at nanoscale affecting the optical, electrical and magnetic 
behavior. Examples of such behaviors include the rendering of gold nanoparticles as 
ruby red at room temperature, and optical electric-field enhancement at a metal 
surface arising from surface-plasmon excitation. The reduction of the bulk gold to 
nanoscale results in the a conduction band of electrons which oscillate due to the 
interaction with the electromagnetic field which can be used to trigger payload 
release or induce localized heating. [21,29,30] This phenomena is known as the surface 
plasmon resonance effect which arises due to the drastic change in electronic 
properties as a result of the vast reduction in size and when they are exposed to 
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external optical fields, plasmonic coupling causes electric field enhancement, which 
originates from the charge separation in the AuNP during the plasmon resonance and 
can occur at small, sub-micron sizes. [31,32] 
Noble metallic nanoparticles can be attached to single strands of DNA non-
destructively; furthermore they can navigate through vasculature and localize targets. 
As a result they offer the opportunity for a wide array of in vivo medical diagnostic, 
therapeutic, imaging and biomedical applications. [33]  
 
Some of the most well studied nanoparticles are illustrated in Figure 2-2; they 
include quantum dots, carbon nanotubes, Nano shells, magnetic nanoparticles and 
dendrimers. Nanocarriers comprise mainly polymer therapeutics (polymer–protein 
and polymer–drug conjugates), where the drug is covalently bound or conjugated to 
a polymeric structure, and particulate drug nanocarriers, where the drug is physically 
entrapped within molecular assemblies with different structures made from different 
materials, such as polymers (polymeric micelles, dendrimers and polymeric 
nanoparticles), lipids (liposomes), or organometallic compounds (carbon nanotubes). 
The first generation of anticancer nanocarriers to be approved by FDA included both 
liposomal drugs and polymeric conjugates. [23,34,35] 
 
Figure 2-2 The various types of nanoparticles for 
biomedical applications 
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Covalently conjugating anticancer proteins to polymers can reduce immunogenicity 
and increases its circulation time in blood. [36] Drugs commonly result in cytotoxic 
affects, therefore a polymer-drug conjugate offers the cytotoxic drug an increased 
circulation time in blood, an improved aqueous solubility, a passively targeted 
delivery to tumors, and a reduced toxicity, improving the therapeutic value of the 
anticancer drug. [37–39]  
 
Liposomes are self-assembled colloidal vesicles with a characteristic lipid bilayer 
membrane composed of amphiphilic phospholipids. [23] Hydrophilic anticancer drugs 
can be encapsulated in their aqueous core, and hydrophobic cytotoxic agents in its 
hydrophobic membrane. A major limitation with liposomes however is the low drug 
loading capacity, due to the small membrane space; they are also prone to instability 
when drugs are loaded onto the membrane. [40,41]  
 
Carbon nanotubes are tubular hydrophobic networks of carbon atoms with a 
diameter of approximately 1–4 nm (depending on the number of graphene layers), 1–
100 lm in length and unique structural, electronic, optical and mechanical properties. 
[42][43] Carbon nanotubes can contain a range of anticarrier drugs within their hallow 
inner cavity, or on their surface, they overcome the limited space apparent from the 
liposomes, however they are insoluble in all solvents, which results in an array of 
toxic problems. Theses carriers have the ability to cross the plasma membrane and 
enter into the cancerous cells by endocytosis. [43–45] 
 
Dendrimers are highly branched three-dimensional synthetic polymeric 
macromolecules. One of their major advantages is that they allow a high level of 
control over their properties, such as the ability to adjust biocompatibility by tuning 
the chemical synthesis of the dendrimer. They have good water solubility and high 
drug loading capacity, while there is an abundance of literature available for the 
application of dendrimers for oncology; their slow translation form preclinical to 
clinical trials is most likely due to the toxicity of the dendrimers as a result of their 
multiple functional groups found on their surface. [23,46–51] 
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 Properties and Applications of Gold nanoparticles 
Extensive research has been focused on the area of gold nanoparticles (AuNPs) as 
drug delivery systems (DDS). The current goal is to synthesize non-toxic particles 
capable of delivering high doses of a payload to a target cell without triggering a 
undesired immune response with minimal side effects to the surrounding tissue. In a 
sense it is the ideal of improving chemotherapy via selectivity. [52] AuNPs have a 
range of unique properties, namely ease of synthesis, inert nature, ease of 
functionality and the potential to act as a radio sensitizing agent or for photothermal 
therapy (PTT). As a high Z material, AuNPs have shown great promise at increasing 
the effectiveness of conventional radiotherapy. [53]  Hainfeld et al. has shown that 
radiotherapy is enhanced from a 20% survival rate for tumor bearing mice to an 86% 
1-year survival rate when used in conjunction with a 1.9 nm AuNP/PBS suspensions. 
While this experimental design was unlikely to represent a clinically feasible option 
due to the prohibitive AuNP concentrations used and the high single fraction 
radiation dose, the study demonstrated clear proof-of-concept that AuNPs can 
significantly augment the efficacy of radiotherapy. [21,54] Using a mouse model 
seeded with melanoma cells, Chang et al. reported a survival time of 20 days for a 
control group receiving radiation alone compared  to 65 days for those treated with 
AuNP and irradiation. [55] This radio sensitization effect is driven by an increased 
yield of low energy secondary electrons following photoelectric adsorption events. 
Differential photoelectric adsorption is most prominent at kV energies that are 
closest to those of the binding energies of the lower shelled electrons of the gold. 
[24,25] A potential issue is that the kV energies used, have an inherently shallow 
penetration, therefore limiting the exploitation of this physical effect for non-
superficial tumors, Mesbahi et al. have shown that monoenergetic kilovoltage beams 
demonstrated a dose enhancement factor of 1.4 to 3.7, whereas the dose 
enhancement factors for megavoltage beams were negligible and less than 3% for all 
AuNP sizes and concentrations. [21,53,56,57] 
AuNPs can be functionalized by attaching various ligands by means of thiol groups. 
This elicits the appending of a high density of ligands for targeting or therapeutics 
among others.  [58] Drugs can be covalently bonded via cleavable linkers, or bound 
non-covalently to be released upon external stimulation. Therefore they can be 
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Table 2-1 Clinical applications of AuNPs adapted from Harrison et al. 2016 
exploited for various treatment modalities including photothermal ablation therapy, 
radio sensitization, imaging and drug delivery.  
 Table 2-1 and Table 2-2 adapted from Harrison et al. (2016) outlines clinical trial 
results to date for AuNP based treatments, and overviews the preclinical (animal 
studies) results for the use of AuNPs in cancer therapy. Promising results have been 
obtained across a range of applications, using a wide variety of AuNP formulations. 
The results highlight both the potential of AuNP treatments and their inherent 
complexity. 
Particle Application Functionalization Model Result Ref 
Clinical Trials 
Particle Application Functionalization Model Result Ref 
AuNPs 
(CYT-
6091: 
Cyt-
immune
) 
Advanced 
solid tumors 
Human tumor 
necrosis factor 
alpha & SH-PEG 
30 
advance
d-stage 
cancer 
patients 
Phase I and Pharmacokinetic 
Studies of CYT-6091 
(NCT00356980, 
NCT00436410). CYT-6091 
may be administered 
systemically at doses of 
rhTNF that were previously 
shown to be toxic and that 
CYT-6091 may target to 
tumors 
[59–63] 
 
Silica-
AuNPs: 
NANO
M FIM 
Treatment of 
coronary 
athero - 
sclerosis 
Silica-AuNP & 
silica-AuNP iron 
bearing 
180 
patients 
with 
CAD 
and 
angiogra
phic 
SYNTA
X score 
≤22 
NANOM FIM- a completed 
phase I\II clinical trial 
(NCT01270139)12.6% 
reduction in the percentage 
atheroma volume (PAV) 
post procedure. The 
plasmonic resonance therapy 
using silica-gold NP proved 
efficient regression of 
coronary atherosclerosis in 
both approaches 
[64] 
Silica-
gold 
nanoshe
lls 
(AuroS
hells: 
AuroLa
se®) 
Photothermal therapy for the treatment of 
advanced lung tumors resulting from either 
primary lung cancer or metastatic tumors in the 
lung 
FDA-approved pilot study 
(NCT00848042, 
NCT01679470). Human 
trials were on-going as of 
2014, the trials are complete, 
the results have not yet been 
disseminated 
[65] 
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 Table 2-2 Preclinical studies of AuNPs adapted from Harrison et al. 2016 
 
Figure 2-3 Schematic dictation of both the "Top Down" and "Bottom Up" methods 
Preclinical/Animal Studies 
Particle Application Functionalization Model Result Ref 
AuNP 
Glioma 
targeting & 
accumulation 
efficiency 
Gelatin (G) 
n noparti les, 
doxorubicin 
(DOX), Cy5.5 
and RRGD, a 
tandem peptide of 
RGD and 
octarginine 
C6 cells 
xenograft-
bearing mice 
G-AuNPs-DC-RRGD displayed the best 
glioma targeting and accumulation 
efficiency, with good colocalization with 
neovessels. Cy5.5 also showed good 
colocalization with DOX, indicating the 
Cy5.5 could be used for imaging of the 
DOX delivery. 
[66] 
AuNRs 
Targeted 
photothermal 
(PT) therapy 
and 
chemotherapy 
of triple 
negative 
breast cancer 
(TNBC) 
Cisplatin–
polypeptide poly 
(L-glutamic acid) 
(PGA), wrapping 
and folic acid (FA) 
functionalization 
(FA-GNR@Pt) 
4T1 tumor 
bearing 
mice 
The Folic acid gold nanorod hybrid 
nanoparticles significantly inhibited the 
growth of the TNBC tumor and 
extensively suppressed the dissemination 
of TNBC cells from the primary tumor to 
the lung 
 
[67] 
Hollow 
AuNS 
(DOX@
HAuNS) 
Photothermal 
ablation 
(PTA) 
Multifunctional 
doxorubicin 
(DOX)-loaded 
hollow gold 
Nanospheres 
DOX@HAuNS) 
Hey tumors 
bearing mice 
(5.0×106 
cells/mouse) 
Tumors in six of the eight mice treated 
with laser & T-DOX@HAuNS regressed 
completely with only residual scar tissue 
by 22 days following injection 
[68] 
AuNP 
Chemotherapy 
and radiation 
head and neck 
squamous cell 
carcinoma 
(HNSCC) 
Epidermal growth 
factor receptor 
(EGFR), C225 
antibody, liposomal 
green fluorescent 
dye & 2C5 antibody 
conjugate 
Pretreated 
HN31 cells 
subcutaneously 
into the flanks 
of mice 
Improved the efficacy of standard chemo 
and radiation treatment in resistant and 
aggressive head and neck cancer by 100-
fold in vitro and 17-fold in vivo, reduced 
the effective entry doses of drugs and X-
rays to 2–6% of their clinical doses 
[69] 
Uniform 
gold 
nano-
stars 
Integration of 
targeting 
tumors, 
chemotherapy 
and photo-
thermotherapy 
into a single 
system 
Cyclic RGD 
(cRGD) and near 
infrared 
(NIR) fluorescence 
probe (MPA) (Au-
cRGD-MPA) or 
anti-cancer drug 
(DOX) (Au-cRGD-
DOX) 
S180 tumor-
bearing mouse 
models 
Viability of MDA-MB-231 cells was 
only 40 % after incubation with Au-
cRGD-DOX and irradiation with NIR 
light. Both tail vein and intratumoral 
injections showed Au-cRGD-DOX 
treated mice exhibiting the slowest tumor 
volume increase 
[70] 
AuNP radiotherapy N/A 
B16F10 
melanoma 
tumor-bearing 
mice 
Tumor volume in the combination 
therapy group was significantly smaller 
compared with that in 
radiation alone group (P < 0.05), whereas 
administration of AuNP or PBS alone 
did not exert any antitumor effect on 
tumor bearing mice 
[55] 
AuNP radiotherapy N/A 
Mice bearing 
subcutaneous 
EMT-6 
mammary 
carcinomas 
Those receiving injections of 1.35 or 2.7 
g Au/kg before radiation showed 50% 
and 86% long-term (>1 year) survival 
compared to 20% for the control group. 
[54] 
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 The Concept of the ‘Magic Bullet’ 
Paul Ehrich gave the preliminary description of drug delivery as a ‘magic bullet’ in 
1891. Most drugs are administered orally or intravenously, the ‘magic bullet’, or 
now commonly known as ‘the magic gold bullet’ is a fictional description of a drug 
delivery system which would be able to administer drugs to a specific cell. It is 
considered fictional as it is the perception of forming a perfect DDS to administer 
therapeutic drugs with minimal side effects and ease of access. This ideal would be 
extremely difficult to achieve, due to sheer complexity, and as such, has not yet been 
realized. It is this concept on which this research is based. [71] If AuNPs can 
successfully overcome the natural barriers of biocompatibility, targeting and toxicity 
then they have the potential to revolutionize cancer treatment. For this, the AuNPs 
would have to carry specific peptides, payloads and polymers with quantities 
sufficient enough to target the cell, resist a biological response, initiate uptake and 
deliver a therapeutic.  [27]  
 Biocompatibility of Gold Nanoparticles 
AuNPs have been widely reported as being non-toxic in a range of in vitro and 
animal studies. [72,73] However, it is recognized that the published literature on AuNP 
toxicity varies both in methodology and conclusions, with several publications 
reporting toxic effects [2,48,47]. For example it has been reported that citrate capped 
AuNPs of 8-37 nm diameter were toxic in animal studies resulting in fatigue, loss of 
appetite, change in fur color, and weight loss. [76] Mironava et al. reports that 45 nm 
AuNPs display greater toxicity than 13 nm particles and are internalized via a 
different clathrin mediated pathways; they penetrate the cell membrane and 
accumulate in large vacuoles. [77]   
Several studies have also reported toxic effects with various types of functionalized 
AuNPs; Pan et al. reported toxic effects (cell death) of triphenylphosphine 
functionalized 1.4 nm particles in four cell lines. [78] It is generally understood that 
functionalized AuNPs have greater toxicity. This poses a potential obstacle for the 
application of AuNPs in vivo as functionalization is paramount to synthesize a 
clinically useful AuNP treatment. Cho et al. also reported toxic effects in the case of 
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exposure to PEG functionalized AuNPs in animal studies, observing liver 
inflammation and apoptosis, with gene expression profiles showing alterations in 
apoptosis, cell cycle and inflammation mediators. [79] Goodman reported that cationic 
surface modification of AuNPs induced greater toxicity than anionically 
functionalized particles. [80] While Alkilany et al. also found greater toxicity in 
AuNPs with a cationic coating compared to uncharged particles. [81] Several studies 
have suggested that such toxic effects arise from the presence of unreacted chemicals 
left over from the synthesis process, such as sodium citrate or 
cetyltrimethylsmmonium bromine (CTAB). [82] This can be studied by determining 
the functional impact of the supernatant following centrifugation. 
N. Chanda et al. overcame toxicity issues by functionalizing Au-198 nanoparticles 
(198AuNPs) with gum arabic glycoprotein (GA) plant extract; by the end of the 30-
day study, all control mice (30 μL of DPBS intratumorally) were sacrificed due to 
deteriorating health, whereas the treatment group (intratumoral injections of GA-
198AuNPs (408 μCi) in DPBS (30 μL)) showed no cause for termination. It was also 
noted that the therapeutic payload had remained within the tumor site throughout the 
30-day treatment regimen, as the therapeutic payload found within non-target organs 
was insignificant, with 2% to 5% of the injected dose being released from the tumor 
and cleared through renal pathways. The paper reports an impressive 82% reduction 
in tumor volume. [83] The influence of the method of attachment on toxicity is not 
fully understood and due to the complexity of clinically relevant AuNP preparations, 
it is necessary to conduct extensive cytotoxicity analysis prior to animal studies.  It 
should be noted that the amount of in vivo toxicity data is limited and that the 
translation of cell studies to in vivo behavior is problematic. [84,85] 
 Synthesis of Gold Nanoparticles 
The reduction of tetrachloroaurate solution by phosphorous in carbon disulphide is 
one which ignited the interest in gold nano formation in 1857. [86] After the seminal 
report by Faraday in 1857 of the reduction of a tetrachloroaurate solution by 
phosphorus in carbon disulfide, the preparation of AuNPs with controlled sizes and 
shapes received considerable attention, leading to the breakthroughs by Turkevich, 
Frens and Schmid in 1951, 1973 and 1981 respectively.  [87] Although the work of 
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Turkevich and his co-workers is a landmark for AuNP synthesis, the synthesis is 
actually traceable back to Ernst A. Hauser and J. Edward Lynn who published their 
research in 1940 reporting the formation of gold colloids using HAuCl4 and 
trisodium citrate (Na3Ct) solution. 
[88,89] Further sophistication of the synthesis 
technique led to the stabilization of AuNPs with thiol groups by  Mulvaney and 
Giersing (1993) and finally the Schiffrin group in 1994 whom devised a more 
efficient thiol stabilization methodology. [87] 
 
AuNPs were produced at an approximate size of 20nm; Frens obtained a broad size 
range (15 – 150nm) by controlling the amount of trisodium citrate added which has 
been widely adopted by research groups such as Kimling et al. whom concluded that 
low sodium citrate levels results in larger molecules. [90,91] Another example of 
chemical AuNP synthesis, via the reduction of HAuCl4 is the Brust-Schiffrin 
method. This two-step method allows the synthesis of AuNPs in sizes of 5 nm or 
less. The relative ease of synthesis coupled with the high thermal and air colloidal 
stability of the AuNPs have resulted in the wide spread adoption of this technique. A 
limitation is that the AuNPs are typically stabilized using a separate thiol terminated 
group such as an alkanethiol, which can be difficult to subsequently replace with 
other functional groups. [30,92–96] 
 
Figure 2-4 Schematic dictation of both the "Top 
Down" and "Bottom Up" methods 
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Nanoparticles can be prepared by either “top down” or “bottom up” approaches. A 
schematic of both these approaches is illustrated in Figure 2-4. For “top down” 
procedures a bulk state is systematically broken down in steps for the synthesis of 
the nanomaterial. In this case particle formation is generally controlled by a pattern 
or matrix and is considered limited concerning the control of the size and shape of 
particles as well as further functionalization. [30,97] 
“Bottom up” approach is one in which the material is synthesized from individual 
molecules utilizing reduction. This reduction method involves two steps, nucleation 
and successive growth. When both these progressions are completed in the same 
process it is known as in situ synthesis. Seed-growth enlarges the nanoparticles step 
by step, initially small seeds are prepared, those seeds are then added to a growth 
solution, Natan et al. pioneered gold nano seeds by utilizing citrate as the reducing 
and capping agent of spherical seeds. In this procedure, AuNPs between 20 nm and 
100 nm were prepared by adding citrate-capped, NaBH4-reduced seeds into a 
“growth” solution containing a mild reducing agent such as citrate. [98,99] The newly 
reduced Au0 then grows on the Au seed to develop the nanoparticles. [30,100]  
 
The synthesis of AuNPs using chemical in situ synthesis by means of the Turkevich 
method (Figure 2-5) is elegant as it utilizes citrate as both the stabilizing and 
reducing agent. Citrate capping results in a distinct advantage as the citrate ions 
(which display a surface potential of -20 - -40 mV as observed by DLS) are loosely 
Figure 2-5  AuNP synthesis using the Turkevich method adapted from Zhao 
et al. and taken from Harrison et al. 2016 [30] 
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bound on the nanoparticle surface and can therefore be easily replaced by external 
groups. In the approach HAuCl4 solution is brought to the boil and whilst 
undergoing vigorous stirring, an aliquot of trisodium citrate (Na3Ct) solution is 
added. The process is generally accepted as nucleation and growth, however there 
are various discrepancies in the literature, with the number of proposed growth 
mechanisms almost being the same as the number of publications on this topic; 
ranging from nucleation and growth, an ‘organizer’ model, Ostwald ripening and a 
Finke-Watzky growth mechanism. [90,101–107] 
Upon the addition of sodium citrate, a color change will occur from clear yellow to 
blue. It has generally been accepted that this color change indicates the formation of 
the nuclei and the following change from blue to red indicates the formation of the 
nanoparticle itself. However this topic is controversial in the literature. Nucleation 
events are thought to be induced by the production of dicarboxy acetone (DCA) 
which is a product of the oxidation of sodium citrate. The auric salt is then reduced 
to aurous salt and Au0; the aurous salt is then assembled onto the Au0 atoms to form 
AuNPs. Thus reflecting that the actual stabilizer in the Turkevich/Frens method is 
dicarboxy acetone as a result of oxidation and not the citrate itself. [108]  
Studies in 1994 attributed the blue color to the reversible aggregation of primary 
particles; this was only to be later redefined as the formation of 2D nanowire 
networks or the formation of linear assemblies from clusters. Mikhlin et al. 
hypothesized the growth mechanism as being the formation of liquid domains from 
Au clusters and the formation of aggregates. [109] The uncertainty in this area is 
further empathized by the publication by Wuithschick et al. in 2015 that highlights 
the work of Polte et al... Polte et al. combined X-Ray scattering (SAXS) and X-Ray 
absorption near edge spectroscopy (XANES) to allow real time measurements of the 
reduction of Au3+ and monitoring of the particle growth in situ. [110,111] Instead it was 
declared that the in situ process is comprised of four steps, the partial reduction of 
the precursor and the formation of small clusters from Au monomers. The formation 
of nano seeds (radii >1.5nm) from these clusters and the attraction of the remaining 
gold ions to the seeded particles and the subsequent attachment of the ions as co-ions 
in the electronic double layer (EDL) . The final step involves the reduction of ionic 
gold and the growth of the gold monomers on the seed particle surfaces until the 
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precursor is expanded. [110,111] Therefore, it was concluded that the origin of the blue 
color during the initial phase is misinterpreted, that there are no aggregates formed 
during the Turkevich method, and the bluish color is most likely caused by the 
attachment of gold ions in the EDL and the subsequent change of their electronic 
properties. [90,101–107] 
 Surface Functionalization 
Au-citrate bonds are very weak (Au-OCOOH (~2 kcal/mol)), this results in the Au-
citrate bonds being easily substituted with stronger bonds, such as thiolate bonds 
(Au-S (~40 kcal/mol)). [30] [112] This reaction can be carried out with relative ease 
under ambient conditions, for example, this replacement reaction has previously 
allowed the successful conjugation of gold with thiolate DNA and Polyethylene 
Glycol (PEG), in the form of a mixed monolayer. [30,113,114] Throughout this Thesis, 
unless otherwise stated, conjugation refers to the functionalization of the AuNP with 
the respective ligand and/or peptide via covalent bonding. While the Au-thiolate 
reaction is commonly used throughout the literature, there are a range of limitations 
associated with utilizing the Au-thiolate bonds.  The main limitations associated with 
this method of surface functionalization include the potential for irreversible 
aggregation, minimal control over the arrangements of the groups on the surface and 
potential issues with the biological availability of shorter ligands when used in 
conjunction with longer ligands such as high molecular weight PEG. 
PEGylation is the most common way of reducing uptake by the Reticular 
Endothelial System (RES), thus enhancing circulation time in vivo. Referring to 
Table 2-3 and the later Table 2-5 it is apparent that PEG or the lower molecular 
weight Oligo Ethylene Glycol (OEG) variety are the most widely adopted anti-
fouling agents, with a limited number of studies adopting alternative agents such as 
BSA. PEG produces a steric barrier which hinders the attachment of phagocytes by 
preventing non-specific protein adsorption. [115,116] It has been widely reported in the 
literature that ‘as synthesized’ AuNPs are readily recognized as foreign in vivo and 
consequently a protein corona is formed, encapsulating the AuNP for removal. PEG 
reduces non-specific protein adsorption of serum proteins thus increasing circulation 
time while rendering AuNPs stable at in vivo salt concentrations. [73,117,118] 
19 
 
PEGylated gold nano shells were one of the first models to successfully harness the 
potential of metallic nanoparticles for use in photothermal ablation therapy. [119] 
AuNPs capped with both PEG and targeting ligands hold great promise. For 
example, AuNPs functionalized with both PEG and tumor necrosis factor alpha 
resulted in a significant reduction in tumor volume and enhanced survival in MC-38 
tumor-burdened C57/BL6 mice. [60–62] A snapshot of various functionalization 
ligands are highlighted in Table 2-3. 
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Table 2-3 Summary of ligands used for AuNP functionalization and their 
intended application 
 
d.nm Ligand 
Application of 
functionalization 
ligand 
End 
nanoparticle 
application 
notes ref 
5 
Cetuximab & 
Gemcitabine 
Cetuximab is 
targeting, 
gemcitabine is 
therapeutic 
DDS for 
pancreatic 
cancer 
in phase 2 of 
clinical trial 
[120] 
2-
100 
Trastuzumab, 
antibodies 
Targeting 
drug delivery, 
SK-BR3 breast 
cancer 
internalized 
into cytoplasm 
by cross 
linking with 
HER-231 
[121] 
110 PEG 
Enhanced 
circulation time 
PC3 human 
prostate cancer 
xenografts 
complete 
resolution of 
tumor in 93% 
of mice 
[122] 
2 
Tetra ethylene 
glycol, TTMA ligand 
and BODIPY 
The dye molecule 
doped into the 
particle monolayer 
provides an 
analogue for 
hydrophobic drugs 
and allows facile 
detection of 
payload release. 
Payload 
release  
[13] 
2 
Trimethylammonium 
and DNA clusters 
(MMPCs) 
Inhibition of DNA 
transcription of T7 
RNA polymerase. 
DNA release 
Release 
caused by 
intracellular 
concentrations 
of glutathione 
[123] 
4 
Polyethyleneimine 
and β-gal DNA 
Delivery of plasmid 
DNA into monkey 
kidney cells (COS-
7) 
Gene therapy 
 
[124] 
10 
PEG, thioctic acid 
and folic acid 
Targeting 
Uptake by 
folate receptor 
positive (FR+) 
cancer cells via 
receptor-
mediated 
endocytosis 
Solubility over 
a broad range 
of pH and 
ionic strength 
values 
[125] 
  
21 
 
  Targeting 
Nanoparticles can enhance the intracellular concentration of drugs in cancer cells 
while avoiding toxicity in normal cells. [126] There has been considerable debate 
about the mode of entry of the AuNPs into cells, with the most likely being non-
specific receptor mediated endocytosis (RME). [127] 
Before AuNPs can internalize into the desired cancerous cell, the AuNPs must 
accumulate at the desired tumor site. This can be achieved via both passive and/or 
active targeting strategies. In vivo AuNPs can accumulate at the tumor sites passively 
due to a phenomenon known as the Enhanced Permeability and Retention factor 
(EPR). This phenomenon is a result of leaky vasculature with wider fenestrations 
than normal vasculature which allows the nanoparticles to pass through (Figure 2-6). 
Previous experimental data which utilized plasma proteins and synthetic polymers 
and various conjugates showed that macromolecules accumulate in solid tumors and 
are retained there for longer periods of times, thus lending the name, enhanced 
permeability and retention. [128] Molecular substances of a lower weight are not 
Figure 2-6 Schematic of the Enhanced Permeability and 
Retention Factor 
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retained, and are therefore returned to circulation at a greater rate. [129] Tumors also 
have a unique blood flow. Studies conducted in 1981 discovered that tumor blood 
flow could be increased through inducing hypertension by infusing angiotensin II; 
whereas blood flow in the normal organs remained constant irrespective of pressure. 
[130] This led to the conclusion that the tumor tissue was unable to auto regulate the 
homeostatic control of the blood flow. Therefore, manipulation of the blood pressure 
may lead to enhanced AuNP accumulation and consequently enhanced drug 
delivery.   
The EPR effect is a result of tumor vasculature which is limited at poorly 
differentiated cancers, it also allows the possibility of detection and uptake by the 
RES. [115] A major challenge for improving anticancer treatments is to direct the 
therapeutic agent specifically to the tumor cells or tumor blood vessels, thus 
enhancing the efficacy of the treatment and decreasing these undesirable side effects. 
Therefore the application of a targeted drug delivery system is significant for 
reducing the undesirable side effects of anticancer drugs in healthy cells/organs.  
Active targeting is the functionalization of the AuNP surface with ligands for 
specific recognition by cell receptor surfaces (Figure 2-7). These can be in the form 
of antibodies, peptides or small molecules which can be used to recognize specific 
receptors on the tumor surface; which can then be followed by receptor mediated 
endocytosis and nanoparticle internalization. [131]   
Figure 2-7 Schematic of active targeting using 
specific receptor sites found on the cells 
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The idea of tumor targeting is one which is currently contentious, recent work has 
shown that targeting ligands do not increase the total accumulation in the tumor but 
instead functions to increase the receptor mediated internalization. [132–135] Therefore 
it is argued through the literature whether targeting has any influence on 
internalization, or if they are two separate entities. Quantitative pharmacokinetic and 
biodistribution data has previously shown that targeting ligands only marginally 
improve the total gold accumulation in xenograft tumor models for AuNRs in 
comparison with non-targeted controls. However targeting could greatly alter the 
intracellular and extracellular nanoparticle distributions. When the AuNRs were 
administered via intravenous injection, it was found that the active molecular 
targeting of the tumor microenvironments (e.g., fibroblasts, macrophages, and 
vasculatures) did not significantly influence the tumor nanoparticle uptake. [131] 
There is also a considerable amount of opposing data showing that the use of tumor 
targeting ligands is effective in delivering imaging and therapeutic agents into solid 
tumors. [136–141] For example, Fluorescent studies have successfully identified that by 
conjugating the nanoparticles with labelled antibodies that there is a higher tumor 
uptake (measured on the basis of per gram of tumor mass) compared to that of the 
unconjugated species. [136] [138] [135] [132] 
It has also been shown that PEGylated liposomes co-functionalized with HER2 
antibodies have previously been used for targeting and cellular internalization. While 
it was found that they were successfully internalized into the tumor cells, the total 
volume was not different from the unconjugated nanoparticles [134]. This concluded 
that while not adversely affecting the internalization, there was no obvious benefit to 
targeting the nanoparticles with HER2. This conclusion has since been 
complemented by the work by the Davis group whom used transferrin to target the 
tumor cells, it was found that it improved the cellular internalization but did not 
increase the total tumor uptake. [132,133]  
Adding yet another variable is the concerns that using a targeting ligand may in fact 
hinder the nanoparticle potential by initiating opsonization at a higher rate. PSMA is 
a Prostate Specific Membrane Antigen that is found in abundance on the membrane 
of prostate cancers. It is also commonly referred to as glutamate carboxypeptidase II 
(GCPII) and is a classic type – II membrane glycol protein and acts as an enzyme 
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biomarker target due to its expression in both primary and metastatic prostate cancer 
cells. [142–146] PSMA can be induced for internalization by bound antibodies or 
inhibitors. The Liu group developed a novel approach by the synthesizing of 
phosphoramidate peptidomimetic inhibitors of PSMA. [142] Biotinylated PSMA 
inhibitor, CTT54 was found to have an exceptionally high affinity and rate of uptake 
and internalization. It worked based on a biotin – streptavidin coupling system, 
where the inhibitor would target and bind to the PSMA, concurrently using the biotin 
to attract cy5-streptavidin for drug delivery or imaging. [142,143] 
Another method of targeting the prostate specific membrane antigen PSMA is by 
using an A10 RNA aptamer that binds to the extracellular domain of the PSMA. This 
methodology was investigated in LNCaP cells injected subcutaneously into the right 
flank of mice [144].  
PSMA is only one of a few receptors for active targeting, both the Nrp-1 receptor 
and the laminin receptor Lam67R have been successfully targeted in PC3 cell lines 
by the Kumar et al. and Payton et al. respectively. [147,148] Although both displayed 
successful targeting, both groups used very different methods to do so. Kumar et al. 
sought to deliver the current anti-cancer drugs cisplatin, oxaliplatin and carboplatin 
by developing a glutathione stabilized AuNP. A lethal dose was administered to the 
cells by co-functionalizing the AuNP with a Nrp-1 targeting RGD peptide 
(CRGDK). [147] Payton et al. instead conjugated AuNPs with epigallocatechin-gallate 
(EGCg) which reduces tumor volume and targets the Lam67R receptors. Platinum 
based anti-cancer drug research holds great promise, high anticancer activity is 
displayed by the upregulation of nuclear factor kappa-B (NF-kB) protein expression 
and activation of NF-kB-DNA binding activity. [147,149] 
Once targeted, the AuNPs must initiate internalization, while functionalizing the 
AuNP surface with PEG increases colloidal stability in vivo, it greatly reduces 
cellular uptake in comparison to citrate capped AuNPs. [73] This problem can be 
overcome by co-functionalizing the AuNP surface with ligands to initiate cellular 
uptake, such as a receptor mediated endocytosis peptide (RME) which operates 
effectively for nanoparticles. [150,151] Macromolecules and particles are internalized 
by phagocytosis, pinocytosis and receptor mediated endocytosis pathways such as 
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caveolae-mediated, clathrin-mediated and caveolae/clathrin independent 
endocytosis. [151,152] All these different pathways operate by using different cellular 
receptors, some of which would be unsuitable for AuNPs, such as phagocytosis. 
Therefore the most common way to obtain cellular internalization is by utilizing the 
receptors on the cell for receptor mediated endocytosis [150,151]. Cells absorb 
molecules (endocytosis) by the inward budding of plasma membrane vesicles 
containing proteins with receptor sites specific to the molecules being absorbed.  
Various research groups such as Lui et al. (2007) utilized an RME peptide sequence 
CKKKKKKSEDEYPYVPN to enhance internalization into the cell. [153,154] It is also 
worthy of note that RME is dependent upon temperature and previous studies 
investigated the uptake of gold nanoparticles at 37 versus 4 °C. These results are in 
agreement with previous RME studies, where ligands did not enter cells at 4 °C but 
were only bound to the cell membrane. [127,155,156] A significant benefit of this 
approach is that it bypasses recognition of P-glycoprotein which is one of the main 
drug resistance mechanisms encountered by the AuNPs as they are enveloped by 
endosomes upon entrance into the cells. [126,157–159] 
H5WYG, sometimes referred to as H5 is an endosomal escape pathway. Once 
internalized the problem emerges that it will be entrapped by endosomes for 
degradation, therefore with reference to Tkachenko et al. (2003) the identification of 
an endosomal escape pathway is crucial for nuclear targeting. [157]   
There are a range of viral and bacterial proteins and synthetic peptides and polymers 
that have been synthesized to achieve endosomal escape, there are also various 
routes which can be taken, such as pH buffering and lipid bilayer fusion. A few of 
the proteins and synthetic peptides are outlined in the Table 2-4 which is  adapted 
from Varkouhi et al. (2010).  
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Table 2-4 Commonly used endosomal escape pathways identified from the 
literature 
Agent 
Mechanism of 
escape Ref 
hemagglutinin (HA2) fusion [160–162] 
dilNF-7 fusion [163–167] 
TAT unclear [168–171] 
L2 from Papillomavirus fusion [172] 
Pneumococcal pneumolysin (PLO) pore [173] 
streptococcal streptolysin O pore [173] 
KALA fusion [174] 
bovine prion protein (bPrPp) pore [175,176] 
SAP peptide fusion [177] 
 
Literature has shown that endosomal escape can be achieved by the incorporation of 
analogues of viral proteins such as H5WYG which is taken from the N-terminal 
segment of the HA-2 subunit of the influenza virus hemagglutinin. [178] It is proposed 
that unprotonated amines would exhibit a proton ‘sponge’ effect, in which the 
unprotonated amines found on the H5WYG would absorb protons as they are 
pumped into a lysosome. This would result in more protons being pumped in and an 
increased influx of Cl- ions and water, ultimately causing osmotic swelling and 
rupture of the lysosomal membrane. [179] 
H5WYG permeabilized the cell membrane at a slightly acidic pH but not at neutral 
pH, therefore as the pH drops towards degradation the peptide undergoes a 
conformational change which correlates with the protonation of the histidyl residues. 
[180] 
The Midoux group showed great cell permeabilization at pH 6.4 that was not present 
at a pH of 7 and consequently increased the expression of genes transferred to cells 
as glycosylated polylysine-DNA complexes. Therefore, it was concluded the several 
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histidines become positively charged when the pH decreases which is induced by 
acidification of endosomes.  
 Optimizing Attachment 
It is generally assumed that the higher binding energy of the covalent Au-S bond 
surface relative to the loosely bound citrate results in functionalization via ligand 
exchange. [21,181–185] However, in a detailed study using FTIR and XPS, Park and 
Schumaker-Parry found that a proportion of the citrate oxidizes into acetoacetate on 
the AuNP surface, and that it is largely this acetoacetate that is replaced by the thiol 
bound ligands. They also reported that much of the citrate capping remains after 
ligand attachment, with the citrate and thiol bound ligands forming a regular 
structure on the AuNP surface. This co-absorption, results in a lower ligand packing 
density on citrate capped AuNPs compared to that which has previously been 
observed with self-assembled monolayers of PEG on planar gold.  
Whilst citrate capped AuNPs form stable colloidal suspensions, they aggregate under 
physiological salt concentrations and a protein corona is quickly formed in the body 
which leads to their removal. Aggregation is usually prevented by the repulsive force 
between particles due to electrostatic repulsion, steric exclusion or the synthesis of a 
hydration layer on the nanoparticle surface. [117,186–188] Thiol and disulfide containing 
ligands bind irreversibly to gold substrates, therefore the thiol containing amino acid 
groups cysteine and cystine (the oxidized dimer of cysteine) readily form self-
assembled monolayers at these surfaces. [189–191] The adsorption of thiol bound 
ligands onto planar flat gold (111) surfaces has demonstrated that sulfur adsorption 
is influenced by the rate of oxidation of the gold and that many lattice structures are 
feasible and can be manipulated via the control of external factors such as pH. L-
cysteine forms (√ 3x √ 3)R30° adlayers consistent with hexagonal packing, under 
neutral (H2O) and slightly acidic (0.1 M KClO4 +1 mM HClO4) conditions. 
[189,192–
195] The relationship of pH on binding proteins and peptides to gold is not very well 
understood, it has been previously reported that functionalization can be achieved 
by, ‘non-specific’ adsorption through altering the pH close to that of the pI of the 
protein or the nanoparticle so that the electrostatic repulsion is reduced. [196]  It has 
also been suggested that AuNP – ligand surface binding can be initiated by 
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introducing an opposite charge on the desired ligand which is to be attached by van 
der Waals forces, hydrogen bridges, gold–thiol bonds (from cysteine residues) or  by 
hydrophobic interaction. [186] ‘As synthesized’ citrate capped AuNPs have a zeta 
potential of approximately -30mV.  Goldman et al. (2002) synthesized electrostatic 
interactions between negatively charged dihydro- lipoic acid (DHLA)-capped CdSe-
ZnS core-shell QDs and a positively charged leucine zipper affixed onto the C-
terminus of engineered recombinant proteins. It was reported that proteins absorbed 
onto the nanoparticles by electrostatic attraction if both partners are oppositely 
charged. [197–200]  Adjustment of the pH to below the pI value (isoelectric point 10 - 
10.5) has previously been used to bind avidin to AuNPs.  [197,201] 
As zwitterionic molecules, peptides can display both negative and positive charges 
on different functional groups simultaneously depending on pH. However, the ratio 
of functional groups bearing a charge changes with pH, resulting in peptides being 
predominantly positively charged at pH values below the peptides isoelectric point 
and negatively charged above. At the isoelectric point the overall net charge is zero. 
This offers the possibility to attract peptides electrostatically to negatively charged 
nanoparticles. [186] 
 Mixed Monolayer and PEG Linker Approaches to Co-
Functionalization  
Functional groups are typically designed to overcome specific barriers that limit 
therapeutic efficacy. These include ligands to promote the endocytotic and targeting 
potential of the nanoparticle whilst reducing undesirable nanoparticle agglomeration. 
This typically requires the development of multi-functional particles. Peptides are 
only an example of ligands which can be used to target tumors, increase cellular 
uptake, and target the nucleus. [24,136,147,153,157,158,202] Nuclear targeting is challenging 
due to four principles that must be satisfied for success. The nuclear probe has to 
enter the cell, escape endosomal/lysosomal pathways, and possess a nuclear 
localization signal (NLS) for nuclear interaction, while remaining small enough to 
cross the nuclear membrane. [157] 
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Three common methods are used for co-functionalization. The first uses a thiol 
terminated mono-functional PEG is used to partially cap the AuNP surface; the 
surface is then co-functionalized with additional ligands to form a mixed monolayer 
(Figure 2-8a). [158,184] The second method uses a hetero-bifunctional linker, typically 
in the form of BSA or PEG. One end is usually thiol terminated, which again binds 
to the AuNP surface while a second active functional group on the opposite end of 
the linker offers the potential to bind with a peptide or other functional ligand 
(Figure 2-8b). The linker approach can potentially offer complete surface saturation 
and offers the promise of improved biological availability as the peptide is on the 
end of the PEG as opposed to being on the AuNP surface. The third method of 
surface functionalization is a combination of both the mixed monolayer and linker 
approaches. First the nanoparticle surface is functionalized with both mono-
functional and bifunctional PEG forming a mixed monolayer/linker complex, then a 
second ligand is used to co-functionalize the surface by fastening onto the end of the 
PEG linker. [203,204] Studies involving thiol bound PEG on planar gold, have 
confirmed that when saturated with PEG that the ligands adopt a monolayer 
arrangement of the surface [205,206] It has also been reported that 5000Mw thiolate 
PEG forms a monolayer on the surface of ~19 nm AuNPs with the ligands adopting 
an extended random coil confirmation. [12] 
All three approaches have been widely employed in the synthesis of co-
functionalized AuNPs for applications in cancer therapeutics. [182] While the use of 
PEG renders the AuNP stable under in vitro conditions it greatly reduces biological 
activity and cellular uptake. It can be seen from Table 2-5 that all three methods for 
co-functionalization have been successfully employed to enhance cellular uptake. 
Nanoparticles based on both the mixed monolayer and linker methodologies have 
also been used for sensing and monitoring biological events and Photodynamic 
Therapy (PDT). [58,204,207–209] Inconsistencies in the literature include the effect on 
colloidal stability, the resulting opsonization and the effect each methodology has on 
cellular internalization. Currently there is little consensus regarding which approach 
should be applied in a situation. However, from analyzing the literature which is 
summarized in Table 2-5, it is apparent that the greatest in vivo significance has been 
achieved by using the mixed monolayer arrangement, such as that reported by 
Paciotti et al. (42,44,53,54)  
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Figure 2-8 schematic illustrating a) mixed monolayer and 
b) bifunctional linker 
 
  
b a. 
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 Table 2-5  Mixed monolayer versus hetero bifunctional linker (*NI – not included) 
d. 
nm 
PEG 
MW 
Arrange-
ment 
Attached ligands 
Internalization\ 
colloidal stability 
Notes Ref 
 
10 
900, 
1500, 
and 
5000 
Mixed 
Monolayer 
PEG, an adenoviral 
NLS, an adenoviral 
RME, 
Entered HeLa cells in 6h, 
Found in cytoplasm or 
nucleus 
5000 MW PEG was 
internalized as efficiently as 
900 Mw 
[153] 
 
17 
 
5000 
Mixed 
Monolayer 
PEG, Bodipy Dye Controlled release of dye 
Inhibiting the initial burst 
release of payloads as well 
as preventing particle 
aggregation 
[182] 
 
14 
 
NI 
Mixed 
Monolayer 
PEG & TAT 
peptide 
Freely roam the cell 
including crossing the 
nuclear membrane in HeLa 
lines 
 [210] 
 
NI 
 
NI 
Mixed 
Monolayer 
Nanostars, TAT 
Peptide and Thiol 
PEG 
Bound to the membrane or 
were found outside the 
vesicles in the cytoplasm 
TAT Peptide enhanced 
BT549 breast cancer cell 
uptake 
[211] 
26 NI 
Mixed 
Monolayer 
PEG-Thiol & 
Tumor Necrosis 
Factor 
7-10-fold increase was 
seen in the amount of TNF 
that is delivered to the 
tumor 
In a small animal study, 15 
µg-native TNF resulted in a 
60% survival compared to 
the 100% survival after 
treatment with15 µg–PT–
Au-TNF 
[59–
63] 
 
 
80- 
290 
Å 
N/A Linker 
BSA Linker, SV40 
large T NLS 
peptide 
nucleus of HepG2 cells  
[158,2
12–
215] 
 
25 
 
N/A 
Linker 
BSA, SV40 large T 
NLS, adenoviral 
NLS, adenoviral 
RME adenoviral 
fiber protein 
Found in 
cytoplasm/trapped in 
endosomes and/or nucleus 
 [157] 
 
20-
30 
 
N/A 
Linker 
Acetal-PEG-PLA 
co-polymers 
PEG linker allowed  
colloidal stability in what 
was considered ‘harsh 
environment’ [216] 
Protein adsorption reduced 
with increasing the number 
of micelle coating 
[217] 
 
10-
15 
 
1500 
Linker 
Coumarin-PEG-
thiol 
Large dose found in 
endosomes OF MDS-MB-
231 cells in culture 
Flexible enough in the 
attached fluorescent ligand 
without compromising 
cellular uptake. 
[218] 
 
30 
 
2080 
Linker PEG, Oxaliplatin 
Unusual ability to 
penetrate the nucleus in the 
A549 lung cancer cells 
Extensively cytotoxic [149] 
 
 
13 
 
NI 
Mixed 
Monolayer 
&linker 
Complex 
OEG and cyanine 5 
alkyl thiol 
terminated spacer 
>99% uptake in cytoplasm 
Cyanine 5 used for 
fluorescent tracking with 
confocal microscopy 
[219] 
 
4 
 
3000 
Mixed 
Monolayer 
&Linker 
Complex 
HER2, PEG and 
C11PC 
photosensitizer 
Readily seen in cell 
interior in SK-BR-3 and 
MDS-MB-231 cells 
 
 
[203] 
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In the early 1990’s the work of Feldherr et al. and Tkachenko et al. marks an early 
discrepancy in the literature regarding surface arrangement. Feldherr et al. 
investigated a “Trojan horse” using a BSA linker and an NLS sequence derived from 
the SV40 large T antigen. [157,158,212–215,220] The “Trojan horse” efficiently facilitated 
nuclear delivery to translocate into the nucleus of both HepG2 and HSC oral cancer 
cells respectively. This was challenged by Tkachenko et al. in 2003 who found a 
number of limitations when applying this BSA model in practice including colloidal 
stability inconsistencies and conjugates being found in the cytoplasm.  [157,220] Thus 
authors such as Oyelere et al. adopted the use of a thioalkyl-triazole linker to 
efficiently facilitate nuclear delivery of AuNPs to HSC oral cancer cells and 
noncancerous human HaCaT cells. [220,221] 
Consequently, however the frequent colloidal instability of peptide-BSA-AuNP 
conjugates prompted the exploration of PEG based alternative formulation strategies 
for cell-targeting nanoparticles. As a result, from 2007 onwards it was felt that a new 
approach for Feldherr’s model may be more beneficial, resulting in the synthesis of a 
mixed monolayer using 10nm citrate coated AuNPs modified with mono functional 
PEG, an adenoviral NLS Sequence (CGGFSTSLRARKA) and/or an adenoviral 
RME sequence (CKKKKKKSEDEYPYVPN). [153] The mixed monolayer approach 
overcame the stability issues identified by Tkachenko et al., thus igniting the 
hypothesis that a linker may compromise nanoparticle colloidal stability. However, it 
is difficult to make direct comparisons due to differences in cell lines, peptides used 
and/or the synthesis technique. [157,221] 
Another apparent inconsistency in the published literature is the role of peptide 
length in relation to biological availability. Initially it was believed that when 
functionalizing a nanoparticle with several biologically active ligands such as 
peptides that these should all be of a similar length. [157] It has been suggested that if 
the stabilizing agent, such as PEG, exceeds that of the peptide then it may sterically 
hinder the peptide’s function. [153] However, in contrast to that, it is possible that if 
the PEG length is shorter than that of the peptide, that the AuNP could instead have 
an ‘anti-PEG’ effect. This is a key issue identified through this Thesis, as it has been 
reported that the PEG length has to exceed that of the peptide to shield the 
nanoparticle from opsonization for maximum circulation. [217,222] Therefore it is 
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plausible that attaching the peptide onto the end of the PEG chain would result in an 
anti-shielding (‘anti-PEG’) effect, making the AuNP susceptible to non-specific 
protein attachment and potential removal by the immune system. [131,153,222] 
This ignites the hypothesis that it may be crucial to have the length of the stabilizing 
agent exceeding that of the functional peptide, thus shielding the nanoparticle from 
opsonization and maximizing circulation time in vivo and preventing an ‘anti-PEG’ 
effect. [131]  
It is apparent that a simple consideration of ligand length does not fully predict the 
biological availability of functions allocated to the AuNP surface. Indeed some of 
the biological results have been obtained using AuNP functionalized with PEG and 
short biological groups in a mixed monolayer arrangement. In a recent uptake study 
by Liu et al. using HeLa cells, PEG5000/RME nanoparticle conjugates were shown 
to have a four-fold higher endocytotic potential over PEG900/RME conjugates. This 
finding supports the mixed monolayer configuration, indicating that steric hindrance 
conferred by PEG chain length is not a critical factor-affecting uptake. [153] In 
support of these findings are various studies which have observed excellent 
biological performance for mixed monolayer functionalized AuNPs. [56,61,63,223]  
In 2011 and 2012 using a TAT peptide both Krpetic et al. and Yuan et al. 
respectively formulated a mixed monolayer comprising of PEG and functional 
peptides (CALNN-based peptides, TAT, Pntn, and NLS which were all oligopeptide 
sequences derived from elongations of the standard stabilizing pentapeptide 
CALNN). The authors reported that particles were found roaming freely in the 
cytosol and able to negotiate intracellular membrane barriers freely. [210] Using 
nanostars in BT549 breast cancer cells Yuan et al. concluded that attaching a TAT 
peptide in a mixed monolayer arrangement enhanced uptake. [211] Furthermore, 
Kumar et al. utilized the mixed monolayer configuration to allow the controlled 
release of dye over a period of 2 h, inhibiting the initial burst release of payloads as 
well as preventing particle aggregation by using a PEG array. [182]   
A more clinically significant development was made in 2006 with the development 
of CYT-6091. In this preparation, TNF was assembled onto a 26 nm AuNP with 
PEG-Thiol forming a mixed monolayer. A 7-10-fold increase was seen in the 
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amount of TNF that was delivered to the tumor in comparison to native TNF. It was 
also found that a 7.5 µg/ml injection of CYT-6091 was as effective as 15 µg/ml 
native TNF, and that the 15-µg native TNF dose resulted in a 60% survival 
compared to the 100% survival after treatment with 15 µg PEGylated Au-TNF. This 
data led to the development of CYT-6091 by CytImmune with subsequent 
progression into clinical trial. [59–63]  
Despite the reported success of the mixed monolayer approach, there are potentially 
significant benefits of attaching ligands using a bifunctional PEG linker. The ability 
to develop a method of attaching active groups to the end of the PEG rather than 
directly to the AuNP surface may allow for enhanced colloidal stability and 
bioavailability. [217] Otsuka et al. utilized a hetero bifunctional PEG obtaining acetal-
PEG-PLA on aminated polypropylene surfaces. The aldehyde group was then further 
reacted with ligand molecules and saccharide ligands for the development of a non-
viral delivery system. It was found that the PEG linker allowed colloidal stability in 
what was considered a ‘harsh environment’. [216] Furthermore, it was concluded that 
protein adsorption was reduced with increasing density of the PEG coating. [217]  
A benefit of using a bifunctional linker would be to allow the AuNP surface to be 
completely saturated with PEG and the remaining active end groups could then to be 
used to anchor a biologically active group. This would have a two-fold benefit as 
firstly, it would allow direct contact with the receptors on the tumor cell, and 
secondly it would allow more of the required therapeutic, targeting or other payloads 
to be attached in comparison to a mixed monolayer arrangement.  
Even when fully saturated with PEG the nature of the packing may allow further 
interaction with the gold surface. Shi et al. investigated gold nanoparticles 
functionalized with 11-mercaptoundecanoic acid (Au-MUDA) and found that even 
in excess surfactants, a closely packed 100% coverage could not be achieved. 
Polystyrene was added to AuNPs that were completely saturated with MUDA, if the 
AuNP surface was successfully saturated, then binding the polystyrene would not 
have been possible, however it was found that even in excess of bifunctional ligands, 
polystyrene particles were successfully conjugated to the surface. [202]  
Understanding the packing of PEG on the AuNP surface is critical to any subsequent 
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co-functionalization. It has been reported that 5000 MW PEG adopts a somewhat 
extended random coil when fully saturating the surface of a ~17nm AuNP. [184] This 
packing density was originally thought to be higher than that reported for PEG 
coated planar gold due to the highly curved AuNP surface resulting in less 
confinement at the free end of the PEG. However more recent publications have 
since argued that citrate is not displaced by the thiol groups, and as such the co-
absorption of these molecules on the AuNP surface could consequently result in as 
lower packing density in comparison to planar gold, which would too explain how 
even after an excess of bifunctional ligands was added to the Au surface by Shi et al. 
that polystyrene could still be added to the surface. [188,224] 
Kumar et al. and Sanz et al. both achieved surface saturation in 2011 and 2012 
respectively. Using a mono-functional PEG and the combination of UV/Vis analysis 
and TGA, Kumar et al. was able to show the point at which the AuNP surface was 
saturated by analysis of the PEG concentration in the supernatant determining an 
approximation of 1,140 thiol terminated PEG molecules per 17nm AuNP. [184] Sanz 
et al. developed a 14.47 nm AuNP two-step mixed monolayer and PEG linker 
complex, a schematic of which is illustrated in Figure 2-9. Initially the AuNP was 
functionalized with mono functional PEG and then an EDC coupling reaction was 
used to couple the carboxyl groups forming a bifunctional PEG which was 
subsequently used to bind to the primary amines of the TAT peptide. Both the 
Figure 2-9 Schematic of Bio conjugation of the surface-modified 
gold nanoparticles with different thiol-PEG layer compositions 
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bifunctional complex and a mono functional PEG were then anchored to the AuNP 
surface formulating a mixed monolayer of bifunctional ligands. [225] It was concluded 
that approximately 5000 thiolate chains would cause complete saturation, and the 
degree of coverage was controllable. Furthermore, the groups reported that the 
degree of binding was stronger for the linker and that the spacer played an important 
role in the loading yield of thiolate oligonucleotide.  [225]  
It is apparent from the literature that any advantages from the use of a bifunctional 
linker are not fully understood. It is possible that any benefits lie solely in enhanced 
colloidal stability [216,217,226]; however there has been a wide array of cellular studies 
showing successful internalization utilizing the linker surface arrangement but very 
few preparations have been evaluated in vivo.  
Feldherr et al. synthesized a polyvalent RNA-nanoparticle conjugate (RNA-Au NPs) 
using RNase-free inorganic gold nanoparticles with a PEG linker and alkylthiol; 
analytical flow cytometry confirmed uptake of the RNA-Au NPs in >99% of the cell 
population. [203,219] Another positive outcome involved the synthesis of a combined 
chemo-AuNP conjugate. Oxaliplatin was grafted onto AuNPs via a PEG linker for 
the treatment of A549 lung adenocarcinoma cells. Nanoparticle uptake as determined 
by TEM indicated intracellular accumulation of the chemo-AuNP conjugate, while 
simultaneously exhibiting a high cytotoxic profile. While this may benefit the final 
goal of promoting tumor cell death without external stimulation, the passive 
targeting of the molecule to the cancer site poses a major limitation likely resulting 
in high level systemic toxicity. This therefore highlights the necessity of active 
targeting and indicates that the use of a linker may be particularly appropriate for 
targeting as the loading yield may be increased relative to a mixed monolayer 
arrangement allowing for more specific targeting and the conjugation of a 
therapeutic ligand. [149] These studies proved that the linker was stable without 
compromising cellular uptake.  [203,218,219] 
 Conclusions 
AuNPs have widely been shown to have excellent advances both in vitro and in vivo. 
A vast amount of work has been conducted using gold nanoparticles co-
37 
 
functionalized in either a mixed monolayer or bifunctional arrangement, and while 
some excellent results have been reported for multifunctional AuNPs produced using 
PEG linkers, the arrangement of the groups onto the surface is not well understood. 
There is also a niche which remains to be exploited regarding which surface 
arrangement may result in improved in vitro and in vivo colloidal stability, or if 
literature is correct in predicting an ‘anti-PEG’ effect if the attached ligand exceeds 
the length of the stabilizing ligand. The niche also requires an in-depth 
characterization profile of each surface arrangement and investigations into the 
biological response regarding non-specific protein adsorption, cellular toxicity and 
cellular uptake. In addition, the studies which have adopted the approaches 
mentioned previously do not present evidence to support the arrangement of ligands 
on the surface. Indeed, given the problems discussed in achieving a tightly packed 
PEG layer on the AuNPs it may be that when using PEG linkers that some or all of 
the subsequently added ligands attach directly onto the AuNP surface instead of onto 
the end of the PEG linker. This however remains to be confirmed. Several methods 
have been identified in the literature which should help in concluding the AuNP 
surface arrangement, such as FTIR, UV/Vis and DLS analysis. 
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3. MATERIALS AND METHODS 
 Introduction 
This chapter details both the materials and methods employed to synthesize the 
various AuNP systems. It describes the techniques and methodologies used for the 
synthesis of gold nanoparticles and the functionalization with PEG and other ligands.  
The chapter will finish with a description of the protocols and techniques used to 
investigate the colloidal stability and opsonization of each of the conjugates and the 
characterization methods employed throughout this Thesis.  
 Experimental Overview 
The aim of this research is to determine whether the method of co-functionalization 
would directly affect the colloidal stability, and biological response of a gold 
nanoparticle conjugate for prostate cancer therapeutics. To synthesize a stable 
colloidal complex, extensive characterization and in vitro analysis must be carried 
out and understood. Thus, the research can be sub divided into various sections, 
namely, the synthesis and characterization of the AuNPs, the modification with PEG 
followed by co-functionalization with peptides. The synthesis of a mixed monolayer 
or linker system. Investigations into the arrangement of peptides on the AuNP 
surface. This will also detail the methods applied to optimize the attachment of the 
peptides via investigating the role of pH. 
 Materials 
Materials used for the synthesis and characterization of gold include Gold (III) 
chloride hydrate, Sodium Citrate Na3C6H5O7 molecular weight 294.1g/mol and 
potassium bromide (KBr) were all purchased from Sigma Aldrich UK. PEGylation 
was carried out by using either Methoxyl PEG Thiol mPEG-SH MW 5000 or Thiol 
PEG Succinimidyl Glutaramide SH-PEG-SGA MW3500 which were both purchased 
form Jenkem; and co-functionalization was achieved by using a combination of 
CKKKKKKSEDEYPYVPN Receptor Mediated Endocytosis peptide (RME), 
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GCGLFHAIAHFIHGGWHGLIHGWYG & GLFHAIAHFIHGGWHGLIHGWYG  
Endosomal escape pathway peptide (H5WYG) or the targeted Nrp-1 receptor peptide 
both with and without FITC fluorescent labeling (CRGDK and FITC-Ahx-CRGDK) 
purchased from BIOMATIK (UK). All peptides investigated were synthesized with a 
minimum of 99 % purity measured by HPLC, apart from the H5WYG peptide which 
did not contain a thiol containing cysteine residue. TBE running buffer, MTT (3-[4, 
5-dimethylthiazol-2-yl]-2, 5- diphenyl tetrazolium bromide; thiazolyl blue), DMEM 
media sodium dodecyl sulfate (SDS) (ThermoFisher) and Dimethylformamide 
(DMF)  and Dimethyl sulfoxide (DMSO) were purchased from Sigma Aldrich. 
The Glassware involved two 500 ml neck parallel round bottom flask, one 1000 ml 
neck parallel round bottom flask, water condenser magnetic flea and round bottom 
and flat bottom heaters. 50 ml polyethylene plastic containers were used for storage 
as well as 50 ml plastic centrifuge vials and 500/1000 ml glass jars. Biological 
samples were kept refrigerated while all other samples were stored at room 
temperature. Prior to use, all glassware was rinsed with aqua regia (1:3 nitric acid : 
hydrochloric acid) and then rinsed with distilled water and dried at 100 °C in a 
vacuum oven. 
The instrumentation involved included Perkin Elmer Lambda 35, 1.4 ml glass 
spectrometer cuvettes, Varian 640-IR FTIR Spectrometer, Malvern ZetaSizer Nano 
ZS Series. Disposable 2 ml cuvettes type DTS0012. 
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 Methods 
3.4.1 Synthesis of Gold Nanoparticles by the Turkevich Method 
Gold nanoparticles were synthesized by an adaptation of the Turkevich/Frens 
method. [30,100] 0.01 wt% solution of chloroauric acid (HAuCl4) was prepared by 
diluting 0.01 wt% of Gold (III) Chloride Hydrate in 1L of distilled water. The 
working solution was brought to the boil under reflux whilst undergoing vigorous 
stirring via a magnetic flea.  22.5 ml of 1 wt% sodium citrate solution was added. 
The solution changed from transparent to blue, indicating the formation of the nuclei, 
then blue to wine red, indicating the formation of the nanoparticle itself. The solution 
was left to boil under reflux for a period of 2 hours and the applied heat was 
switched off and left to stir vigorously for a minimum period of 8 hours.  [12,91,108] All 
the samples were kept refrigerated after synthesis and all glassware was cleaned with 
aqua regia before each use.  
3.4.2 Functionalization of PEG Modified Gold Nanoparticles 
The AuNPs synthesized by the Turkevich method were functionalized with either 
mono functional or hetero bifunctional Polyethylene Glycol for enhanced colloidal 
stability and circulation time in vivo. A pre-calculated weight of PEG was measured 
and dissolved in 1 ml of distilled water and added to the required mount of gold 
stirring by a magnetic flea under ambient conditions. [184] Both PEGs were 
terminated with a thiol group for ease of surface functionalization. The loosely 
bound citrate capping the AuNPs because of the synthesis method could therefore be 
easily displaced by the stronger thiolate ligands. Both structures can be seen in 
Figure 3-1. 
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A previous publication from this research group synthesized AuNPs with increasing 
weights of SH-PEG (5000Mw) and combined UV/Vis analysis with 
Thermogravimetric analysis of the supernatant of the AuNP conjugate to produce 
Figure 3-2. The relationship between the concentration of PEG used during 
synthesis, the amount bound to AuNPs surface after washing and that remaining in 
the supernatant is illustrated in At low concentrations, all the PEG added adheres to 
the AuNPs, with increasing amounts remaining in the supernatant at higher addition 
rates as the AuNP surface becomes saturated. It was observed that saturation of the 
AuNP surface with tethered PEG occurs at a PEG loading level of ∼14 wt.% and 
that saturation occurs for PEG 5000Mw at approximately 25 μg/ml. Therefore to 
saturate the AuNP surface with 5000Mw PEG, a minimum of 25 μg/ml should be 
added, whereas to partially cap the AuNP surface, an estimate of 10.7 μg/ml of 5000 
Mw PEG should be added. Partially capping the AuNP surface allows room for 
further functionalizing the surface with other peptides, drugs or other ligands. This 
relationship can therefore be used to estimate the μg/ml required to achieve partial 
capping to varying degrees.  
Figure 3-1 Chemical structure for a) mono functional 
PEG and b) hetero bifunctional PEG 
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Figure 3-2 PEG concentration remaining in supernatant after first 
centrifugation and bound to the AuNP surface measured by UV–Vis (black) and 
TGA (blue) taken from Manson et al. [184] 
An interpretation of this relationship using the molecular weights can therefore be 
implemented to identify the required weight of bifunctional PEG of a different 
molecular weight to achieve the same level of surface saturation. 
 
Equation 3-1  
degree of saturation = 
 desired saturation based of Figure 3 − 2(µg/ml)  ∗ (
 desired Mw
5000 Mw
)  
 
100
% 
50% 
0% 
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Therefore, implementing Equation 3-1 above, for the bifunctional PEG SH-PEG-
SGA (3500Mw), the point of complete saturation should theoretically be calculated 
by: 25 μg/ml *((3500 Mw)/ (5000 Mw)) = 17.5 μg/ml of PEG 3500Mw. An example 
of the calculations drawn from this equation can been seen in Table 3-1. 
Table 3-1 Calculated concentrations required for desired surface saturation of 
each ligand based upon the study of PEG 5000MW using TGA and UV/Vis 
analysis of the supernatant [184] 
 
 
3.4.3 Washing and Calculating the Concentration of Gold Nanoparticles 
Both the ‘as synthesized’ and functionalized AuNPs were collected and aliquoted 
evenly into 50 ml centrifuge tubes and centrifuged for 90 min at 13,500 RCF. 90 % 
of the supernatant was then decanted and discarded leaving the remaining 10 % of 
the AuNP as a pellet in the bottom of the centrifuge tube. The gold was then made 
back up to the starting volume and re-dispersed. The sample concentration was 
measured by Atomic Absorption Spectroscopy detailed in section 3.5.7 and sterilized 
by a mild heat treatment at  ̴  65 - 75°C for 24 hours, as recommended by the World 
Health Organization (2015).[227] Sterility checks were performed using agar plates 
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and broth, visually inspected for contamination and compared to a positive and 
negative control.  
3.4.4 Co-functionalized Gold Nanoparticles 
Co-functionalization was achieved by returning the re-dispersed AuNP-PEG samples 
to a 500 ml round bottom flask. While continually stirring, 4.45 μg/ ml (calculated 
from Equation 3-1) of free RME peptide (dissolved in 1 ml of distilled water) was 
added. The samples were left for 8 h at room temperature to allow for complete 
reaction. The process of centrifugal washing was then repeated to remove any 
unattached reactants. The Receptor Mediated Endocytosis peptide and the targeting 
peptides were both cysteine terminated leaving a free thiol group at the N-Terminus 
for attaching to the AuNPs, while the H5WYG endosomal escape peptide had a  
Glycine group which contains an amine (NH2) which also facilitates nanoparticle 
functionalization by displacing the citrate ions on the surface. Both amino groups are 
illustrated in Figure 3-3 and the peptides used throughout this Thesis are detailed in 
Table 3-2. 
 
 
 
 
 
 
 
 
 
 
Figure 3-3 Chemical Structures for Cysteine and 
Glycine 
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Table 3-2 List of Ligands for AuNP co-functionalization 
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3.4.5 Colloidal Stability of Co-functionalized Gold Nanoparticles 
The colloidal stability (ability of the AuNP to resist aggregation under physiological 
conditions) of the citrate capped AuNP, PEG capped and the peptide co-
functionalized AuNPs were examined using UV/Vis in chapters 4 & 6. A PBS tablet 
was crushed and vortexed with the AuNP to induce physiological NaCl molarity and 
monitored for a period of 24 h, the concentrations were then increased to 1M NaCl at 
intervals of 0.1M NaCl and the SPR patterns were monitored by UV/Vis for any 
indication of instability (agglomeration). [30] 
The PBS tablet was used to prepare a salt concentration of 0.137 M in 100 ml, each 
tablet was crushed and weighed prior to use. The required weight of PBS tablet 
required to obtain a AuNP solution of 0.137 M was calculated as follows: 
Equation 3-2  
weight of PBS tablet (g) ×  
Volume of AuNP solution (ml)
Required total volume for the PBS tablet (ml)
 
The molarity can be increased by adding the required amount of NaCl. The 
following equation was used to calculate the amount required. 
Equation 3-3  
No. of moles × 
Volume of AuNP (ml)
Required volume of solution for the moles (ml)
 
 
This equation is similar to Equation 3-2, however the number of moles of NaCl 
(58.54) is used instead of weight (g), and the required volume is 1 liter (1000 ml) as 
NaCl is 58.54 moles in 1 liter. The resulting value is then simply multiplied by the 
desired molarity, e.g. 0.05 M, 0.1 M, and 0.2 M as required.  
3.4.6 Rate of Opsonization of Gold Nanoparticles 
The ability of each conjugate to resist non-specific protein attachment was 
investigated by aliquoting each sample into a 1.5 ml Eppendorf and micro 
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centrifuging at 10,000 RCF for 30 minutes. The supernatant was decanted and the 
sample was re-dispersed in DMEM FCS (10%) then incubated for a period of 2 h at 
37 °C 5% CO2 and characterized using gel electrophoresis and/or DLS. 
3.4.7 Optimizing Binding based on pH 
AuNPs were functionalized with either mono functional or hetero bifunctional PEG 
and centrifuged as outlined above. The pellet was then re-dispersed in a pH buffer 
solution and the samples were characterized with DLS and UV/Vis. A pre-calculated 
weight of the required peptide was then dissolved in 1 ml of the respective pH buffer 
and added to the PEG capped AuNPs under ambient conditions undergoing vigorous 
stirring. The reaction was monitored for a period of 24h with UV/Vis reading being 
recorded at the following time intervals: 30 minutes, 1 hour, 2 hour, 3 hours, 4 hours, 
5 hours, 6 hours, 7 hours & 24 hours. UV/Vis analysis was conducted in the range of 
400nm-600nm with intervals of 0.8nm step with a 360-scanning speed. DLS was 
used to measure both size and zeta potential, prior to and after peptide addition.  
3.4.8 Cell Culture  
Human epithelial breast cancer cell line MDA-MB-231 was cultured in Dulbecco’s 
modified eagle’s medium (DMEM) supplemented with 10% fetal bovine serum. 
Human epithelial normal breast cell’s MCF-10A were cultured in DMEM/F 12 
supplemented with 5 % horse serum, 1 % penicillin-streptomycin, 20 ng/ml 
epidermal growth factor, 0.5 mg/ml hydrocortisone, 100 ng/ml cholera toxin and 10 
µg/ml insulin. All cells were purchased from the American Type Culture Collection. 
Cells were maintained in monolayers in a tissue culture incubator at 37°C with 5 % 
CO2 and sub-cultured every 3-4 days to maintain exponential growth. These 
conditions were used throughout the thesis unless otherwise stated.  
3.4.9  MTT Assay/Cell Viability 
MTT is a cell viability assay known as MTT (3-[4, 5-dimethylthiazol-2-yl]-2, 5- 
diphenyl tetrazolium bromide; thiazolyl blue), it is a water soluble tetrazolium salt 
which yields a yellow solution when lacking phenol red indicator and when prepared 
using media or salt solutions. Active mitochondrial dehydrogenase enzymes of living 
cells convert the dissolved MTT into an insoluble purple formazan by cleavage of 
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the tetrazolium ring. Dead cells will not have this effect. The purple formazan can 
then be solubilized by the use of a solvent; the dissolved material can then be 
measured spectrophotometrically in the result of absorbance in relation to 
concentration by measuring the converted dye hereby reflecting the viability of cells. 
The amount of formazan produced is directly proportional to the number of viable 
cells.  
The MTT assay was carried out over a range of concentrations. Each sample was 
centrifuged and the supernatant decanted until concentrations of 1800 µg/ml, 900 
µg/ml and 225 µg/ml were attained. 200 µl containing 1.3 x 104 cells were seeded 
into each well of a 96 well polystyrene coated plate and incubated for 24 hours at 
37°C 5% CO2 to adhere. Each AuNP sample was then aliquoted into the wells 
containing 200 µL of DMEM media, thereby having a 1 in 9 dilution factor, 
resulting in the overall concentrations of 25 µg/ml, 100 µg/ml and 200 µg/ml 
respectively. The study was conducted over 7 days with 3 time points for a range of 
cell lines (chapter 4 & 6) and H2O2 was used as a positive control.  
MTT (5 mg/ml in phenol free DMEM) was added to the wells in amounts equivalent 
to 10 % of the cell culture medium. The plates were then incubated for 3 hours at 
37°C, 5 % CO2, after which the liquid was aspirated and the intracellular  formazan 
product was solubilized with acidified (0.1 N HCL) 20 % SDS sodium dodecyl 
sulfate DMF in double distilled deionized water and incubated for a period of 30 
min. 
3.4.10 Uptake into Target Cells 
All the AuNP uptake studies were conducted in concurrence with our collaborators 
in Queens University Belfast. Queens University were responsible for the 
experimental procedure while the author was responsible for the data analysis and 
interpretation. 4.5 x104 cells were plated out and left to adhere for 24 h then exposed 
to 25 µg/ml gold nanoparticles for 24 h. The nanoparticles were then aspirated off, 
the cells washed twice with phosphate-buffered saline (PBS), trypsinized and 
reconstituted in 0.5 ml 18Ω deionized water to a total of 1 ml and counted using a 
Beckman Coulter counter. 1 ml aqua regia was added to the remaining cells (3:1 
hydrochloric: nitric acid), left for 2 hours to digest before the addition of 3 ml of 
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18Ω deionized water.  Samples were analyzed via atomic absorption spectroscopy 
(AAS). 
3.4.11 Clonogenic Survival Assay 
The clonogenic assay (colony formation assay) is the gold standard assay for 
radiation studies in vitro. The clonogenic survival assays were also performed by our 
collaborators in Queens University, Belfast however analysed by the author. A total 
of 2 x 105 cells were plated in 6 well plates (Nunc, UK) and incubated overnight 
before being pre-incubated in the presence of AuNPs for 24 h in complete medium at 
37°C in 5 % CO2 / 95 % air. Excess AuNPs were removed, cells washed with PBS 
and incubated in complete media prior to irradiation. Cells were exposed to 0-6 gray 
(Gy) X-rays, which is a derived unit of ionizing radiation dose in the International 
System of Units (SI). It is defined as the absorption of one joule of radiation energy 
per kilogram of matter. [228] Following radiation cells were washed with PBS, 
trypsinised, diluted 1:2 with fresh medium and vortexed to ensure a homogenous 
solution before being counted using a coulter counter (Beckman-Coulter, ROI). Cells 
were then plated at pre-determined cell densities in 6 well plates. After 12 days, 
colonies were fixed with 0.4 % crystal violet in 70 % methanol and counted using 
the 50-cell exclusion criterion. The plating efficiency was calculated as the ratio of 
colonies to cells seeded. The surviving fraction (SF) could then be calculated as the 
plating efficiency of the treated groups divided by the plating efficiency of untreated 
cells. The area under the curve (AUC), which represents the mean inactivation dose 
(MID), was calculated using Prism 6.0 (GraphPad software) and the sensitizer 
enhancement ratio (SER) calculated by dividing the MID of untreated cells with 
AuNP treated cells. Statistical analysis was performed using a two-way ANOVA 
comparing the different AuNP preparations to the untreated control.  
Mean plating efficiency values for 0 Gy were used to determine the long term 
toxicity of the AuNPs. 
3.4.12 BCA Assay 
Peptide concentrations were calculated using a Micro Bicinchoninic acid (BCA) kit 
(Thermo Scientific Micro BCA Protein Assay Kit, Pierce Biotechnology). This assay 
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is used to colorimetrically detect and quantify protein concentrations. Standard 
protocols in the kits were used in this study and serial dilutions were used to dilute 
the stock bovine serum albumin (BSA) in accordance with the BCA kit 
manufacturer’s instructions to produce the calibration curve standard. This standard 
was used across all three peptide types. The experiments were performed in 96-well 
microplates were N > 4. After incubating the assays for 4 h, the absorbance was 
measured at 562 nm using an absorbance plate reader (TECAN Sunrise, TECAN 
Austria). The concentrations quoted were calculated using the calibration curve.  
 
 Characterization Techniques 
3.5.1 Dynamic Light Scattering  
3.5.2 Particle Size Analysis 
Dynamic Light Scattering (DLS) detectors enable the particle size and zeta potential 
measurements of small amounts of proteins, biomaterials and particles suspended in 
solutions in the size range of 0.3 nm to 8 µm. Particle size measurement is important 
as it can act as a valuable indicator of quality; most commonly for powders, 
suspensions, emulsions and aerosols. [229,230] Many nanotechnologies require the 
tracking of changes in particles size; such as filtration, functionalization/growth and 
washing, DLS makes this possible by enabling the monitoring of size both prior to 
and after each technique.   
DLS size measurement is dependent on the shape of the particle to be measured. It is 
of note that it is in fact the hydrodynamic diameter (Dh) which is recorded. This is a 
value that refers to how a particle diffuses within a fluid. Non-spherical particles can 
be described by a combination of multiple length and width measurements which 
provide greater accuracy, the reported value is typically an equivalent spherical 
diameter – this means that the diameter which is acquired refers to the diameter of a 
sphere which would have the same translational diffusion coefficient as the particle; 
essentially taking the physical measured value and determining the size and shape of 
a particle that would produce that data. [230] Spherical particles can be described by 
the diameter alone, because each dimension is equal.  
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DLS is a measure of Brownian motion, which is the random motion of particles, and 
relates that to the size of the particles; the larger the particle, the slower the motion. 
Particles in suspension are constantly undergoing Brownian Motion due to the 
subatomic molecules, the distance between the scatterers in solution are constantly 
changing and is dependent on size; the larger the molecules then the slower the 
Brownian motion will be.  
The temperature and concentration must be kept constant as temperature will affect 
the viscosity, and to stabilize the convection currents which will cause non-random 
movements, and the ions in the medium can change the thickness of the electric 
double layer. A low conductivity medium will produce an extended double layer of 
ions around the particle reducing diffusion speed, resulting in a longer hydrodynamic 
diameter (Dh). The hydrodynamic diameter (Dh) refers to how a particle diffuses 
within a fluid. DLS is sensitive to the coating on the AuNP. An adsorbed polymer 
projecting out into the medium will change the speed; therefore as the AuNPs are 
functionalized, the particle becomes slower, thus resulting in a larger AuNP size 
output. [230] Scattering is caused by an incident light inducing electronic distortion. 
The incident light induces an oscillating dipole in the electron cloud. As the dipole 
changes, energy is radiated, or scattered in all directions. This phenomenon is known 
as Rayleigh Scattering. The intensity of light scattered is dependent on the size of the 
particle and the angle of refraction and the detector. Dynamic Light Scattering (DLS) 
refers to the measurement and interpretation of light scattering data on a 
microsecond time scale. The particle motion is measured from determining 
fluctuations in intensity of the scattered light; this is performed by a digital signal 
processor known as a correlator, which characterizes that noise in real time.  The 
correlator is a signal comparer, the correlation function compares the intensity of the 
delay time and the intensity of the reference time. It measures the degree of 
similarity between two signals or one signal with itself at varying time points. DLS 
interprets this scattering data on a time scale to determine particle size via particle 
motion, the longer the time, the weaker the relationship due to diffusion. Therefore 
for a correlogram, the longer it takes to decay, the larger the particle due to the 
slower motion, and the steeper the gradient, then the more mono-disperse the 
solution.   
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Light from the laser light source illuminates the sample in the cell; the scattered light 
undergoes either constructive or destructive interference by the surrounding particles 
and within this fluctuation, information is contained about the time scale of 
movement of the scatterers. The scattered light signal is collected with one of two 
detectors either at a 90 right angle or 173 back scattering angle. The obtained 
optical signal shows random changes due to the randomly changing relative position 
of the particles.  
DLS then uses the correlator to characterize that noise in real time to give an 
exponential decay with delay constant gamma using  
Equation 3-4 to give the autocorrelation function expressed in Figure 3-5. C is 
simply an exponential decay of the autocorrelation function, the decay constant is 
proportional to the diffusion coefficient.   
 
 
 
Figure 3-4 Experimental set-up schematic for DLS particle size detection 
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Equation 3-4 
C(𝜏) =  exp( −Γτ) 
 
C – Exponential decay of the autocorrelation function 
Γ – Gamma calculated from the delay function 
The decay of this function is used to extract particle size. Faster decays correspond 
to smaller particles. This means that after a long period has elapsed, there is no 
correlation between the scattered intensity of the initial and final states. The delay 
function below gives gamma and gamma can then be used to calculation the size. 
The diffusion coefficient is the proportionality factor ‘D’ in Fick’s Law, it is a 
physical constant dependent on molecule size and other properties of the diffusing 
substance as well as on temperature and pressure and is obtained from the 
relationship expressed in Equation 3-5 where q is the scattering vector derived from 
Equation 3-6. 
 
Figure 3-5 Autocorrelation function 
showing exponential decay 
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Equation 3-5 
Γ = Dt q
2 
Γ – Gamma 
D – Diffusion coefficient (m2 s-1) 
q – Scattering vector 
Equation 3-6 
q =
4𝜋𝑛
𝜆
 sin (
𝜃
2
) 
𝑛 = refractive index 
 = wavelength of laser light (nm) 
 = scattering angle  
q = scattering vector 
 
Finally, inserting the diffusion coefficient into the stokes Einstein relationship then 
solves for the particle size. 
Equation 3-7 
Dh =
K𝐵T
3 πŋDt
 
 
Dh - Hydrodynamic diameter (d.nm) 
KB - Boltzmann’s constant (1.38064852 × 10-23 m2 kg s-2 K-1) 
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T -  Temperature (°C) 
ŋ -   Dynamic viscosity (Pa s) 
Dt - Translational diffusion coefficient (m
2 s-1) 
DLS average size can be reported in several ways, Z-avg size, Number or Volume. 
Z-average size is not the intensity width size, instead it is the intensity width of a 
harmonic.   
Z-avg has more confidence than PDI as it is a first order term so there is minimal 
range for error, the PDI however is extremely important as it informs us about the 
width of the size distribution. The calculations for PDI are defined under 
ISO13321:1996E and ISO22412. PDI describes the polydispersity index of the 
solution, which defines the degree of non-uniformity. For size distribution, a 
perfectly uniform solution would have a PDI of zero, this would tell the user that the 
particles in solution are completely monodisperse, whereas if the PDI came back 
with a value of 0.7, it would indicate to the user that the solution is extremely poly 
disperse. DLS also facilitates the conversion of ‘Intensity’ to a ‘Number’ or 
‘Volume’ mean calculation.  
To run the equipment the power source must be turned on, two beeps will sound 
when the default temperature of 25C is met, then the equipment must be left for a 
minimum time of 30 minutes to allow for the stabilization of the laser; this is 
necessary to prevent any thermal equilibrium problems that may produces errors or 
inconsistencies in the results. For this thesis, the DLS size measurements were all 
obtained by using the same SOP. This SOP detailed 15 measurements per one run 
with a total of 9 runs per sample which were averaged and used to calculate the 
statistics. Throughout this thesis, unless otherwise stated, Number average was 
reported when comparing results to minimize any errors and measurements have 
been carried out on each sample a minimum of 3 times, the mean calculated and 
standard deviation and COV (standard deviation / mean) as per ISO13320.   
Standard deviation and variance are the most common descriptions of dispersion. 
Throughout this Thesis, all error bars were calculated using Equation 3-8 and  
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Equation 3-9 respectively. Statistics were all calculated either using either a t-test, 
One-way ANOVA or Two-way ANOVA with Tukey or Dunnett post-test (as stated) 
with *  p-value <0.05, ** p-value <-0.01, *** p-value <0.001. 
 
 
Equation 3-8  
σ =  ∑ √
∑(x − x̅ )2
n
 
 
Equation 3-9  
s2 =  
∑(x −  x̅ )2
n − 1
 
 
x - Mean value of the sample,  
Σ - Summation  
n-1 - Number of values in the sample minus 1 
S - Standard deviation 
Σ - Variance 
  
57 
 
1.1.1.1 Zeta Potential Measurement 
DLS can also be utilized to measure the zeta potential which is a measure of the 
magnitude of the electrostatic or charge repulsion/attraction between particles, and is 
one of the fundamental parameters known to affect colloidal stability. The value of 
this knowledge stems for the potential understanding of interactions between 
particles, and changes in the zeta potential can be used to confirm AuNP attachment. 
It is measured by electrophoretic light scattering where particle motion is detected in 
an applied electric field.  
Zeta potential is the value measured from a double electric layer surrounding a 
nanoparticle having some surface charge using Dynamic Light Scattaring technique 
at the present conditions: pH, ionic strength, temperature, etc. of a nanoparticle 
medium, therefore it can be used to define the charge on the surface of a particle in a 
specific medium. The zeta-potential is a (relative) indicator for the surface potential 
of the particle. The more positive or negative the zeta-potential, then the more stable 
the particles are (due to electrical repulsion). At a value of zero aggregation would 
occur. The zeta-potential of a particle arises from its surface charge density (i.e. the 
Figure 3-6 Schematic illustrating DLS size and zeta analysis 
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greater the number of charged ligands on the particle per unit surface area, the 
greater the magnitude of the particle's zeta-potential). 
Zeta potential measurements work based of the stern layer and diffuse layer of the 
particles as the charge on the particle surface can affect the ionic environment of the 
suspension solution (Figure 3-6). The environment is described as being a ‘double 
layer’ which consists of: 
1. The Stern layer of ions which are firmly attached adjacent to the particle 
surface. 
2. A diffuse layer which is located further away from the particle surface but is 
still attracted to the particle and moves in sync with said particle.  
There is an invisible boundary between this layer and the remaining ions in solution, 
which is called ‘the slipping plane’ and the zeta potential measurement is the 
measurement in mV at the slipping plane ( Figure 3-6).  
Zeta potential is measured using a capillary cell which consists of two electrodes. 
These electrodes formulate an electric field which when applied causes the particles 
to move towards the anode or the cathode depending on the charge. The speed of this 
motion is used to calculate the magnitude of the charge and is affected by the 
viscosity, size, dielectric constant and surface charge. When the particles are 
illuminated with the laser light, a reference beam mixes with the scattered beam to 
extract the frequency shift in the scattered light; the magnitude of this frequency shift 
allows the calculation of the particle velocity. Equation 3-10 therefore calculates the 
electrophoretic mobility (µ) using the measured frequency shift. 
 
Equation 3-10 
µ =  
∆ωλ0
4πnE sin (
θ′
2 )
 
µ = electrophoretic mobility (V/cm) 
ω = measured frequency shift (Hz) 
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λ = laser wavelength (nm) 
n = refractive index of medium 
’ = contains the angular light scattering information 
The zeta potential can therefore be calculated based on the electrophoretic mobility 
by using the Henry’s equation which is outlines in Equation 3-11. 
 
Equation 3-11 
µ =  
2ℶε f(κr)
3η0
 
 
µ= electrophoretic mobility (V/cm) 
 = zeta potential (mV) 
ε = the dielectric permittivity of the medium (F/m) 
η0 = the viscosity (Pa. s) 
f= (κr) = a function describing the ratio of the particle radius to the double layer 
 
The testing in this Thesis was conducted using the Malvern Zetasizer Nano ZS 
Series. Using disposable 2 ml cuvettes (type DTS0012). The samples were analyzed 
9 times at 25°C, meeting the requirements of ISO13320 where each analysis 
consisted of 15 measurements.    The system parameters were as follows: 
 
Refractive Index:  1.33 
Absorption:  1.00 (max) 
Measurement Angle: 173° (standard) 
Cell Type:  DTS0012 
Dispersant:  Water 
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3.5.3 UV-Visible Spectroscopy 
UV/Vis belongs to a class of instruments known as spectrophotometers; a 
spectrophotometer measures the transmittance of light which passes through a cell 
containing a sample to be analyzed. This light is collected and converted into an 
electrical current via a photodiode; the current is directly proportional to the amount 
of light hitting the photodiode. The current is then converted into voltage which 
corresponds to absorbance. This basis of the theory of operation is initially based on 
the principle discovered by Bouger and Lambert which determines that when light 
was passed through a material, a portion of the light’s energy was absorbed while the 
remaining light passes through. The transmittance of this light is proportional to the 
path length of the material and is dependent on both the material and the wavelength 
of the light. Thus, identifying a linear relationship between thickness of the material 
and the transmitted light.  Beer later developed this this principle to include 
solutions, and demonstrated that the transmission of light is directly proportional to 
the concentration of the solute and the path length at which it travels. [231] 
The Beer Lambert Law therefore states that the absorbance of light by a chemical in 
solution is directly proportional to: 
1. The concentration of the solute in solution 
2. The path length of the cell  
3. The molar absorptivity of the solute 
 
 
Equation 3-12 
Absorbance = log (
I0
I
) = abc 
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Beers Law is expressed in Equation 3-12 where: 
I0 = Intensity of light beam at entrance of flow cell 
I = Intensity of light at exit of flow cell 
a = Molar Absorptivity (L mol-1 cm-1) 
b = Cell path length (cm) 
c = Solute strength (molL-1) 
 
When both the cell path length and the molar absorptivity are held constant, the 
absorbance measured should be directly proportional to the concentration of the 
sample. This relationship is only true for monochromatic light and low absorbance.  
In UV/Vis, the major energy levels are determined primarily by spatial distributions 
of electrons known as electronic energy levels, and to a lesser extent, vibrational 
energy levels which include stretching and bending of covalent bonds.  
Elements or molecules which contain sigma (σ), pi (π) or non-bonding (n) electrons 
can absorb energy from ultraviolet or visible light to excite these valence electrons to 
higher antibonding (*) molecular orbitals. The lower the energy gap between the 
highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular 
orbital (LUMO) the easier the excitation of the electron, and thus the longer the 
wavelength of light which can be absorbed. There are four types of transitions 
obeyed, σ - σ* > n - σ* > π - π* > n - π*, where the energy required for each, 
increase respectively. [232,233] 
The energy and wavelength of absorption is defined by the difference in energy 
levels of an electronic transition, E1 being the energy level of the molecule before 
absorption and E2 the energy level reached by absorption. This relationship is 
expressed in Equation 3-13. 
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Equation 3-13 
λ = ℎ𝑐/(𝐸2 − 𝐸1) 
λ – Wavelength (nm) 
h – Planck’s constant (6.62607004 × 10-34 m2 kg /s) 
c - speed of light (299 792 458 m/s) 
E2 – energy of higher state (eV) 
E1 – energy of lower state (eV) 
 
If an electron receives more or less than that energy calculated from Equation 3-13, 
then it cannot jump to a higher energy state. However, photons of light which are of 
that exact energy will be absorbed by the electron in state E1 and will jump to state 
E2.  Orbital energies are described by vibrations, so each orbital has a range of 
possible vibrations, therefore the transition from one electronic level to the next can 
occur between many vibrational levels. When we excite the electron, it has both the 
potential to be excited to a range of vibrational modes, and the potential to be excited 
from a range of various vibrational modes; this results in differences in the width of 
the spectra obtained. If all transitions were between only the lowest vibrational levels 
of ground and first excited state, then the absorption peak would be narrow and 
discrete.  [234] 
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UV/Vis spectroscopy is a very common characterization technique used for gold 
nanoparticle analysis. Literature would demonstrate that AuNPs exhibit an 
absorption peak at approximately 520 nm for nanoparticles of ~15 – 20 d.nm; the 
position of this peak varies with nanoparticle size. The Surface Plasmon Resonance 
is the phenomena which gives rise to this peak. Electrons are confined to the surface 
of the gold nanoparticles which occur at the interface of the gold and the suspension. 
The electrons in the conduction band interact with the photons of polarized light, a 
wave like oscillation is induced, which causes a reduction in the reflected light 
intensity. AuNPs absorb light in the green and reflect in the red which denotes the 
color of the solution, the relationship of the visible light region of the 
electromagnetic spectrum is illustrated in Figure 3-7. When the light hits the electron 
cloud, the electrons begin to oscillate resulting in some polarization, the electrons 
begin to bounce back and forth between the now positive and negative charges and 
therefore resonate with the frequency of visible light.  
In order to determine the absorbance two measurements are taken, first the 
measurement of I0 is taken by running a blank scan, with distilled water in the 
reference and sample holders. This is then followed by the measurement of I by 
taking a measurement of the sample in the sample holder. [235]  
UV/Vis measurements were taken by a Perkin Elmer Lambda 35 Spectrometer; this 
machine consists of a holographic concave grating found in the monochromator. The 
optical system is coated in silica and is illustrated in Figure 3-8. There are two 
Figure 3-7 Schematic representing the electromagnetic spectrum 
highlighting the visible region 
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sources of radiation, a deuterium lamp and a halogen lamp. When operating in the 
visible range of the spectrum the mirror labelled M1 reflects the radiation from the 
halogen lamp, onto the mirror M2 meanwhile blocking the radiation from the 
deuterium lamp which is used for the ultra violet (UV) region of the electromagnetic 
spectrum. When analyzing in the UV range the M1 mirror is raised to allow the 
radiation from the deuterium lamp to seek the source mirror M2. Radiation is then 
reflected through an optical filter on the filter wheel which is driven in 
synchronization with the monochromator. An appropriate filter (dependent on the 
wavelength used) is then selected in the beam path to pre filter the radiation before it 
enters the monochromator. [235] The radiation leaves the optical filter and passes 
through slit 1 of the monochromator, it is then dispersed at the grating which 
produces a spectrum, a segment is selected from this spectrum and reflected through 
slit 2 to the mirror M3. The function of the exit slit is to restrict the spectrum until it 
is a near monochromatic beam; this beam is then reflected onto the beam splitter 
which divides the beam by allowing 50 % of the radiation to pass onto the plane 
mirror M4 while reflecting 50 % of the radiation onto the plane mirror M5. M4 
focuses the beam into the sample cell while mirror M5 focuses the radiation through 
the reference cell. Both beams are then picked up by a convex lens and focused onto 
the photodiode detector. [235]  
For UV/Vis spectroscopy, 1.4 ml of each of the sample is aliquoted out into a quartz 
cuvette. Unless otherwise stated the samples were analyzed in the range of 600-400 
nm with a 0.1 nm step and 240 scanning speed using the Perkin Elmer Lambda 35 
Spectrometer.  The technique is used to measure the standard absorbance of AuNPs 
which is usually in the range of 510-540 nm; by monitoring the peak and the 
absorbance of the peak it is possible to confirm the colloidal stability in the presence 
of PBS and NaCl (chapters 4 & 6) and colloidal stability and agglomeration in a 
range of pH buffers (chapter 5) and the attachment of any ligands which is monitored 
throughout this Thesis.  
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3.5.4 Transmission Electron Microscopy 
Transmission Electron Microscopy (TEM) is an electron microscopy imaging 
technique. TEM uses electrons as a light source typically from a Tungsten or 
lanthanum hexaboride filament and due to their low wavelength compared to visible 
light, they allow a much higher resolution to be obtained in the image. Materials can 
be studied at an atomic level, cells can be examined in minute details and objects can 
be studies to the order of a few angstroms (0.1 nm).  
The electron source is found at the top of the microscope and emits electrons that 
travel down through a vacuum in the column of the microscope (which is illustrated 
in ). Electromagnetic lenses focus these electrons into a narrow beam which 
transmits through the sample specimen, depending on the density of the sample some 
of the electrons scatter; some are blocked while the un-scattered electrons are 
gathered at the bottom of the microscope column. The sample needs to be very thin, 
typically < 100 nm. The objective lens is used to focus this beam. All the lenses in 
TEM are operated by either an electrostatic or magnetic field (for example, a 
magnetic coil), the first condenser lens controls the ‘spot size’ which is the size of 
the beam when it hits the sample; the second condenser lens controls the size the 
Figure 3-8 Illustration of the optical system of a Perkin Elmer Lambda 35 
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beam appears on the sample from a pinpoint to wide dispersed beam, the condenser 
aperture removes high angle electrons from the beam. The objective aperture is used 
to enhance the contrast within the beam by blocking high angle electrons which have 
been scattered by the sample. This forms a shadow image which is in grey scale with 
different parts of the sample displayed in varied greys according to the density of the 
sample. Those un-scattered electrons which gather at the bottom of the column are 
passed through the intermediate and the projector lenses which enlarge the beam; 
they are then focused onto a fluorescent screen or a detector which converts the 
beam into a digital image for analysis. 
The samples were dried on carbon coated copper grids and imaged using a JEOL 
2100F Transmission Electron Microscope at 200 kV.  TEM was used to analyze the 
shape, size, agglomeration and to image the uptake within the cell throughout this 
thesis. Image J was used for size analysis and the measure the number of 
nanoparticles with a minimum of 80 measurements taken per image. 
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3.5.5 Fourier Transform – Infra Red Spectroscopy (FT-IR) 
Infrared Spectroscopy (IR) is a powerful tool for the analysis of a sample; it is the 
study of interactions between infrared electromagnetic energy and matter and allows 
for qualitative and quantitative measurements. If the infrared light is absorbed by a 
sample it will result in the excitation of the samples molecular vibrations which 
cause the amplitude of bonds to change. This change is measured with FTIR. 
FTIR can be used to measure all three states of matter, almost all compounds absorb 
variations of infrared light, and only chemical bonds that have a dipole moment that 
changes as a function of vibrations are capable of absorbing infrared light, only 
active IR bonds produce peaks. Every bind that absorbs IR light vibrates at a 
different, specific frequency, the small variations result in the peak position and is 
commonly referred to as the compounds fingerprint. It is commonly used to identify 
contaminants and in forensics as it can be used for hair and fiber analysis, or to 
identify compounds in unknown powders. 
Figure 3-9 TEM cylinder Schematic 
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There are 4 sampling modes used in FTIR. Transmission, Reflectance, Diffuse 
Reflectance and Attenuated Total Reflectance. For this thesis, Diffuse Reflectance or 
DRIFTS was used, the sample was mixed with potassium Bromide (KBr), the water 
was evaporated off and the remaining pellet was ground and placed in the drifts cup.  
During transmission FTIR spectroscopy IR radiation is passes through a sample, 
some of this radiation is absorbed by the sample while some if transmitted. The 
spectrum obtained represents a molecular fingerprint. In addition to identifying the 
unknown materials of a sample, FTIR can also determine the quality of a sample in 
conjunction with the amount of components within a mixture. [236] FTIR was initially 
invented to overcome the problems associated with a slow scanning process which 
was commonly found in all other dispersive instruments. The development of an 
interferometer overcame this, this is an optical device which produces a unique 
signal which has all of the infrared frequencies encoded into it, therefore the infrared 
frequencies could be measured simultaneously and not individually, thus reducing 
scanning time to mere seconds and not minutes.  
A beam splitter divides the incoming infrared beam into two optical beams, one 
beam reflects off a fixed mirror while other reflects off a moving mirror. Both beams 
are re-joined, however due to the difference in paths due to the fixation and 
movement of the mirrors, the two beam now interfere with each other resulting in a 
signal known as the interferogram. The novelty of this interferogram is that each data 
point which makes up this signal contains information about every infrared 
frequency originating from the source. This interferogram signal must then be 
decoded for analysis via a technique known as the Fourier transformation.  
The main components consist of a source, an interferometer, a sample, a detector and 
a computer. Before each sample analysis a background spectrum must be obtained as 
a reference point for a relative scale for the absorption intensity. The background is 
usually an empty cell, and then the percentage transmittance can be measured by 
comparing the measurement with a sample to the background scan. For this thesis, 
however the background is KBr. The background results in a spectrum with all the 
instrumental characteristics removed; therefore the data generated is solely a result 
of the sample. [236] 
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Samples were prepared by centrifuging 50 ml AuNP and removing 90 % of the 
supernatant. 1 ml of the now concentrated pellet was dropped via a plastic disposable 
pipette onto 1-2 g of KBr and dried in a Teflon flask at 40°C under vacuum. The 
remaining 4 ml were aliquoted onto the KBr powder over the course of 2-5 days as 
required* and the powder left to dry for a further 24 h.  
*Due to the complexity of the AuNPs and the difficulty obtaining some spectra, the 
amount of KBr powder was tailored depending on the quality of the spectra obtained 
and the Absorbance value of the atmospheric peaks at 2000 – 2500 cm-1.  
For this Thesis, all spectra were obtained from a Varian 640-IR FTIR Spectrometer, 
the method used for AuNP analysis is more commonly referred to as DRIFTS.  
Diffuse Reflectance Infrared Fourier Transform Spectroscopy (DRIFTS-FTIR) 
analysis verifies the chemical and physical structures of materials. It analyses the 
sample by studying the surface chemistry of high surface area powders; it utilizes a 
controlled DRIFT cell by focusing the IR light onto the powder and collecting the 
scattered light. The DRIFTS cell used was a PIKE EasiDiff Diffuse Reflectance 
Infrared Fourier Transform Spectroscopy accessory. 4 scans per sample were 
obtained from 4000-400 cm-1 in absorbance mode at 4 cm-1 resolution. 
3.5.6 Gel Electrophoresis 
Agarose gel electrophoresis is a routinely used method for separating proteins, DNA 
or RNA. Nucleic acid molecules are size separated by the aid of an electric field 
where negatively charged molecules migrate toward anode (positive) pole.[237] For 
gold nanoparticles, gel electrophoresis is a useful tool as it will characterize the 
AuNPs based upon size and charge of the AuNPs. Like DLS, gl electrophoresis is 
sensitive to the organic coating of the AuNPs; larger AuNPs will have a slower 
migration profile than the smaller AuNPs. Therefore gel electrophoresis can be used 
in conjunction with DLS to confirm surface functionalization, as successful 
PEGylation and/or co-functionalization with peptides would result in a AuNP size 
increase and affect the migration profiles of the AuNP in relation to particle size. As 
well as size, gel electrophoresis is sensitive to charge, and the zeta potential of the 
AuNPs. Therefore a charge in zeta potential will affect which pole, and subsequent 
direction, which the AuNPs migrate to. Gel electrophoresis was carried out on 2 % 
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agarose eluted with 0.5 x TBE running buffer to confirm both conjugation and non-
specific protein adsorption. 20 microliters of the AuNP samples containing 50 % 
sucrose solution were added to each gel well, and the gel was run at 100 V for 2 
hours. Electrophoretic migration is dependent on the charge and size of the particles. 
[238] Gel electrophoresis was used in this thesis to confirm conjugation of both PEG 
and peptide as indicated by the migration profiles for each of the AuNP sample 
types, and to analyze the non-specific protein adsorption of the samples (chapter 6). 
[239]  
3.5.7 Atomic Absorption Spectroscopy 
Atomic Absorption Spectroscopy was performed by the collaborators in Queens 
University, Belfast, to measure the intracellular concentration of AuNPs. Initially 4.5 
x104 cells were plated out and left to adhere for 24 hours then exposed to gold 
nanoparticles for 24 hours. The nanoparticles were then removed, the cells washed 
twice with phosphate-buffered saline (PBS), trypsinized and reconstituted in 0.5 ml 
18 Ω deionized water to a total of 1 ml. 1 ml aqua regia was added (3:1 
hydrochloric:nitric acid), left for 2 hours to digest and a further 3 ml 18 Ω deionized 
water added. Samples were then read using a flame atomizer AAS, AAnalyst 400 
AA spectrometer (flame atomizer) from Perkin Elmer, and software Winlab 32 for 
AA. Atomic Absorption Spectroscopy (AAS) measures the concentrations of 
elements by measuring the wavelength of light absorbed by the element. Those 
wavelengths correspond to the amount of energy required to promote the electrons 
from one energy level to a higher energy level. Applications include pharmaceutical 
manufacturing to calculate residual catalysts, or in industry to examine raw materials 
and quantify toxic impurities. For this Thesis AAS was used to measure the 
concentration of the functionalized gold nanoparticles in solution and to quantify the 
mass of AuNPs endocytosed by cells after 24 h incubation with the various AuNP 
conjugates (chapter 5). 
For AuNPs, a hollow cathode lamp, containing a tungsten anode and a cylindrical 
hollow cathode made of gold emits light from excited gold atoms to be absorbed by 
any gold atoms from the sample. These are sealed in a glass tube filled with an inert 
gas at a pressure between 1 Nm–2 and 5 Nm–2. During AAS, the sample is atomized, 
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(converted into ground state free atoms in the vapor state). The atomizer can be 
aspiration or electro thermal atomization, which is the aspiration of a liquid into a 
flame or the placement of a sample droplet into a graphite tube to be electrically 
heated. The gaseous ions in the lamp bombard the cathode and eject gold atoms from 
the cathode (sputtering), some of these atoms are in an excited state and are emitted 
as a beam of electromagnetic radiation which is characteristic of gold and is passed 
through the vaporized sample. Some of the radiation is absorbed; the amount of 
radiation absorbed is dependent on the number of vaporized atoms. Therefore, the 
amount of light absorbed is proportional to the amount of gold atoms. The unknown 
sample is then compared against a calibration curve generated from running 
numerous known gold concentration samples under the same conditions.  [240] 
 
3.5.8 Photoluminescence 
There are various forms of luminescence; these include chemiluminescence, 
incandescence, bioluminescence and photoluminescence. When an external energy 
supply is applied by either infra-red, ultraviolet or visible light, if the emitted light is 
of a different wavelength, the light is known as photoluminescence (pL). It is this 
light which undergoes fluorimetric analysis. When luminescence occurs, the system 
loses energy, therefore for continuous emission energy must be supplied from an 
external source. [241] 
For this Thesis, the ultraviolet and visible regions of the electromagnetic spectrum 
are of most interest, which result in the excitation of outermost electrons of the 
molecule. All fluorescent tags had to be stored under tin foil, away from direct light 
as the energy associated with this radiation of this frequency is high which can be 
sufficient enough to break down the adsorbing tags resulting in fading.  
The adsorption of light results in the formation of excited molecules which in turn 
dissipate their energy in other ways, for instance, our tags adsorbed energy in the 
ultraviolet and emitted light in the visible. The efficiency of this process is known as 
the quantum efficacy and is defined by Equation 3-14. 
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Equation 3-14 
ΦΕ =  
𝑒𝑖𝑛𝑠𝑡𝑒𝑖𝑛𝑠 𝑒𝑚𝑖𝑡𝑡𝑒𝑑
𝑒𝑖𝑛𝑠𝑡𝑒𝑖𝑛𝑠 𝑎𝑏𝑠𝑜𝑟𝑏𝑒𝑑
 
ΦΕ – Quantum efficiency 
Photoluminescence was performed using an Agilent Technologies, Cary Eclipse 
Fluorescence Spectrophotometer, model G9800a. The fluorescent tags which were 
added are as follows: 
 
Texas Red:   excitation @ 595 nm,  Emission max @ 615 nm 
FITC:   excitation @ 494 nm,   Emission @ 520 nm 
The required amount was calculated based on Equation 3-1 and dissolved in an 
appropriate solvent and added to the AuNP solution which was stirring under 
ambient conditions wrapped in tinfoil.  
3.5.9 ICP-MS 
ICP-MS was performed by the collaborators in Queens University, Belfast, to 
measure the intracellular concentration of AuNPs. 2x105 cells were plated in 6 well 
plates (Nunc, UK) with 2 ml of complete media and allowed to adhere overnight. 
The cells were then treated with the samples to be tested at a concentration of 50 
g/ml for 24 h. AuNPs were removed, cells washed three times in PBS, trypsinized 
and diluted 1:1 with PBS before being counted using a coulter counter at a dilution 
of 1:200 (Beckman-Coulter, ROI). Cells were then dissolved in 1 ml of aqua regia 
for 30 min. Samples were then made up to 5 ml with distilled water. Analysis of the 
samples was carried out using inductively coupled mass spectrometry (ICP-MS) 
Thermo Scientific iCap Q ICP-MS, which was connected to a CETAC ASX-520 
auto-sampler. The ICP-MS operating conditions were: Standard (STD) mode: 
forward RF power 1550 W, nebuliser gas flow was ~1 L/min and the nebuliser liquid 
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sample flow rate was ~0.35 ml/min. A PFA mirco-flow nebuliser was used in a 
cyclonic quartz glass spray chamber, chilled to a constant 2.6 oC Collision cell 
(KED) mode: all aforementioned parameters were employed with the addition of 
helium as a collision cell gas at a flow rate of ~4.0 ml/min.  
Gold 197Au mono-isotope was selected and analysis was performed in both STD 
and KED modes, using 6 replicates of 30 seconds per sample, giving a total of 3 
minutes acquisition per sample. A linear series of Au only calibrations standards 
were prepared at 0, 1, 10 and 100 ppb made up in 1% HNO3/1%HCl (by volume). 
Samples were analysed by comparison to the standards previously mentioned. A 
quality control standard QC, was analysed every tenth sample and results are only 
reported given a suitably precise calibration and acceptable QC recoveries. Both 
STD and KED modes returned comparable results and the STD mode results were 
reported. 
Intracellular concentrations of AuNPs were then calculated by dividing the ICP-MS 
reading by the cell number and multiplying up to calculate pg of Au.  
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4. THE SYNTHESIS OF CO-FUNCTIONALIZED 
AUNPS USING A BIFUNCTIONAL LINKER 
As discussed in the Literature Review, two methodologies are commonly used to co-
functionalize the AuNP surface, both of which are illustrated in Figure 4-1. The first 
involves the synthesis of a mixed monolayer, for example, by attaching both a 
stabilizing ligand and a peptide or targeting ligand directly to the AuNP surface 
using thiol chemistries (Figure 4-1a). [12,158,184,203–206] The second method uses a 
hetero-bifunctional linker such as thiol-PEG-succinimidyl glutaramide which has a 
thiol at one end for attachment to the AuNP surface, and an NHS ester group at the 
other, which can react with the nucleophilic primary amine groups which exist at the 
N-Terminus of each peptide, thus acting as a linker (Figure 4-1b). While there are 
various in vitro and in vivo studies using both functionalization methodologies, there 
is no consensus within the published literature regarding the influence of attachment 
method on colloidal stability and biological response. [59–63,153,211] 
Chapter 2 discussed the various methods to functionalize the AuNP with peptides. 
The method of chemically conjugating a peptide onto the AuNP surface does not just 
vary with the physical interaction between the Au and S or N atoms (ionic attraction, 
hydrophobic attraction) or through the chemical interactions between the ligand and 
b) a) 
Figure 4-1 Schematic representing a) the synthesis of a mixed monolayer and b) co-
functionalization using PEG as a thiol linker. 
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the surface (chemisorption via thiol derivatives, bifunctional linkers etc.) but can 
also vary via the physical process of conjugation, these processes are known as either 
sequential or parallel loading. [242–245]  
Sequential loading is the process of adding the stabilizing agent, followed by the 
desired biologically active ligand in sequence, as described in the section 3.4.2. 
Parallel loading, involves the subsequent reaction of two or more ligands separate to 
the AuNP suspension, then adding the pre-conjugated ligand to the nanoparticle 
surface (Figure 4-2). [157]  
 
Figure 4-2 Illustration of the parallel loading method  
An example of this is the reaction of lysine with the succinimide ester in parallel to 
form a BSA and MBS (3-maleimido benzoic acid N-hydroxysuccinimide ester) 
linker; this was the first of three steps to synthesize a BSA-peptide conjugate 
complexed to 20 nm diameter citrate-stabilized gold particles. A cysteine terminated 
peptide was then conjugated to the remaining exposed maleimido group and then 
washed via dialysis before being conjugated to AuNPs. While peptide concentrations 
were estimated via a mobility shift assay coupled with isoelectric focusing 
electrophoresis and the addition of fluorescein labels, the arrangement on the surface 
was confirmed by an increase in size by DLS, however DLS revealed that BSA-
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peptide conjugates added < 2 nm to the radius of the nanoparticle complex. From 
this study, it was observed that the thiol in the cysteine residue was used to react to 
the maleimido group and not the gold leaving the C-terminus to bind to the gold 
surface using weak amine bonds. [157] It is possible that the chemical conjugating 
occurred through the amine groups found on the C-terminus and/or a combination of 
the C-terminus and the other amines present on the side chains of the remaining 583 
amino residues which compose BSA. [157]  
Otsuka et al. studied the conversion of acetal groups to aldehydes on immobilized 
block co-polymers before incorporating the process into the synthesis of a 
heterobifunctional PEG on an AuNP surface. The PEG acetal terminal group was 
converted to aldehyde by gentle acid treatment, followed by the reaction with sugar 
derivatives followed as a function of time through optical changes in the surface 
plasmon band in the UV–Vis spectrum. [217,246] Other examples utilized the shaking 
of a linker with AuNPs for surface functionalization, followed by centrifugal 
washing and tethering of platinum via amine-carboxylic acid reactions. PEGylated 
nanoparticles were characterized by electron probe microanalysis (EPMA) to 
confirm that both gold and platinum were present through their elemental peaks at 
2.12 and 2.05 keV, respectively. [149] Amide linkage to Carboxylic (COOH) groups 
has also been identified in the literature through EDC (1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide hydrochloride) and NHS (D- 
hydroxysulfosuccinimide sodium salt) two-step coupling activation mechanism of 
the carboxylic group of the PEG derivative for conjugation to antibodies. [203] This 
process was carried out in THF (tetrahydrofuran). None of the methods outlined 
above attempt the synthesis of a linker with a cysteine containing ligand.  
From analysis of the table in chapter 2, it is apparent that other methods to achieve a 
linker include the parallel loading of RNA to thiolated OEG. It is also observed that 
most linker formations were synthesized as a whole, prior to addition to the gold 
surface. [218,219]  The techniques used to confirm the surface arrangement also vary, 
by the addition of coumarin dye, Shenoy et al. were able to prove the synthesis of 
linker via nucleophillic addition and the successful functionalization to gold via 
fluorescence. [157,218,219] 
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It is therefore of important note that most of the linkers previously discussed either 
involved the complete synthesis of the ligands in in a pre-linked formation via 
bottom up approaches, or was achieved via parallel loading. Sequential loading was 
only successfully observed from the literature in chapter 2 via the implementation of 
an EDC coupling reaction, and even then, this is usually not carried out in the 
presence of a thiol group on the additional ligand. [218] 
Therefore, this chapter will outline the synthesis and co-functionalization of gold 
nanoparticles in a mixed monolayer arrangement using mono-functional (SH-PEG), 
and using a PEG hetero bifunctional linker (SH-PEG-SGA)  – via both sequential 
and parallel loading – covalently attaching a peptide either to initiate receptor 
mediated endocytosis (RME) or a peptide to elicit endosomal escape (H5WYG). The 
chosen RME peptide is a 17-amino acid residue peptide (sequence 
CKKKKKKSEDEYPYVPN) terminated with a thiolated cysteine unit at the N 
terminus. This peptide can form a mixed monolayer arrangement when used in 
conjunction with mono-functional PEG by the strong thiolate bonds formed with the 
AuNP surface. The free amine group found on the cysteine could also potentially be 
used to form a bifunctional linker in the presence of the NHS ester found on the 
hetero bifunctional PEG. As illustrated in Figure 4-3 for a linker surface arrangement 
to be successful, the NHS ester reagent would react with the primary amine on the 
protein or peptide to form a stable amide bond with an NHS by product. 
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Literature has identified that H5WYG (H5) can be used for successful endosomal 
escape both with and without a thiol group present. Therefore H5WYG was 
purchased from BIOMATIK with the following sequences 
(GCLFHAIAHFIHGGWHGLIHGWYG)& (GLFHAIAHFIHGGWHGLIHGWYG). 
Both RME and H5WYG peptide were chosen due to the results obtained from the 
collaboration with Queens University Belfast, Pharmacy. Previous collaborative 
studies have shown marked differences between the endocytotic potential of various 
cell lines following 24 h incubation with 25 µg/ml AuNPs. Intracellular AuNP 
concentrations of between 7-8 pg/cell in MCF-10A, MDA-MB-231 and MCF-7 
cells, reducing to 1.34 pg/cell in ZR-75-1 cells were observed. It was observed that 
the addition of PEG severely impaired AuNP uptake, with a 98-100 % reduction in 
all cases. Functionalization with the cell penetrating RME peptide helped to restore 
internalization in all cases generating a significant increase in AuNP uptake in 
MDA-MB-231 cells, MCF-7 and ZR75-1. [156,247] 
Interestingly, however, AuNPs conjugated with the endosomal escape peptide 
H5WYG demonstrated an increased volume of intracellular Au content (but was not 
found to be statistically significant). [247] This is most likely a result of the net 
positive charge of these peptides conferred through the five histidine ligands. This 
peptide has previously been shown to initiate membrane disruption of the endosome 
Figure 4-3 The reaction of an NHS ester with a Primary amine and the 
formation of the amide bond 
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once internalized by the cell, subsequently allowing the release of the nanoparticles 
into the intracellular environment. [178] This also facilitates an increased AuNP 
surface area for electron emission. Endosomal escape provided by H5WYG and 
homogeneity from PEG help facilitate a larger therapeutic surface area, thereby 
promoting electron emission from the nanoparticle surface and subsequently a 
greater efficacy. [156] 
The potential of endosomal release caused by H5WYG functionalized AuNPs could 
allow for an increased intracellular distribution and therapeutic surface area of 
nanoparticles, this combined with the ability to cause internalization translates into 
the potential for improved efficacy. The results from a previous publication from this 
research group have shown (Nicol et al.) the radio sensitizing potential of the various 
functional groups. [247] The annotated sensitizer enhancement ratio’s (SER) within 
these graphs (resuts not shown - (Nicol et al.) ) represent the RME, H5WYG and DP 
functionalized AuNPs respectively. Sensitizer enhancement ratio’s (SER) document 
the enhancement at specific radiation doses of the nanoparticle preparations. Normal 
breast cells MCF-10A showed that the addition of H5WYG resulted in a 31% 
increase in radio sensitivity respectively as indicated by the SERs (results not 
shown). [247] MDA-MB-231 cells show a more significant impact following 
conjugation of the peptides producing SERs of 1.57, 1.84 with RME and H5WYG  
respectively. [247] 
Two considerations must be considered for the successful synthesis of a linked ester 
and amine group. The first consideration is whether a peptide which contains a thiol 
residue can be successfully linked using a pre-synthesized NHS ester for reaction to 
the amine groups during AuNPs functionalization due to a thiols higher binding 
affinity to gold; and likeliness to be chemisorbed on Au via strong thiolate – Au 
bonds (40-50 kcal/ mol-1). Review of the literature identified that many research 
groups facilitate the synthesis of a linker prior to conjugation to the AuNP surface 
and as such, to the authors best knowledge, the co-functionalization using a pre-
synthesized NHS ester as demonstrated with the Thesis, is quite novel.  Therefore, it 
can be postulated that one of the main challenges presented for bifunctional linker 
formulation is controlling the addition of peptides when one or more ligands are 
thiol-containing molecules. [248] It is therefore hypothesized that conjugation of 
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ligands (thiol or not thiolated) in parallel could facilitate reaction with a pre-
synthesized NHS ester reaction and thus when added to the gold, the ‘pre-linked’ 
ligand could bind conveniently to the gold via the thiol found on the PEG, while 
retaining enhanced colloidal stability and potentially being able to elicit a positive 
biological response, in comparison to a mixed monolayer counterpart.  
To test this first hypothesis, AuNPs will be functionalized with both mono-
functional and bi functional PEG, then co-functionalized with RME (sequentially) 
and directly compared to identify how each peptide has bound to the AuNP surface. 
An equivalent sample will be synthesized concurrently for both arrangements in 
parallel to compare to the sequentially loaded samples to identify if the physical 
conjugation steps may play an important role in AuNP functionalization.  
The second consideration is the solvent used for the dissolution of the NHS ester and 
the peptide. Solvents for the peptide must be carefully chosen due to the polarity of 
the peptide. Hydrophobic amino acids are usually buried within the core of the 
peptide structure, while charged residues are exposed to the solvent to a much higher 
degree, allowing the potential formation of hydrogen bonds. The H5WYG sequence 
consists of the following 32 residues: GLFHAIAHFIHGGWHGLIHGWYG. 
Glycine, Leucine, Phenylalanine, Alanine & Isoleucine are all uncharged 
hydrophobic residues, while Histidine (+1), Tyrosine & Tryptophan are polar. Based 
on the low propensity of the side chains to be in contact with a polar solvent like 
water, it was concluded that based on the Hydro-2 hydrophobicity parameter, the 
percentage of hydrophobic residues for this peptide is approximately 61% 
hydrophobic and as such should be dissolved in small amounts of organic solvents 
such as DMSO, DMF, Acetic acid or methanol.  [249]  
The solvent used for the dissolution of the PEG must also be carefully considered. 
As previously described; the simplest and most versatile technique for 
functionalizing AuNPs with proteins involves the utilization of chemical groups such 
as an NHS ester which can react with the nucleophilic primary amine groups which 
exist at the N-Terminus of each peptide. To the best of the author’s knowledge, this 
approach is novel as most literature involves the conversion of a carboxylic group to 
an ester using carbodiimides such as EDC coupling reactions. The approach in this 
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Thesis uses a bifunctional PEG with a ready-made NHS ester for functionalization, 
thus improving efficiency. The reaction of NHS esters with amines is strongly pH 
dependent, at a lower pH the amino group is protonated, at a higher than optimal pH 
hydrolysis is quick. [250] 
NHS esters hydrolyze and glutaramide succinimidyl esters like the one used for this 
bifunctional PEG, have a half-life of only 15-20 minutes in water, this rate of 
hydrolysis increases with pH. As well as the potential hydrolysis of the ester, the 
solubility also varies with the buffer, and is dependent on the structure. Non-
sulphonated forms of the NHS ester are water insoluble and ThermoFisher 
recommends organic solvents such as DMF or DMSO in 0.5-10% of the final 
volume, elsewhere it is recommended to PEGylate proteins or nanoparticles in a 
large excess of the PEG NHS esters due to the competitive hydrolysis reaction in an 
aqueous solution. [251] Based on these observations from the literature, it can be 
hypothesized that when using water, the synthesis of a linker will compete with the 
hydrolyzation of the ester, and therefore it is possible that a pre-linked ester may be 
completely dependent on the solvent it is suspended in. To investigate if the 
synthesis of a linker is dependent on the presence- or lack there of - of a thiolor if it 
will be dependent on the solvent, the two H5WYG peptides both with an without the 
cysteine residue will be testing – sequentially and via parallel loading – to idenfity 
which parameters are mandatory to synthesize a linker using a ‘ready-made’ NHS 
ester for amine reaction.   
This chapter will outline the steps required for the successful synthesis of 
functionalized AuNPs using a PEG linker, and the characterization of each 
nanoparticle vector. The chapter will then directly compare the two surface 
arrangements in regards to colloidal stability, non-specific protein adsorption, 
internalization, cell viability and radio sensitization to determine if one arrangement 
results in more favorable biological result in comparison to its counterpart.  
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 Results and Discussion 
4.1.1 Sequentially loaded RME peptide 
AuNPs were synthesized using the Turkevich method outlined in the Materials and 
Methods section of this Thesis. To prepare the mixed monolayer PEG capped 
AuNPs, 10.68 μg/ml of free SH-PEG was dissolved in 1 ml of distilled water and 
added to the citrate capped AuNPs. As described in chapter 3, this level of PEG 
addition yields approximately 50% of potential surface saturation with this ligand. 
[184] Therefore, to prepare the PEG linker samples, 20 μg/ml of free SH-PEG-SGA 
was dissolved in 1 ml of distilled water and added to the ‘as synthesized’ AuNPs to 
fully cap the nanoparticles with PEG Linker. [184] A PEG Linker sample was co-
functionalized with both 4.45 μg/ml of RME, and 10 μg/ml RME to provide 50% 
coverage and complete saturation as calculated via Equation 3-1 in chapter 3 for 
comparative purposes.  
The nanoparticles were characterized at various points during synthesis, including 
post synthesis, post PEGylation, post centrifugation and after co-functionalization 
with RME peptide. The characterization techniques employed for this chapter 
include DLS, TEM, UV/Vis, FTIR, Gel Electrophoresis and AAS. As synthesized 
AuNPs will be referred to as AuNP citrate capped. AuNP with mono functional PEG 
is AuNP SH-PEG, AuNP with bifunctional PEG is AuNP SH-PEG-SGA and the 
RME peptide co-functionalized counterparts will be referred to as AuNP SH-PEG & 
RME and AuNP SH-PEG-SGA & RME, with 4.45 μg/ml RME coverage being 
addressed as 50% and 10 μg/ml RME referred to as 100% for ease of report.  
DLS size measurements were gathered by 9 runs per sample, with 15 measurements 
per one run, these were averaged and used to calculate the standard deviation 
highlighted in Table 4-1. 
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Table 4-1 DLS size and zeta measurements for functionalized AuNPs 
Sample name Size (d. nm) PDI Zeta (mV) 
AuNP Citrate capped 17.4 ± 1.15 0.22 -30.65 ± 3.11 
AuNP SH-PEG 37.29 ± 0.43 0.22 -6.74 ± 2.43 
AuNP SH-PEG-SGA 34.84 ± 4.31 0.28 -28.8 ± 1.10 
AuNP SH-PEG RME 50% 38.23 ± 1.54 0.32 -4.41 ± 0.29 
AuNP SH-PEG-SGA RME 50% 34.87 ± 2.76 0.26 -13.8 ± 1.8 
AuNP SH-PEG-SGA RME 100% 35.23 ± 0.30 0.28 -12.53 ± 1.18 
This variation in nanoparticle length as a result of PEGylation is proposed to be a 
consequence of the different molecular weights of the PEG. Upon co-
functionalization with SH-PEG & RME, the hydrodynamic diameter increased 
slightly to 38 d.nm.  If we refer to Figure 4-1 the mixed monolayer arrangement is 
obtained by both the peptide and PEG attaching directly to the nanoparticle surface. 
Therefore, a large increase is size was not expected as the PEG chains are longer 
than those of the peptide. Any slight increases in size are hypothesized to be a result 
of ‘straightening’ of the polymer chain as a result of surface saturation by the 
peptide. Co-functionalizing the bifunctional AuNP SH-PEG-SGA with either 50% of 
100% RME resulted in average AuNP diameters of 35 d.nm respectively, and 
therefore does not indicate the synthesis of a linker with the NHS ester.  
The zeta potential showed an increase in surface charge from approximately -29 mV 
to -14 and -13 mV for the 50% and 100% RME co-functionalized samples 
respectively. Therefore, the DLS size measurements are concluded to be a result of 
the conformation of the peptide in solution. With slight changes in sizes increasing 
with the amount of PEG attached a result of straightening of possible coils of RME 
peptide suspended in distilled water.  
Transmission electron microscopy (TEM) images for citrate capped showed an 
average particle size of 13.3 ± 4.2 nm. The PEG functionalized and RME peptide co-
functionalized samples do not show any increase in size, which was expected as the 
acceleration voltage used is not sensitive to the organic coating. However from the 
images obtained in Harrison et al. it is apparent that functionalization minimizes the 
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degree of aggregation to some extent in comparisons to the citrate capped AuNPs, 
and – to some degree - the level of AuNPs overlapping for both the mono-functional 
and bifunctional PEGylated counterparts. [12,185] 
AuNPs are subject to the quantum size effects, which gives rise to the unique 
properties known as the Surface Plasmon Resonance (SPR), which renders gold 
nanoparticles a ruby red color. Because of this SPR, which is the oscillation of 
electrons in the conduction band of AuNPs in resonance with a specific wavelength 
of light, AuNPs result in strong absorbance bands in the visible region [252,253] 
Severe aggregation (referred to as instability throughout this Thesis), or a particle 
size increase towards the bulk limit reflects light in the infra-red portion of the 
electromagnetic spectrum and therefore most visible wavelengths are reflected, 
resulting in a clear solution. It is the unique property of the SPR which is of major 
clinical interest, as the SPR can be tailored by size and shape to enhance different 
applications.  [254] 
A study was conducted to determine the colloidal stability of AuNPs with varying 
amounts of PEG attached. This was an important study as to be able to functionalize 
the AuNPs with an array of ligands for various applications, the AuNP must be 
primarily functionalized with PEG for enhanced stability, if the AuNP remains stable 
with minimal amounts of PEG attached it potentially enables to AuNP to have 
minimal stabilizing agent and consequently a larger amount of ligand or payload for 
a biological consequence. Figure 4-4 displays the absorbance spectra for AuNPs 
functionalized with increasing amounts of SH-PEG. The characteristic peak at 520 
nm is clearly visible for all AuNP samples in Figure 4-4, [183,252,255,256] and as such, 
all the AuNPs remained colloidally stable regardless of the amount of PEG attached, 
this state remained true for the bifunctional PEG, illustrated in Figure 4-5. Citrate 
capped AuNPs are stable due to the repulsions caused by like charges between 
particles, PEG offers a steric barrier, therefore partially covering the AuNPs may 
have resulted in aggregation due to slight changes in the surface charges (Table 4-1) 
while not offering sufficient steric barriers to prevent aggregation, whereas both the 
AuNP SH-PEG and the AuNP SH-PEG-SGA were stable irrespective of the amount 
of PEG attached.  
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Figure 4-4 UV/Vis absorbance spectra for AuNP functionalized with increasing 
amounts of SH-PEG 
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Figure 4-5 UV/Vis absorbance spectra for AuNP functionalized with increasing 
amounts of SH-PEG-SGA 
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UV/Vis measurements were then conducted on the AuNP samples co-functionalized 
with RME (AuNP SH-PEG & RME and AuNP SH-PEG-SGA & RME). The results 
showed in the previous publication that the colloidal solutions have maintained a 
high degree of colloidal stability following centrifugal washing and dispersion for 
the PEGylated colloidal gold and the co-functionalized RME samples. The colloidal 
stability of the co-functionalized samples was investigated by comparing each 
sample to the PEGylated counterpart prior to the peptide addition, dispersed in 
distilled water as a control. The mixed monolayer and linker spectra’s exhibit a 
distinctive absorption peak at ~521 nm with small shifts apparent from 519.9 nm to 
approximately 521 nm as a result of the complex conjugation of AuNP citrate 
capped to PEG and peptide functionalized AuNPs. The results do not indicate any 
differences between the two surface arrangements in terms of length in relation to 
the successful synthesis of a linker. 
To further investigate the influence of a hetero bifunctional linker on AuNP stability, 
AuNPs were functionalized with 50% or 100% coverage of SH-PEG-SGA, a pre-
caluculated amount of PBS tablet was crushed and added to the AuNP samples and 
vortexed for 1 minute. The PEGylated samples were then monitored over a period of 
Figure 4-6 PBS colloidal stability study displayed the UV/Vis relative absorbance 
of AuNP functionalized with either 50% or 100% SH-PEG-SGA over 24h 
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24 h to determine if aggregation occurred from monitoring the absorbance maxima 
of the SPR peak for AuNPs. PBS is commonly used to elicit physiological 
conditions of cells, these include a pH value within the range of 7 ~ 7.6, and often set 
to be 7.4 as the pH of blood nears 7.4, a value referred to as the physiological pH in 
biology and medicine. In addition to maintaining a constant pH, PBS in general has 
an osmolality that matches those of the human body (isotonic) and is non-toxic to the 
cells.  [257] PBS has a molarity of 137 mM NaCl, when salt is added to gold 
nanoparticles the surface charge of the AuNPs neutralize, and without the like 
negative charges induced via the citrate, the particles aggregate. It was found that 
both samples retained their colloidal stability irrespective of the amount of 
bifunctional PEG added. This relationship is outlined in Figure 4-6.  
Fourier Transform Infrared Spectroscopy was performed on the AuNP samples. 
FTIR serves to confirm the attachment of the ligands on the nanoparticle surface. A 
lot of complications can arise with FTIR analysis, especially with PEG and peptide 
attachment due to the similarities between the structures.  As illustrated in Figure 4-3 
for a linker surface arrangement to be successful, the NHS ester reagent would react 
with the primary amine on the protein or peptide to form a stable amide bond with an 
NHS by product. FTIR was therefore conducted on the samples to determine the 
formation of S-Au bonds and/or the loss of an NHS ester group. 
Figure 4-7 displays the FTIR absorbance spectrum obtained for citrate capped 
AuNPs, the bands recorded can be ascribed to the internal frequencies of the citrate 
ion. 2923 cm-1, 2956 cm-1 and 2854 cm-1 can be attributed to the out f phase and in 
phase CH and CH2 vibrations. Bonds present at 1589 cm
-1 and 1403 cm-1 are due to 
the CH2 – O deformation and C=O stretching of the citrate ligand with the peak at 
1644 cm-1 due to O-H-O bending modes. The peaks evident between 1500 cm-1 – 
1630 cm-1 and 1305 cm-1 – 1415 cm-1 are due to the carboxylate group exhibiting. an 
asymmetric COO- stretching vibration and with reference to Parry et al. the bands 
between 1111 cm-1 and 1137 cm-1 are resultant of trisodium citrate. [258]The bonds 
between the 1041 cm-1 and 1093 cm-1 have been scribed to the oscillations of the C-
OH group.  
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Prominent differences are visible in Figure 4-8 for the SH-PEG capped AuNP 
spectrum compared to that for the citrate capped AuNPs. Surface functionalization 
was confirmed by a decrease in the peaks corresponding to citrate capping 
aforementioned.  Figure 4-8 displays the citrate capped AuNP, AuNP SH-PEG and 
‘free’ SH-PEG. AuNP citrate capped (black) displays a peak at 1033 cm-1 
corresponding to alkoxy C-O bonding. The decrease in this peak signifies a loss of 
the citrate ion from the surface.  
The presence of the characteristic vibrations found in ethylene glycol ligands are 
expressed at 1106 cm-1 (C-O-C stretching), the acyl C-O groups (1300 cm-1) and the 
phenol C-O groups (1245 cm-1). The presence of the mono-functional thiol PEG 
(SH-PEG) on the AuNP-PEG is confirmed by an increase in the relative intensity of 
the peaks associated with C=O stretching (1,660 cm-1) and bending (1,380 cm-1) and 
2923, 2956, 2854cm-1 
CH2 and CH stretching vibrations 
 
1644cm-1  
     1589cm-1 
 
1070cm-1 C-O 
 
Figure 4-7 FTIR absorbance spectra for AuNP citrate 
capped 
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the presence of additional peaks relating to N-H bending and N-H wagging (600-900 
cm-1). [184,202,258–261] 
For this area of research, the focus of the FTIR analysis was to determine surface 
arrangement, therefore it is important to note that the weak S-H vibrational stretch 
found at approximately 2550-2620 cm-1 on the ‘free’ SH-PEG was no longer 
observed on the AuNP SH-PEG conjugate as the thiol groups had reacted with gold 
to form S-Au covalent bonding.  
 
 
1660 cm-1  
C=O stretching  
 
 
Figure 4-8 FTIR Spectra for AuNP citrate capped (black), 
'free' SH-PEG (green) and AuNP SH-PEG (red) 
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The FTIR spectrum obtained after functionalization with the NHS ester containing 
SH-PEG-SGA corroborated with the loss of an S-H bond as seen in Figure 4-8 
(circled in red). Figure 4-9 displays the FTIR spectra for citrate capped, ‘free’ SH-
PEG-SGA and AuNP SH-PEG-SGA. Highlighted in blue are the bonds which are 
found on the AuNP SH-PEG-SGA conjugate but are not on the AuNP SH-PEG. Five 
bonds were found to be unique to the SGA containing PEG compared to the mono-
functional PEG described previously. These bonds included asymmetric nitro at 
1551 cm-1; symmetric nitro or C-H bend at 1387 cm1 and an alkene C-H bend at 992 
cm-1. The peak at 1781 cm-1 on the ‘free’ SH-PEG-SGA is ascribed to the carbonyl 
stretch made in COO- NHS ester ligand from the succinimide group, while the peak 
at 1735 cm-1  is ascribed to the saturated ester.[259,262]  
 
 
1781 cm-1 
 
1735 cm-1 
1781 cm-1 
1551 cm-1 
Figure 4-9 FTIR spectra for AuNP citrate capped (black), 
'free' SH-PEG-SGA (green) and AuNP SH-PEG-SGA (red) 
91 
 
The solid-phase FTIR spectrum of the C=O stretch of the ester obtained by Tan et al. 
(2006) was given as 1787 cm-1. [263] a peak is observed on the AuNP SH-PEG-SGA 
sample which plateaus between 1720-1740 cm-1, peaks at 1720-1735 cm-1 belong to 
an aromatic ester and/or saturated ester while literature describes peaks at 1740 cm-1 
to belong to an NHS ester as illustrated in Figure 4-9, the synthesis of a linker would 
involve the loss of the NHS ester, therefore the presence of this saturated ester on the 
AuNP surface confirms conjugation directly to the surface. [264,265] 
Thiol bonds are present on the ‘free’ RME sample between 1550-1620 cm-1 in 
Figure 4-10. They are not present on either the AuNP SH-PEG or the AuNP SH-
PEG RME sample. Thus, confirming conjugation via the S-H found on the cysteine 
unit. S-Au bonds are expected to appear at 1777 or 1545 cm-1. Both conjugates 
present a minor peak at 1750 (highlighted in blue). While the shift may indicate the 
Figure 4-10 FTIR spectra for 'free' RME (green), AuNP SH-
PEG (black) and AuNP SH-PEG RME (red) 
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presence of Au-S bonds it cannot be confirmed, however, the relative intensity has 
increased for the AuNP SH-PEG RME sample in comparison to the AuNP SH-PEG 
conjugate.  
This suggests an increase in the number of Au-S bonds formed at this wavenumber 
via the attachment of the RME peptide.  The presence of RME on the nanoparticle 
surface is further confirmed through the formation of amide bonds and N-H wagging 
(600cm-1 – 900cm-1) on the RME conjugated sample. [266,267] 
 
Figure 4-11 compares the ‘free’ SH-PEG-SGA to the AuNP SH-PEG-SGA & RME 
conjugate to look for the disappearance of a NHS ester group; saturated esters are 
present at 1735 cm-1. Figure 4-12 compares the AuNP SH-PEG-SGA & RME 
Figure 4-11 FTIR spectra for 'free' SH-PEG-SGA' (green), 
AuNP SH-PEG-SGA (black) and AuNP SH-PEG-SGA & RME 
(red) 
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conjugate to ‘free’ RME to identify the loss of a thiol group or the formation of the 
N-Au bond.  
AuNP SH-PEG-SGA as described previously the successful conjugation of RME to 
the nanoparticle surface was confirmed by the appearance of new amide bonds 
around 1670 cm-1and 1550 cm-1for amide I and II respectively. The NHS ester 
groups which would react to form the linker with the amine group on the N 
Terminus of the RME cannot be confidently identified. However the peaks observed 
for symmetric nitro (1551 cm-1), C-H bend (1387cm-1), C-H alkene bend (992 cm-1), 
saturated ester (1735 cm-1) and the C=O stretched of the succinimide in the AuNP 
SH-PEG-SGA sample previously are still evident.  
The peaks present at 1735 cm-1 corresponding to the saturated ester found on the SH-
PEG-SGA are still present post co-functionalization with the RME peptide. 
However, the peak ascribed to the succinimide group has decreased in intensity post 
functionalization with RME, while this could signify the synthesis of a linker by the 
loss of the ester group, it cannot be confidently concluded. Therefore, it leads to the 
Figure 4-12 FTIR spectra for 'free' RME (green), AuNP SH-PEG-
SGA (black) and AuNP SH-PEG-SGA RME (red) 
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likely conclusion that the RME peptide has not reacted with the SH-PEG-SGA.  
From Figure 4-12 the conjugation of RME is evident from the increase in the relative 
intensity of the amide bonds. However, while the formation of Au-N from the free 
amine group on the N-terminus is unlikely, due to the likeliness of a mixed 
monolayer formation through the cysteine due to the high affinity of gold for thiols, 
the presence of Au-N cannot be confirmed. Au-N should peak in the far Infrared 
region at IR at 391cm-1, 474 cm-1, 368 cm-1, 476 cm-1, 375 cm-1 and 415 cm-1. The 
commonly used region for infrared absorption spectroscopy is 4000 ~ 400 cm-
1 because the absorption radiation of most organic compounds and inorganic ions is 
within this region. Therefore due to the expected peak position, the peaks are not 
characteristic enough for identification.  
The presence of Au-S cannot be confirmed on either the AuNP SH-PEG-SGA or the 
AuNP –SH-PEG-SGA RME samples. The frequency of the S-Au bond is expected 
to be low due to the concentration of thiol groups present in the entirety of the 
sample therefore it is suggested that the signal has been quenched due to the ratio of 
the bonding found within the other ligands. There is an increase in noise present at 
1777 cm-1 for the RME conjugated sample in comparison to the PEGylated sample, 
and there is no noise around that bond for the ‘free’ RME, however because of this, 
the synthesis of the S-Au covalent bond is inconclusive, however it is noted that 
there is no thiol group present on the conjugates.  
In addition to the FTIR results, the literature supports the idea that the RME peptide 
bound directly to the gold and not to the PEG via the amine group as required to 
synthesize the desired linker. Sulphur atoms are better soft donor atoms than 
Nitrogen, Park et al. functionalized three bifunctional ligands, 2-pyridylphophines, 
thioamides and 1,1-dicyanoethylene-2,2-dithiolate to the  gold through the P and S 
atoms due to the higher affinity that Sulphur and Phosphorous have for gold. [268,269] 
Therefore, it was generally assumed that gold (I) will not effectively coordinate to a 
donor nitrogen atom. [268,269]  
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As a further secondary technique to conclude that the RME peptide is not creating a 
linker with the SH-PEG-SGA, gel electrophoresis was employed to analyze the chare 
and migration profiles of each of the AuNP samples. Gel electrophoresis is an 
analytical technique normally employed for separating macromolecules or particles 
based upon size and charge, due to the unique red color of gold, gel electrophoresis 
enables direct observation of the particles migration profiles. As seen from the zeta 
results in Table 4-1, altering the AuNP surface with ligands results in a difference in 
zeta potential on the particle surface, which can be observed by variations in the 
migration pattern (Figure 4-13). In conjunction with that, there is an increase in size 
caused by the surface functionalization. Like DLS, gel electrophoresis is sensitive to 
the organic coating on the nanoparticles, therefore differences in the electrophoretic 
speed indicates differences in size and surface charge as a result of particle 
modification. 
Gel electrophoresis confirmed conjugation of both PEG and peptide as indicated by 
the migration profiles for each of the AuNP sample types (Figure 4-13).  [239]  
However, for the linker samples, AuNPs were functionalized with both 10.68 µg/ml 
and 20 µg/ml of SH-PEG-SGA, and then co-functionalized with RME peptide in the 
hope to synthesize an NHS ester - amine linker as illustrated previously Figure 4-3. 
However it is likely that the faster migration decay SH-PEG-SGA is a result of the 
hydrolysis of the ester, as the ester hydrolysis competes with the primary amine 
reaction, the ester appears to be hydrolyzing and splitting into carboxylic acids, 
which accounts for the change in charge, and the differences in zeta potential 
previously observed in Table 4-1. [153] 
 
96 
 
The characterization techniques have so far indicated that RME peptide has 
successfully attached to the AuNP conjugate for both the AuNP SH-PEG and AuNP 
SH-PEG-SGA functionalized particles, however that the co-functionalization with 
RME has produced a mixed monolayer in both approaches. Photoluminescence was 
carried out on both AuNP SH-PEG & RME and AuNP SH-PEG-SGA & RME to 
confirm this.  
Texas Red C2 Maleimide is a thiol reactive bright red fluorescent bio conjugate with 
excitation/emission maxima  ̴ 595/615 nm. If a thiol group is present in solution, 
Texas Red will bind to the S-H and fluoresce when excited   ̴ 595 nm. Figure 4-14 
illustrates the chemical structure of Texas Red, the required amount was calculated 
using the Molecular Weight by the methods previously described in chapter 3.  
Figure 4-13 Gel electrophoresis for a) citrate capped, b) AuNP 10.68 
µg/ml SH-PEG c) AuNP 10.68 µg/ml SH-PEG-SGA, d) AuNP 20 
µg/ml SH-PEG-SGA, e) AuNP 20 µg/ml SH-PEG-SGA 4.45µg/ml 
RME, f) AuNP 10.68 µg/ml SH-PEG 4.45 µg/ml RME. 
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C37H38N4O8S2 
Molecular weight: 
728.83 
Figure 4-14 Chemical structure for the thiol reactive Texas Red 
C2 Maleimide bio conjugate 
Figure 4-15 Emission spectra for the Texas Red displaying the 
intensity for the thiols for the citrate capped gold (negative control), 
'free' RME (positive control), mixed monolayer (AuNP SH-PEG & 
RME) and the linker (AuNP SH-PEG-SGA & RME) 
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The excitation at 595 nm resulted in the subsequent emission at 617 nm for the ‘free’ 
RME sample confirming the presence of free thiol in solution. As expected, no 
excitation peak was present for the mixed monolayer confirming the attachment of 
the RME peptide to the gold via the thiol found on the cysteine residue. The Texas 
Red results for the linker arrangement corroborated with the conclusions drawn from 
the previous results. There was no excitation peak corresponding to a thiol group 
presents for the linker arrangement confirming that the RME bound to the gold 
surface via the thiol group and not via the NHS ester group as previously predicted.  
This result corroborates with previous literature which involved the analysis of 
pepsin composed of one lysine and five cysteine residues.[270] While it is known that 
amine functional groups from primary amines bind to colloidal gold through weak 
covalent interactions, [271] it was concluded that the pepsin-Au conjugate enzyme 
molecules bound to the colloidal surface via thiolate linkages through the cysteine 
residues as well. [272] 
 
 Parallel Loading 
It is apparent that various methods have been employed to characterize nanoparticles 
post functionalization with various ligands and/or ligands. While most involve the 
utilization of DLS as a fundamental basis for conjugation based on an increase in 
particle size, [157]  many research groups facilitate the synthesis of a linker prior to 
conjugation to the AuNP surface. This process, known as parallel loading, involves 
the subsequent reaction of two or more ligands and the characterization of that 
solution prior to addition to the nanoparticle surface. [157]  
AuNPs were synthesized using the Turkevich method outlined in the Materials and 
Methods chapter of this Thesis. To investigate the initial method of loading, 20 
μg/ml of free SH-PEG-SGA was dissolved in 1 ml of distilled water and added 1 ml 
of dissolved RME peptide in water as illustrated in Figure 4-2. The solution was 
stirred overnight under ambient conditions and then added to the gold nanoparticles 
as described in the Materials and Methods. The parallel loaded samples were 
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compared to the mixed monolayer and bifunctional linker samples synthesized and 
co-functionalized as described previously. [184]  
DLS of the AuNP SH-PEG-SGA & RME parallel loaded sample showed an average 
number measurement of 29.85 ± 1.9 with an average PDI of 0.2. This in comparison 
to the number mean measured previously for the sequentially loaded AuNP SH-
PEG-SGA & RME shows a significant decreased in particle size decreasing from ~ 
35 d.nm for PEGylated gold and between 25 – 37 d.nm for sequentially loaded 
RME. The decrease in particle size could be a result of unsuccessful conjugation of 
the parallel loaded sample to the gold or only partial saturation caused by the 
reaction of the thiol groups found on the cysteine on both the PEG and the RME 
peptide. 
Fourier Transform Infrared Spectroscopy was performed on the AuNP samples dried 
in Potassium Bromide. Figure 4-16 & Figure 4-17 displays the absorbance spectra 
for the AuNP SH-PEG-SGA for both parallel and sequential loading.  
Significant differences were evident between the two spectra. Extra peaks were 
present on the parallel loaded sample at 917 cm-1, 980 cm-1, 1394 cm-1 & 1569 cm-1. 
Extra peaks were found on the sequential loaded sample at 950 cm-1, 1543 cm-1, 
1595 cm-1 & 1738 cm-1. The presence of RME on the co-functionalized sample was 
previously confirmed by the presence of additional peaks assigned as follows; amide 
band I at 1515 cm-1, amide band II at 1710 cm-1 and N-H wagging between 600-900 
cm-1. [185,259] Bands ranging between approximately 1320 - 1400 cm-1 are generally 
ascribed to the sp3 C-H bend, while changes in the amide bonds are likely due to 
structural changes caused by binding with the NHS ester. The most notable change in 
peak is the peak present between 1730 - 1740 cm-1; it is likely that this peak belongs 
to an unsaturated ester, which is present on the sequentially loaded sample but not 
the parallel loaded sample. This peak which would suggest that the reaction was 
successful by the NHS ester for the parallel loaded sample. However, the FTIR 
results combined with the DLS results indicate that while the synthesis of a linker in 
parallel may have been successful, the conjugation to gold is likely to be occurring 
via both the thiol found on the PEG, and the free thiol on the N terminus of the RME 
peptide. [265]  
100 
 
   
Figure 4-16 FTIR absorbance spectra for RME peptide both sequentially (red) 
and parallel loaded (black) 
Figure 4-17 FTIR absorbance spectra for RME peptide both sequentially (red) 
and parallel loaded (black) compared to ‘free’ RME peptide (green) 
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The Texas Red thiol fluorescent probe previously employed was re-applied for the 
mixed monolayer, sequentially loaded and parallel loaded samples. The required 
amount was calculated using the Molecular Weight by the methods previously 
described in chapter 3.  
The excitation at 595 nm did not result in any emission for any of the samples tested.  
The Texas Red results for the parallel loaded sample corroborates with the 
conclusions drawn from the FTIR and DLS.  It can be concluded by the lack of an 
excitation peak corresponding to thiols, that the parallel loaded AuNP conjugate 
bound to the colloidal surface via thiolate bonds through the cysteine residues found 
on the SH-PEG-SGA and the RME peptide. [248,272] 
 
Figure 4-18 Emission spectrum for Texas Red showing the excitation and 
lack of emission for all the samples tested 
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4.1.1 Cysteine binding theory – H5 
The results so far in this chapter have thus indicated that the samples functionalized 
with RME peptide have not successfully synthesized a linker for comparison to the 
mixed monolayer counterpart. Due to the affinity of thiol to gold it is hypothesized 
that the conjugation of peptide in the form of a linker may not be possible when a 
thiol is present. Literature has identified that H5WYG can be used for successful 
endosomal escape both with and without a thiol group present. Therefore H5WYG 
was purchased from BIOMATIK with the following sequence 
(GLFHAIAHFIHGGWHGLIHGWYG) and functionalized both sequentially and in 
parallel and compared to the thiol containing H5 co-functionalized using an SH-PEG 
in a mixed monolayer arrangement. [156] 
To investigate the cysteine binding theory, 1 L of citrate capped AuNPs were 
synthesized, characterized and PEGylated with bifunctional SH-PEG-SGA. DLS 
particle size analysis was repeated and the AuNP SH-PEG-SGA was split in to 10 
batches of 200 ml. each pair of individual batches were then co-functionalized by 
either parallel loading or sequential loading (as detailed previously) with H5 both 
with and without the thiolated cysteine residue.   
Dynamic light scattering was applied to measure the hydrodynamic diameter of 
nanoparticles, which is sensitive to the organic coating associated with the 
functionalized AuNP. DLS is predominantly used in this chapter to evaluate the 
conjugation of ligands to the AuNP surface and to assess the level of aggregation. 
DLS size measurements were gathered by measuring and averaging each pair of the 
same sample, 9 runs per sample, with 15 measurements per run. AuNP citrate capped 
reported an average hydrodynamic diameter of 16.19 d. nm, the SH-PEG-SGA 
reported an increased to approximately 34.6 d.nm. Upon co-functionalization, the 
bifunctional AuNP SH-PEG-SGA & H5 without the cysteine residue resulted in 
average AuNP diameters of 35.79 and 29.89 d.nm for the sequential and parallel 
loaded samples respectively (Table 4-2). The bifunctional AuNP SH-PEG-SGA & 
H5 with the cysteine residue resulted in a hydrodynamic diameter of 36.5 and 36.7 
d.nm for the sequential and parallel loaded samples respectively. The thiol 
terminated H5WYG follows the previosu observations with the RME peptide, 
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indicating that another mixed monolayer may have formed. While unexpected, the 
Number averages for the thiol free H5WYG peptide also mimics this trend when 
added sequentially, the results show a slight increase in size (while not statistically 
different), with a large decrease in size when added in parallel. Due to the amine 
chemistry, it is possible that when added sequentially, that the initial thiol terminated 
PEGylation allows some degree of colloidal stability and anchors the PEG in place. 
Whereas when added in parallel the NHS ester forms the amide bond with the 
H5WYG, but when added to the gold, several of the amine groups found on the 
sidechains of the peptide residues along with the thiolate cysteine my potentially 
cause multiple bonds to the gold positioned at various amino residues (Figure 4-19). 
It is also possible that the strength of the Au amine affinity outweighs that of the 
NHS ester bond, resulting in dissociation, causing several overlapping of the peptide 
on the AuNP surface. However, these results are inconclusive; nevertheless, it is of 
note that the largest error was identified for those samples with parallel loading, 
Dunnett’s Post Test was carried out with 95% confidence limits using GraphPad 
Prism against AuNP SH-PEG-SGA as the control and no significant difference was 
found for any of the samples investigated (P < 0.05). 
 
 
 
 
 
 
 
Figure 4-19 Scheme of the multiple bonding sites available to the AuNP surface 
and potential conjugation through utilization of all the available functional 
groups 
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Table 4-2 Table of nanoparticle size measurements for AuNP SH-PEG-SGA co-
functionalized with H5 (with and without the cysteine unit) 
  
Sample Zeta (mV) Size (d.nm) PDI 
AuNP citrate capped -33.76 ± 1.1 16.19 ± 1.5 0.10 
Sequential loading 
AuNP SH-PEG-SGA -31.38 ± 1.1 34.60 ± 1.6 0.13 
AuNP SH-PEG-SGA & H5 with C -15.42 ± 3.6 36.50 ± 2.3 0.42 
AuNP SH-PEG-SGA & H5 without C -28.45 ± 5.7 35.79 ± 2.9 0.34 
Parallel loading 
AuNP SH-PEG-SGA & H5 with C -12.61 ± 0.3 36.72 ± 8.9 0.38 
AuNP SH-PEG-SGA & H5 without C -20.72 ± 0.6 29.89 ± 7.5 0.26 
Figure 4-20 FTIR absorbance spectra for AuNP functionalized with bifunctional 
PEG and H5WYG both with and without the cysteine residue, and both in 
parallel and sequentially 
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The FTIR spectra for the co-functionalized samples are illustrated in Figure 4-20; all 
4 functionalized samples display similar spectra. While the presence of H5WYG 
peptide can be observed by the addition of peaks corresponding to peaks evident 
from the H5WYG spectrum, the saturated NHS ester peak at 1735 cm-1 remains 
present for all spectra regardless of the type of loading and/or if there is a thiol 
present, this leads to the conclusion that a linker has not yet been successfully 
formed.  
4.1.2 Solvent theory 
Hydrophobic amino acids are usually buried within the core of the peptide structure, 
while charged residues are exposed to the solvent to a much higher degree, allowing 
the potential formation of hydrogen bonds. The H5WYG sequence consists of the 
following 32 residues: GLFHAIAHFIHGGWHGLIHGWYG. Glycine, Leucine, 
Phenylalanine, Alanine & Isoleucine are all uncharged hydrophobic residues, while 
Histidine (+1), Tyrosine & Tryptophan are polar. Based on the low propensity of the 
side chains to be in contact with a polar solvent like water, it was concluded that 
based on the Hydro-2 hydrophobicity parameter, the percentage of hydrophobic 
residues for this peptide is approximately 61% hydrophobic and as such should be 
dissolved in small amounts of organic solvents such as DMSO, DMF, Acetic acid or 
methanol.  [249] As previously described; the simplest and most versatile technique 
for functionalizing AuNPs with proteins involves the utilization of chemical groups 
such as an NHS ester which can react with the nucleophilic primary amine groups 
which exist at the N-Terminus of each peptide.  
To the best of the authors knowledge, this approach is novel as most literature 
involves the conversion of a carboxylic group to an ester using carbodiimides such 
as EDC coupling reactions. The approach in this Thesis uses a bifunctional PEG 
with a ready-made NHS ester for functionalization, thus improving efficiency. The 
reaction of NHS esters with amines is strongly pH dependent, at a lower pH the 
amino group is protonated, at a higher than optimal pH hydrolysis is quick. [250] NHS 
ester hydrolyze and Glutaramide Succinimidyl esters like the one used for this 
bifunctional PEG, have a half-life of only 15-20 minutes in water, this rate of 
hydrolysis increases with pH. As well as the potential hydrolysis of the ester, the 
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solubility also varies with the buffer, and is dependent on the structure. Non-
sulphonated forms of the NHS ester are water insoluble and ThermoFisher 
recommends organic solvents such as DMF or DMSO in 0.5-10 % of the final 
volume, elsewhere it is recommended to PEGylate proteins or nanoparticles in a 
large excess of the PEG NHS esters due to the competitive hydrolysis reaction in an 
aqueous solution. [251] Based on these observations from the literature, it can be 
concluded that the synthesis of the linker using the methods employed in chapters 4 
& 6 was not achievable due to the hydrolysis of the NHS ester combined with the 
lack of solubility; consequently, it is possible that the ester hydrolyzed meaning the 
remaining functional end of the bifunctional linker was no longer available for 
conjugation, resulting in the RME & H5WYG peptide binding directly to the gold.  
 To test this theory, 2 L of AuNP citrate capped were synthesized and characterized, 
then split into batches for co-functionalization to reduce any batch to batch 
variability. An array of solvents in a range of functionalization methods were tested, 
these included organic solvents such as amine-free, anhydrous dimethylformamide 
(DMF) and dimethyl sulfoxide (DMSO), methanol, acetonitrile and pH 8 buffer 
solution, using both sequential and parallel loading.  
Citrate capped AuNPs were centrifuged and re-dispersed in pH 8 buffer solutions, 
the resultant solution was highly unstable and have visually fallen out of solution, 
the same was apparent for the methanol and acetonitrile solubilized samples, as a 
result DLS was not measured. Mono functional thiol PEG proved to be the most 
stable of the PEGylated samples in chapter 4, citrate capped AuNPs were 
functionalized with SH-PEG following the protocols in chapter 3 to achieve 50% 
coverage and were centrifuged and re-suspended in pH 8. To this mixture, an aliquot 
of 1 ml of SH-PEG-SGA & H5WYG (without cysteine) which had been stirred for 
24 h under ambient conditions in DMSO was added and stirred for another 24 h. The 
nanoparticles showed an DLS number average of approximately 32 d.nm ± 7 (PDI 
0.33) for both AuNP SH-PEG & the co-functionalized counterpart indicting no 
increase in size as a result of a linker formation (results not shown). Table 4-3 
outlines the remaining samples and the solvents in which they were suspended. The 
H5WYG peptide used for this part of the research did not contain a cysteine residue.  
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Table 4-3 Table of nanoparticle size measurements for AuNP SH-PEG-SGA co-
functionalized with H5 without the cysteine unit in various solvents 
Sample Size (d.nm) PDI 
AuNP citrate capped 16.19 ± 1.5 0.10 
Sequential loading 
AuNP SH-PEG-SGA in DMSO 34.41 ± 2.1 0.19 
AuNP SH-PEG-SGA & H5 in DMSO 47.11 ± 5.1 0.21 
Parallel loading 
AuNP SH-PEG-SGA in pH8 & H5 in DMF 28.94 ± 5.4 0.32 
AuNP SH-PEG-SGA & H5 in DSMO 36.84 ± 12.3 0.19 
 
From the results outlined in Table 4-3 it is evident that adding the SH-PEG-SGA in 
DMSO did not adversely affect the PEG in relation to AuNP size when compared to 
the AuNP SH-PEG-SGA in water from the previous samples (P > 0.05). Dissolving 
the SH-PEG-SGA in a pH buffer solution of pH 8 and adding H5WYG dissolved in 
DMF resulted in a decrease in AuNP size showing colloidal instability however was 
not statistically significant (P > 0.05). Both parallel and sequentially loaded samples 
showed an increase in nanoparticle hydrodynamic diameter when functionalized in 
DMSO. Although the parallel loaded sample suggested large instabilities via the 
large variance experienced when measuring DLS size. Sequential loading however 
resulted in the largest increase in particle size with narrow error bars and was the 
only statistically significant increase when compared to all the solvents tested via a 
One way Anova with Tukey’s post-test (P = 0.001). 
UV/Vis analysis was applied for the above samples to monitor the red shift of the 
SPR peak in relation to conjugation. From the UV/Vis spectra illustrated in Figure 
4-21 and outlined in Table 6-4 it is evident that a great loss in absorption occurred 
for the citrate capped re-suspended in pH 8 and the AuNP SH-PEG & parallel loaded 
SH-PEG-SGA & H5WYG complex confirming a degree of aggregation for those 
samples and a loss of AuNP colloidal stability. When dissolved in DMF, the 
H5WYG sample did not have peak shift, this combined with the decrease in AuNP 
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size indicated that the DMF had resulted in an adverse effect for the SH-PEG-SGA 
and/or the H5WYG peptide.  
The remaining samples, both parallel and sequentially loaded DMSO samples, 
showed a significant peak shift to approx. 524 nm as a result of co-functionalization 
complementing the results obtained from the DLS previously.  
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Figure 4-21 UV/Vis spectra for the H5 co-functionalized AuNPs in a range of solvents 
both added sequentially and in parallel 
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 Table 4-4 UV/Vis SPR peak shifts for the AuNPs co-functionalized in a range of 
solvents both via sequential and parallel loading 
Sample 
Wavelength 
(nm) 
Absorbance 
(Au) 
Peak Shift 
from 
control 
AuNP SH-PEG-SGA control 521.3 0.65 N/A 
AuNP Citrate capped re-dispersed in pH 8 
buffer 
519.8 0.33 -1.5 
AuNP  25% SH-PEG (pH 8) & SH-PEG-SGA 
& H5 in DMSO (Parallel loaded) 
522.7 0.449 +1.4 
AuNP SH-PEG-SGA & H5 w/o C both 
dissolved in DMSO added Sequentially 
523.6 0.77 +2.3 
AuNP SH-PEG-SGA & H5 dissolved in pH 8 
added in Parallel 
524.6 0.78 +3.3 
AuNP SH-PEG-SGA & H5 in DMSO added in 
Parallel 
525.2 0.89 +3.9 
AuNP SH-PEG-SGA in pH 8 and H5 dissolved 
in DMF added in Parallel 
521.4 0.85 +0.1 
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FTIR analysis demonstrated a clear peak at 1735 cm-1 for both the samples added in 
pH 8 buffer solutions and DMF (Results not shown). This peak corresponds to an 
unsaturated ester and therefore indicates that the NHS ester reaction has been 
unsuccessful. For the parallel loaded H5WYG peptide in water, the presence of the 
peak at 1735 cm-1 is still observed, indicating the lack of a reaction with the NHS 
ester; however the complete loss of the saturated ester for the sequentially loaded 
sample in DMSO indicates that a linker can be successfully synthesized when 
suspended in DMSO (Figure 4-22). This is an important finding fundamental to the 
context of this Thesis.  The FTIR analysis combined with the DLS & UV/Vis 
strongly indicate the successful synthesis if the linker arrangement when added via 
sequential loading using DMSO. However extra peaks are present on the spectra at 
3000, 2900, 1200-1240, 1000-1080, 960 & 690 cm-1, these arise from the DMSO 
spectra as illustrated in Figure 4-23 taken from the NIST Chemistry WebBook, NIST 
Standard Reference Database Number 69, as it is very difficult to remove all traces 
of DMSO. [273]  
Figure 4-22 FTIR absorbance spectra comparing the parallel (green) and 
sequentially loaded  (blue) AuNPs in water to the sequentially loaded sample in 
DMSO (red) 
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Therefore, it could be argued that the lack of the ester peak is a result of signal 
quenching and not the loss of the ester as a by-product. Therefore, the results remain 
inconclusive. 
Therefore, to confidently conclude the successful synthesis of a linker; citrate capped 
AuNPs were functionalized with bifunctional PEG dissolved in 1 ml DMSO and 
stirred overnight under ambient conditions. The PEGylated sample was then co-
functionalized with H5WYG peptide containing a thiolated cysteine residue 
(GCLFHAIAHFIHGGWHGLIHGWYG). The sample was then centrifuged three 
times and measured by FTIR. The FTIR spectra obtained was very like that of the 
H5 peptide without the thiol, although peaks were present at approximately 2550-
2600 cm-1 which corresponds to an unreacted thiol group, indicating further the 
binding via the primary amine and not the cysteine. The remaining pellet was then 
mixed with the required amount of Texas Red thiol sensitive dye and left to stir over 
night. The sample was then centrifuged 3 times and 1 ml of the sample was retained 
after each centrifugation for analysis in triplicate via a fluorescent plate reader. As 
evident in Table 4-5 the fluorescent found that after the first centrifugation, a plateau 
was reached indicating that no more peptide was washed away from the AuNP. The 
Texas Red result concluded definitively that even in the presence of a cysteine 
residue that a linker could be achieved when synthesized sequentially in DMSO. 
Figure 4-24 shows the fluorescent spectra for the Texas Red with the mixed 
monolayer acting as a negative control. it can be observed that an emission spectra 
Figure 4-23 FTIR absorbance spectra for pure DMSO taken from the NIST 
Chemistry WebBook, NIST Standard Reference Database Number 69 [273] 
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occurred for the bifunctional linker samples synthesized in DMSO but not for the 
sampled conjugated in water, indicating that the thiol has remained free in solution, 
that combined with all the previous results which confirm the presence of the peptide 
on the AuNP surface conclude the successful synthesis if a bifunctional linker.  
  
Table 4-5 displaying the OD measured following centrifugation via a plate reader 
  
 
 
 
# of times centrifuged OD Average 
 Rep 1 Rep 2  
1 23520 23520 23520 
2 23806 23806 23806 
3 24383 24383 24383 
Figure 4-24 Texas Red thiol sensitive fluorescent spectra illustrating the 
emission for the mixed monolayer (red), bifunctional linker in water 
(black) and the bifunctional linker synthesized in DMSO (green) 
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4.1.3 Solubility Study  
Dimethyl Sulfoxide (DMSO) is a polar aprotic, organosulfur compound which 
dissolves both polar and non-polar entities and is miscible in water. The methyl 
groups on DMSO ((CH3)
2SO) are mildly acidic with a pK = 35. [274,275] As such it 
can be successfully employed to solubilize a wide variety of molecules, and has been 
commonly used in the literature to solubilize hydrophobic compounds in cell biology 
experiments and poorly soluble drugs in permeation assays such as that using Caco2 
enterocyte-like cells. This coupled with its apparent low toxicity at concentrations < 
10% has led to its ubiquitous use and application in biology. [276,277] Nevertheless the 
cytotoxic effect of DMSO has recently become controversial in the literature. 
Several studies have been identified to evaluate the toxic effect of DMSO in cell 
viability assays, however the results are diverse. Caco2/TC7 cells were cultured for 
21 d on 96-well plates and incubated with DMSO solutions (0-100%) in Hank's 
balanced salt solution containing HEPES (biological buffer (25 mM)), pH 7.4. 
DMSO 10% did not induce any significant increase in lactate dehydrogenase (LDH) 
release whereas a significant increase in LDH activity (ANOVA, p < 0.05) occurred 
at a DMSO concentration of 20 to 50%. NR incorporation in viable cells was 
statistically reduced by 27 to 36% at DMSO concentration of 20% up to 100% 
(ANOVA, p > 0.05). No statistical difference (p < 0.05) was observed between the 
control and 10% DMSO groups. [276] Comparable results were obtained following 
exposure of HeLa cell lines to DMSO for periods of 30, 60, 90 & 120 minutes. At 
concentrations below 15% there seemed to be no significant difference following 
exposure as measured by confluency of cultures at the end of 96 h. [278] In direct 
contradiction with these results, studies have since shown that exposure of astrocyte 
cultures to 1% DMSO for 24 h did not significantly affect cell survival, but 
decreased cell viability and at concentrations of 5% significantly inhibited cell 
variability and promoted apoptosis of astrocytes, accompanied with more severe 
mitochondrial damage. [279] Elsewhere toxicity was confirmed in vitro in a retinal 
neuronal cell line, at DMSO concentrations >1% (v/v), using annexin V, terminal 
deoxynucleotidyl transferase dUTP nick end labelling (TUNEL), 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), and AlamarBlue cell 
viability assays. Low concentrations (2-4% DMSO) induce caspase-3 independent 
neuronal death that involves apoptosis-inducing factor (AIF) translocation from 
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mitochondria to the nucleus and poly-(ADP-ribose)-polymerase (PARP) activation. 
[280] 
As there is such diversity present, and the subsequent effect of DMSO on prostate 
cancer cell lines is still ambiguous, a solubility study was performed to identify the 
lowest concentration of DMSO possible to still elicit the successful solubilization 
and subsequent synthesis of a bifunctional linker. The synthesis of a linker with a 
cysteine residue in DMSO as seen from the Texas Red results in Figure 4-24 became 
highly unstable after just 72 h, with the gold visibly ‘falling out’ of solution. 
Therefore, all the following linker samples were conjugated via sequential loading 
using the SH-PEG-SGA & H5WYG without the cysteine residue in DMSO.  
 
The purpose of this study is to identify if neat DMSO is required to synthesize a 
stable AuNP linker conjugate. A stock batch of 1.5 L citrate capped AuNPs was 
synthesized, and split into 5 x 100 ml batches. Each batch was functionalized with 
SH-PEG-SGA in increasing amounts of DMSO and left to stir under ambient 
conditions then characterized using DLS & UV/Vis.  From the results obtained in 
Table 4-6 & Table 7-7 an obvious trend was observed with increasing zeta potential 
correlating to an increase in % DMSO. The PDI remained consistent for all samples 
indicting that there was no increase in polydispersity because of the varying % of 
DMSO, however the largest (and most consistent size in relation to all the AuNP 
SH-PEG-SGA batches synthesized throughout this Thesis) belongs to the neat 
DMSO. The UV/Vis spectra (Figure 4-25) displays the characteristic peak at 
approximately 520 nm with all peak positions appearing at approximately 524 nm. 
Based on these results 100% DMSO was chosen to continue with co-
functionalization, the remaining 1 L of the stock AuNP citrate capped was then 
functionalized with SH-PEG-SGA dissolved in 100% DMSO and added, 1 ml in 1 L 
yields 0.1% DMSO while still offering the NHS ester for co-functionalization while 
preventing ester hydrolysis.  
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Table 4-6 Table displaying the DLS size and zeta potential measurements for the 
AuNP SH-PEG-SGA samples synthesized using increasing concentrations of 
DMSO 
Sample (% of DMSO) Size (d.nm) PDI Zeta (mV) 
AuNP SH-PEG-SGA (20%) 25.36 ± 2.3 0.26 -32.59 ± 3.1 
AuNP SH-PEG-SGA (40%) 26.58 ± 3.0 0.29 -32.62 ± 2.1 
AuNP SH-PEG-SGA (60%) 26.33 ± 5.6 0.23 -37.74 ± 1.6 
AuNP SH-PEG-SGA (80%) 31.86 ± 3.1 0.22 -20.32 ± 3.1 
AuNP SH-PEG-SGA (100%) 33.72 ± 2.4 0.23 -19.82 ± 4.0 
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Figure 4-25 UV/Vis absorbance spectra for AuNP SH-PEG-SGA in increasing 
concentrations of DMSO varying from 20 % (dark blue), 40 % (red), 60 % 
(green), 80 % (purple) and 100 % (light blue) n = 3 
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After stirring under ambient conditions overnight, the now 1 L AuNP SH-PEG-SGA 
stock batch was split in to 5 x 200 ml batches and co-functionalized with H5WYG 
peptide dissolved in increasing amounts of DMSO (20-100%). After stirring for 24 
hours the samples were then characterized via DLS and UV/Vis. Table 7-7 identifies 
a similar trend as Table 4-6 with increasing zeta potential being a direct result of 
increasing % of DMSO. This is expected due to the lightly acidic nature of the 
DMSO with protonating possibly occurring at the methyl groups. While a One way 
Anova identified no statistical significance between the hydrodynamic diameter, the 
PDI showed an inversely proportional relationship with the % DMSO, decreasing as 
the concentration of DMSO increased. Visual observation observed varying degrees 
of aggregation for the H5 the lower the amount of DMSO, the more aggregation 
observed. This trend can also be observed via the UV/Vis in Figure 4-26. Although 
slight, the absorbance value decreased with the lower amounts of DMSO, while the 
highest absorbance value was observed for the H5WYG peptide added with 100% 
DMSO.  
 
Table 4-7 Table displaying the DLS size and zeta potential measurements for the 
AuNP SH-PEG-SGA & H5 peptide functionalized samples synthesized using 
increasing concentrations of DMSO 
Sample (% of DMSO) Size (d.nm) PDI Zeta (mV) 
AuNP SH-PEG-SGA & H5 (20%) 38.89 ± 1.3 0.58 -38.08 ± 4.3 
AuNP SH-PEG-SGA & H5 (40%) 37.45 ± 5.4 0.47 -38.08 ± 3.1 
AuNP SH-PEG-SGA & H5 (60%) 36.97 ± 3.3 0.48 -29.24 ± 1.4 
AuNP SH-PEG-SGA & H5 (80%) 40.56 ± 2.6 0.39 -22.38 ± 2.8 
AuNP SH-PEG-SGA & H5 (100%) 41.80 ± 1.2 0.24 -0.14 ± 0.3 
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To determine the binding efficiency of the H5WYG in varying % of DMSO, a Micro 
bicinchoninic acid (Micro-BCA) assay was performed to determine the exact 
quantity of peptide present on the surface of the AuNP. The total amount of peptide 
loaded onto the surface of the NPs was calculated in percentages, and the final 
concentration of peptide was obtained in μg/ml (Table 4-8). Each AuNP batch was 
centrifuged and the supernatant decanted, then mixed back to the original volume. 
Both the centrifuged sample and the corresponding supernatant were quantified 
using the Micro BCA. It was concluded that 100% DMSO would be used to 
synthesize the linker. For the remaining studies 2 L of citrate capped AuNPs were 
synthesized, 400 ml was retained for analysis and the remaining AuNP was split into 
2 x 800 ml batches to synthesize the mixed monolayer and the bifunctional linker 
samples for subsequent analysis thus reducing lot to lot variability. 2 ml of DMSO 
would eventually be added in total to 400 ml of AuNPs suspended in water yielding 
a total DMSO % of 0.5% which is below the recommended % identified from the 
literature. Once synthesized the samples were centrifuged and washed 3 times and 
re-dispersed in sterile PBS under cell culture conditions. 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
400 450 500 550 600
A
b
so
rb
an
ce
 (
A
u
)
Wavelength (nm)
 AuNP SH-PEG-SGA & H5 20% DMSO
 AuNP SH-PEG-SGA & H5 40% DMSO
AuNP SH-PEG-SGA & H5 60% DMSO
AuNP SH-PEG-SGA & H5 80% DMSO
AuNP SH-PEG-SGA & H5 100% DMSO
Figure 4-26 UV/Vis absorbance spectra for AuNP SH-PEG-SGA (100% 
DMSO) & H5WYG peptide at increasing concentrations of DMSO 
ranging from 20 % (light blue), 40 % (pink), 60 % (red), 80 % (dark 
blue) and 100 % (orange), n = 3 
526 nm 
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Table 4-8 Table displaying the concentrations obtained through utilization of a 
Micro BCA assay on both the sample and its corresponding supernatant 
 
 Conclusions 
The successful synthesis of AuNPs functionalized with both PEG and/or the 
H5WYG or RME peptide using either a mixed monolayer surface arrangement or the 
incorporation of a hetero bifunctional PEG linker was confirmed via FTIR, DLS and 
through the use of the Texas Red thiol marker. Results from sequentially loading 
RME peptide dissolved in water to AuNPs functionalized with SH-PEG-SGA 
demonstrated no significant differences in size or UV/Vis peak position in 
comparison to the mixed monolayer counterpart. This was expected, as the RME 
peptide sequence encompasses a thiol containing cysteine residue with a binding 
affinity of 40-50 kcal/mol-1 to gold. The subsequent hypothesis was that loading the 
SH-PEG-SGA in parallel with the RME peptide would allow the successful 
synthesis of the linker and the RME peptide, which could then be loaded unto the 
AuNP surface. However results observed no significant difference in the DLS 
Number average measurements, and it was concluded that a linker was not formed 
due to the potential hydrolysis of the ester, and the potential that even if the linker 
was successfully synthesized, the thiol found on the cysteine residue could still be 
potentially binding to the gold (Figure 4-19). To determine if it was the competing 
hydrolysis reaction or the thiol bond preventing the successful synthesis of an AuNP 
conjugate using a linker, H5WYG peptide (both with and without a cysteine residue) 
Sample Centrifuged x1 Supernatant 
% DMSO 
concentration 
(µg/ml) 
% 
concentration 
(µg/ml) 
% 
20% 19.93 64.79% 10.83 35.21 
40% 19.57 61.83% 12.08 38.17 
60% 20.37 64.63% 11.15 35.37 
80% 19.08 63.33% 11.05 36.67 
100% 18.79 60.46% 12.29 39.54% 
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was dissolved in either water or DMSO and co-functionalized to the AuNP surface. 
FTIR and Texas Red concluded that it is necessary to use a solvent such as DMSO, 
to prevent hydrolysis of the NHS ester of the bifunctional PEG – to successfully 
synthesis a gold nanoparticle using a bifunctional linker, even in the presence of a 
thiol group (Figure 4-24). A linker was successfully synthesized when in the 
presence of a cysteine residue (H5WYG peptide) and confirmed via Texas Red, 
however became quickly unstable and visibly ‘fell’ out of solution. Therefore, while 
changing the solvent overcomes the competition of hydrolysis, it is still unadvised to 
synthesize a linker using a pre-ready NHS ester in the presence of a thiol due to the 
instabilities presented from the results in this These. As such it is recommended that 
investigations comparing a mixed monolayer directly to a peptide conjugated using a 
PEG linker should be synthesized in DMSO using a thiol free peptide. Therefore the 
next chapter will encompass the H5 peptide sequences 
GCLFHAIAHFIHGGWHGLIHGWYG & GLFHAIAHFIHGGWHGLIHGWYG to 
synthesize the mixed monolayer and linker respectively, allowing the cysteine 
residue to be available for binding to the AuNP surface when synthesizing a mixed 
monolayer, and the absence of the thiol when synthesizing a linker sequentially 
using DMSO. Further investigations are required to compare the arrangements and 
address the inconsistencies identified in the literature surrounding the ‘anti-PEG’ 
effect predicted, and to determine is using one method of attachment can offer a 
more desirable response for stability, the ability to resist non-specific protein 
adsorption, internalization and enhanced radiosensitivity than the respective 
arrangement.  
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5.  MIXED MONOLAYER ARRANGEMENT VS. THE 
USE OF A HETERO BIFUNCTIONAL LINKER 
It has been hypothesized in this Thesis that the use of a linker would allow for direct 
cell contact between the internalization peptide and the prostate cancer cell, and that 
the use a mono-functional PEG would hinder the peptide interaction to a degree. 
Inconsistencies in the literature include the effect on colloidal stability, the resulting 
opsonization and the effect each arrangement has on cellular internalization. 
Currently there is little consensus regarding which approach should be applied in a 
situation. However the literature has displayed great promise for mixed monolayer 
arrangements, such as that reported by Paciotti et al. [59–63]  
One of the largest inconsistencies from the literature is the role of peptide length in 
relation to biological availability. It is plausible that having peptides which exceed 
the length of the PEG could have an ‘anti-PEG’ effect, and allow for the recognition 
as foreign, making the AuNP susceptible to non-specific protein attachment and 
potential removal by the immune system. [131,153,222] 
Chapter 4 investigated the conditions required to synthesize a linker to co-
functionalize AuNPs. A benefit of using a bifunctional linker would be to allow the 
AuNP surface to be completely saturated with PEG and the remaining active end 
groups could then to be used to anchor a biologically active group. This would have 
a two-fold benefit as firstly, it would allow direct contact with the receptors on the 
tumor cell, and secondly it would allow more of the required therapeutic, targeting or 
other payloads to be attached in comparison to a mixed monolayer arrangement.  
The results indicated that the synthesis of a stable bifunctional linker cannot be 
achieved in the presence of a thiol group or when using an NHS ester suspended in 
water, as such the research effort has identified DMSO as the most suitable solvent 
out of those tested. Therefore, this chapter serves to address whether having a 
bifunctional linker would result in a loss of colloidal stability due to an ‘anti-PEG’ 
effect, or if the bifunctional linker would enable the conjugated peptide to overcome 
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any potential steric hindrance caused by the stabilizing agent in a mixed monolayer 
arrangement. [217,222]  
 Results and Discussion 
AuNPs were synthesized using the Turkevich method outlined in the Materials and 
Methods section of this Thesis. To prepare the mixed monolayer PEG capped 
AuNPs, 10.68 μg/ml of free SH-PEG was dissolved in 1 ml of distilled water and 
added to the citrate capped AuNPs. As described in chapter 3, this level of PEG 
addition yields approximately 50% of potential surface saturation with this ligand. 
5.56 μg/ml of H5 peptide was measured and dissolved in water and aspirated 
vigorously until dissolved, then added to the stirring AuNP SH-PEG under ambient 
conditions and left over night. [184] 20 μg/ml of free SH-PEG-SGA was dissolved in 
1 ml of DMSO and aspirated, then added to the ‘as synthesized’ AuNPs to fully cap 
the nanoparticles with PEG linker. [184] 5.56 μg/ml of H5 was measured and 
dissolved in 1 ml of DMSO and aspirated until dissolved, then added to stirring 
AuNP SH-PEG-SGA under ambient conditions and left over night. The co-
functionalized samples were collected and decanted into 50 ml centrifuge tubes, and 
centrifuged at 10,000 RPM for 90 minutes. The supernatant was decanted off and the 
pellet was re-suspended in sterile water (for the mixed monolayer) or sterile PBS (for 
the linker). This process was repeated in triplicate to further nullify any potential 
toxicity experienced by the DMSO.  
The nanoparticles were characterized at various points during synthesis, including 
post synthesis, post PEGylation, post centrifugation and after co-functionalization 
with H5WYG peptide. The characterization techniques employed for this chapter 
include DLS, UV/Vis, FTIR, ICP-MS, cell culture and Clonogenic survival assays. 
Unless otherwise specified, samples synthesized from this point on include AuNP 
citrate capped, AuNP SH-PEG, AuNP SH-PEG and H5WYG peptide (AuNP SH-
PEG & H5 (mixed monolayer)), AuNP SH-PEG-SGA dissolved in DMSO (AuNP 
SH-PEG-SGA) and AuNP SH-PEG-SGA & H5WYG peptide (AuNP SH-PEG-SGA 
& H5 (bifunctional linker)) dissolved in DMSO. For the mixed monolayer 
arrangement, a cysteine terminated H5WYG peptide 
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(GCLFHAIAHFIHGGWHGLIHGWYG) was used, while for the bifunctional linker 
arrangement, the thiol free H5WYG peptide (GLFHAIAHFIHGGWHGLIHGWYG) 
was employed. 
 Dynamic Light Scattering 
DLS is predominantly used to confirm the conjugation of ligands to the AuNP 
surface and is also employed to assess the level of aggregation of the nanoparticles, 
particularly after co-functionalization. AuNP citrate capped reported an average 
hydrodynamic diameter of 16.18 d. nm, the mono-functional SH-PEG saw an 
increase to approximately 35.35 d. nm and the bifunctional SH-PEG-SGA reported 
an increased to approximately 34.31 d.nm which when compared to the AuNP SH-
PEG-SGA re-suspended in DMSO, identified no significant (P > 0.05) and a 
diameter of 34.78 (Figure 5-1). Upon co-functionalization, SH-PEG & H5 increased 
slightly to 34.5 d.nm which is not unexpected as the H5WYG peptide is shorter than 
the length of the SH-PEG. Co-functionalizing the bifunctional AuNP SH-PEG-SGA 
with H5 resulted in an average AuNP diameter of 39.26, when re-suspended in PBS 
this increased slightly to and 41.25 d.nm, which was again statistically insignificant. 
The change however between the AuNP SH-PEG-SGA both in DMSO and PBS is 
statistically significant when compared to the AuNP SH-PEG-SGA & H5 
counterparts. This contrasts to the results obtained for the ‘linker’ in chapter 4, as a 
large enough increase in diameter to cause a statistical difference did not occur.  The 
PDI for each of the samples outlined in Table 6-1suggests that the samples remained 
relatedly mono disperse, and there were no large variances observed via the error 
bars.  
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Table 5-1 DLS Number average results for the samples synthesized for the mixed 
monolayer and linker biological studies showing the AuNP SH-PEG-SGA and 
AuNP SH-PEG-SGA & H5 samples in both DMSO and PBS 
Conjugate DLS Number average PDI 
AuNP citrate capped 16.18 ± 3.3 0.22 
AuNP SH-PEG 35.35 ± 1.2 0.17 
AuNP SH-PEG & H5 34.5 ± 2.5 0.19 
AuNP SH-PEG-SGA DMSO 34.01 ± 2.8 0.19 
AuNP SH-PEG-SGA PBS 34.78 ± 2.9 0.29 
AuNP SH-PEG-SGA & H5 DMSO 39.26 ± 1.9 0.41 
AuNP SH-PEG-SGA & H5 PBS 41.25 ± 3.1 0.42 
Figure 5-1 DLS Number average results graphically comparing the 
nanoparticle hydrodynamic diameters for AuNP co-functionalized 
samples in DMSO & PBS showing no significant difference between the 
same samples re-dispersed in either PBS or DMSO, but significant 
difference between the PEGylated and co-functionalized counterparts 
(P>0.05) 
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5.2.1 Colloidal stability Studies 
As synthesized AuNPs aggregate instantly under physiological conditions, 
PEGylation overcomes this by shielding the AuNP surface by the conjugated 
polymer. Literature identifies inconstancies when discussing the colloidal stability of 
linkers. It is generically believed that using a bifunctional linker may result in an 
‘anti-PEG’ effect. While there is already some literature available with has 
successfully utilized linker formation both in vitro and in vivo, as outlined in chapter 
2 this study was conducted to directly compare the two surface arrangements to see 
if one enhances colloidal stability in comparison to the other. As previously 
mentioned, aggregated AuNPs are accompanied by a red shift in the electromagnetic 
spectrum, combined with broadening of peaks and a decrease in peak intensities. 
Aggregated nanoparticles are also visibly detectable by an obvious change in 
solution color from ruby red to blue/purple. Therefore UV/Vis provides a simple and 
effective method to assess the colloidal stability of each of the samples in vitro under 
both increasing NaCl concentration and in PBS over an extended periods. [281]   
AuNPs which are not coated with PEG or an alternative stabilizing agent aggregate 
in vivo at physiological salt concentrations. Aggregated AuNPs will change color 
from ruby red to blue, or to clear with particulates visible in solution. This change 
can be monitored via a loss of absorbance and a red shift from UV/Vis analysis. 
[217,222] 
To investigate the effect of functionalization on AuNP colloidal stability the samples 
were centrifuged and re-suspended in PBS. The suspension medium for the linker 
samples have since been changed to PBS to overcome any toxicity prevalent from 
the DMSO, therefore a CCC study was conducted on all samples with increasing 
molarity to 1 M NaCl. The samples were then left at 1 M NaCl for 7 days and re-
analyzed using UV/Vis. The results of both studies are illustrated in Figure 5-2 & 
Figure 5-3 respectively.  
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Figure 5-2 CCC study comparing the relative absorbance for the mixed 
monolayer (red) and the linker (blue) at increasing NaCl molarities up to 
and including 1 M NaCl, n=3 
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Figure 5-3 UV/Vis  CCC time study monitoring the relative absorbance 
SPR pattern for both the mixed monolayer (red) and the linker (blue) 
samples at 1 M NaCl over a period of 7 days, n=3  
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Figure 5-2 & Figure 5-3  depicts the results of the critical coagulation concentration 
study (CCC) which represents the UV-Vis peak height for each of the samples under 
increasing concentrations of NaCl. The results observed in both Figure 5-2 & Figure 
5-3 contradict the literature, it has been previously reported that the use of a linker 
arrangement would have an ‘anti-PEG’- effect, and as such, will decrease AuNP 
stability. [131]  It is apparent from the UV/Vis that there was no loss of colloidal 
stability for the bifunctional linker samples up to 1 M NaCl for a period of 1 week, 
with the relative absorbance remaining at 1 for the CCC study and the absorbance 
dropping by only 0.03 (Au) after 7 days, however a peak shift of -2.7 nm was 
observed with the peak position shifting from 526.5nm to 523.8 nm. A drop in peak 
position could be argued to indicate a decrease in nanoparticle size, potentially due 
to the peptide ‘falling off’ over time. The results from the SPR pattern however, 
when combined with the previous characterization data, do not indicate a loss of 
functionalization and/or colloidal stability as a result of co-functionalization with 
DMSO. A decrease in peak position is also evident for the mixed monolayer 
arrangement, with a peak shift from 523.8 nm – 522.5. The SPR pattern from the 
CCC study indicated increasing aggregation because of increasing molarity, with the 
relative absorbance dropping from 1 to 0.81 Au at 1 M NaCl. The SPR pattern then 
continued to decrease over the 7-day period, plateauing at 0.815 Au showing a 
significant absorbance decrease of 0.53 Au in comparison to day 1.  
Therefore, it is concluded that at the conditions studied, the use of a hetero-
bifunctional linker did not adversely affect colloidal stability; however, the mixed 
monolayer approach displayed significant aggregation when exposed to high NaCl 
concentrations over extended periods. While this is true for the H5WYG studied in 
this chapter, based on the previous chapters utilizing a mixed monolayer with RME, 
H5WYG and RGD peptides, it is likely that this occurrence is a result of the peptide 
investigated and not the arrangement. It is possible that the reduced colloidal 
stability observed with the H5WYG peptide may be because of the lower net charge 
of +0.4 compared to 2.9 for the RME peptide. In addition, the H5WYG peptide 
contains a higher proportion of hydrophobic residues (namely A, F, I, L W &Y) than 
RME rendering the peptide less water soluble.  
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5.2.2 Non-Specific Protein Adsorption 
As well as colloidal stability being an essential attribute of AuNPs, the ability to 
resist protein adsorption is crucial in determining the biological fate of the AuNP. 
Non-specific protein attachment can occur in vivo with a corona of protein adhering 
to the nanoparticle surface. The biological fate of the AuNP is largely determined by 
these nonspecific proteins. Regarding the literature, there is a consensus that using a 
hetero-bifunctional linker will have an ‘anti-PEG’ effect. It has also been reported 
that the PEG length has to exceed that of the peptide to shield the nanoparticle from 
opsonization for maximum circulation. [217,222]  
The DLS results outlined in Table 5-2 indicate that both methodologies (mixed 
monolayer and PEG linker) are effective at inhibiting non-specific protein 
attachment when incubated in DMEM FCS 10%. A highly significant increase in in 
size is evident for the citrate capped AuNP after incubation with FCS from 
approximately 19.97 d.nm - 60.44 d.nm (P value of < 0.0001) indicating the 
presence of protein on the AuNP surface, while the remaining PEG capped and PEG 
& H5 co-functionalized samples indicate no such increase in size.  This data  (Figure 
5-4) therefore concludes that synthesizing a linker does not initiate an ‘anti-PEG’ 
effect. [131,153,222] 
128 
 
 
Figure 5-4 Statistical comparison for average diameter of citrate capped AuNPs 
before and after incubation with 10% FCS in DMEM 
 
Table 5-2 Table displaying the non-specific protein adsorption results for the 
mixed monolayer and linker samples made using H5 peptide both prior to and 
following incubation with FCS in DMEM media 
Conjugate 
DLS volume 
average 
DLS volume average post 
DMEM FCS10% 
AuNP citrate capped 19.97 ± 1.6 60.44 ± 17.5 
AuNP SH-PEG 35.29 ± 2.7 35.14 ± 6.2 
AuNP SH-PEG-SGA 35.64 ± 3.3 33.58 ± 3.8 
AuNP SH-PEG & H5 36.18 ± 2.76 34.03 ± 4.6 
AuNP SH-PEG-SGA & H5 38.74 ± 3.4 36.18 ± 2.3 
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5.2.3 Cell Viability 
The cytotoxicity of AuNPs and the correlation of cytotoxicity and/or the production 
of reactive oxygen species (ROS) as a result of nanoparticle size, shape, 
hydrophobicity and charge have been studied in many research papers. The 
hydrophobicity and charge also determine the binding sites for receptors and 
influence the dispersion and aggregation. Surface charge is often linked to 
hydrophobicity, whereas some studies have found that by using oleic acid coated 
nickel ferrite and stearic acid coated TiO2 (titanium oxide) at the same surface 
charge, that toxicity is due to the surface coating. [282] Cytotoxicity can also be a 
factor caused by contamination, solubility or toxic payloads; however it can also be 
linked to biological parameters such as the cell line investigated, exposure time 
and/or temperature. Recent results demonstrating the potential toxic impact of 
AuNPs have generated controversy. There is vast diversity in the toxic responses 
reported, Raman-active AuNPs (PEG-R-AuNPs) cause minimal toxicity in both 
HeLa and HepG2 cells in an acute setting, [283] Soderstjerna et al. reported toxicity 
was only encountered in concentrations above 20 nM, whereas in osteoblastic cells, 
AuNPs have been reported to enhance differentiation. [284,285] The data therefore 
indicates that cytotoxicity may depend on the type of cell and could vary greatly 
across different cell lines. [286] 
Nanoparticle toxicity was investigated for both surface arrangements by an MTT cell 
viability assay. The aim of this study was to address the literature and determine 
whether a longer PEG length will reduce toxicity as experienced with AuNPs 
functionalized with both tiopronin and a long-chain mercaptoundecyl-tetraethylene 
glycol (MUAPEG);  or will utilizing a linker arrangement induce a toxic effect due 
to the loss of PEG shielding. [222] It also serves to investigate the effect of charge on 
toxicity. 
2 cell lines were investigated for this study, PC3 and DU145 at three time points 
(days 3, 5 & 7). PC3 and DU145 cells are an epithelial cell line from a homosapien 
prostate. PC3 is derived from a metastatic bone of grade IV, adenocarcinoma, 
whereas DU145 is derived from a metastatic carcinoma brain site. Both lines were 
chosen based on the abundance of cellular studies in the literature. The results for the 
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The aim of the cell viability study is 3-fold; to investigate the toxicity induced as a 
result of surface arrangement, increasing nanoparticle concentrations and to confirm 
whether nanoparticle toxicity is a potential result caused by any unreacted species 
(supernatant). Initial observations indicated obvious aggregation for citrate capped 
nanoparticles (see chapter 6), which increased drastically with increasing 
concentrations. However, from the results obtained, it is apparent that loss in 
viability is inversely proportional to the degree of AuNPs aggregation. This 
relationship has also been previously observed in HeLa cell lines. [287] 
 (AuNP SH-PEG & H5) mixed monolayer arrangement are outlined in Figure 5-5 
and the (AuNP SH-PEG-SGA & H5) bifunctional linker results are outlined in 
Figure 5-6. Statistical analysis was performed using a one-way ANOVA and Tukey 
post-test using Graphpad Prism software, with a P number <0.05 indicating 
statistical significance. 
The cytotoxicity of nanoparticles has been studied in an abundance of literature, 
however initial conclusions seem that toxicity is dependent on the cell line and the 
concentration of the AuNPs. [284–286] From the results (Appendix 2 and Appendix 3) 
toxicity was dependent upon increasing concentrations with over 100 µg/ml 
exhibiting some degree of toxicity for all samples tested, and that the degree of 
toxicity exhibited was directly dependent on the level of functionalization that the 
AuNPs had undergone. [287] The aim of the previous study was to address the 
literature and determine whether a longer PEG length would reduce toxicity as 
experienced with AuNPs functionalized with both tiopronin and a long-chain 
mercaptoundecyl-tetraethylene glycol (MUAPEG);  or will utilizing a linker 
arrangement induce a toxic effect due to the loss of PEG shielding. [222] It was 
concluded that that loss in viability is inversely proportional to the degree of AuNPs 
aggregation, a decrease in % survival is evident as the sample concentration 
increases, the supernatant studies have demonstrated that there is no reduced 
viability as a result of any unreacted species and that an increase in AuNP 
functionality, irrespective of the surface arrangement used, results in an increase in 
nanoparticle toxicity. A cell viability assay is essential for this part of the research 
due to the implementation of DMSO as the solubilizing solvent. The most 
standardized and validated test to estimate the cytotoxicity of compounds towards 
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cells is MTT test. This assay is dependent on the ability of live but not dead cells to 
reduce significant amounts of water-soluble yellow MTT dye to insoluble violet 
formazan crystals, which can be measured by a colorimetric method.  
The data indicates that the rate of cell viability decreased significantly (P < 0.05) 
with increasing concentrations of all examined AuNP samples compared to those of 
the negative control group and cytotoxicity increase was surface functionality 
dependent, Figure 5-5 & Figure 5-6 illustrates the cytotoxicity results at Day 7 for 
the individual AuNP samples with increasing concentrations (25, 100 & 200 µg/ml) 
for both PC3 and DU145 cell lines. Citrate capped AuNPs demonstrated toxicity for 
both cell lines at 100 & 200 µg/ml increasing from 92, 81 to 77 % survivals for 25 
100 & 200 µg/ml respectively in DU145 cell lines.  
Aggregation was in abundance at the higher concentrations for the citrate capped 
AuNPs, however was not visible for the remaining samples (see Figure 5-7), this 
indicated that there was no toxicity as a direct result of aggregation as not all 
samples exhibited aggregation but yet all samples displayed similar toxicities. While 
this result may contradict earlier literatures, the results obtained conveys the 
conclusions drawn by Cui et al. (2012), who studied the influence of aggregation on 
HeLa cell lines. [288] They found that when AuNPs are endocytosed and aggregate, 
they result in cytotoxicity, however when the aggregates become too large and 
instead adhere to the cell surface, the growth rate of the HeLa cells increases. A 
similar trend is seen with the DU145 cells lines, at D7 the % survival was calculated 
to be 92 %, which subsequently increased to 96 % by D14 (see appendix 1) showing 
proliferation. When cross referenced with the image displayed in Figure 5-7 it is 
observed that a large degree of aggregation is present, and while some appears to be 
internalized, a large amount appears to be surrounding and obscuring the cells from 
observation. [288] 
There was no statistically significant cytotoxicity evident in the DU145 cell lines for 
all working concentrations apart from the SH-PEG & H5 which displayed an 89.77 
% survival at 25 µg/ml which decreased steadily to 71 % at 200 µg/ml which was 
similar to SH-PEG with 70.53% toxicity (200 µg/ml). While the AuNP SH-PEG-
SGA was non-toxic at 25 µg/ml with 96% survival, it dropped quickly to 69.48 % 
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and 59.8 % with increasing AuNP concentration which is almost 20% below the 
AuNP citrate capped for DU145. While the linker samples retained viability with 92 
% survival for 25 µg/ml, the survival rate dropped and plateaued at 70% for both 100 
and 200 µg/ml. Similar trends were observed for PC3 cell lines however an 
increased % survival was noted for the AuNP SH-PEG-SGA samples retaining 74 % 
survival at 200 µg/ml and 72 % when co-functionalized with H5. 
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Figure 5-5 Cell viability results displaying the survival % for mixed monolayer 
AuNPs at each stage of functionalization for both PC3 (left) and DU145 (right) 
at Day 7 
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Figure 5-7 optical images of DU145 cells treated with AuNP SH-PEG-
SGA & H5 (left) and citrate capped AuNPs (right) 
Figure 5-6 Cell viability results displaying the survival % for bifunctional linker 
AuNPs at each stage of functionalization for both PC3 (left) and DU145 (right) 
at Day 7 
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Figure 5-8 Cell viability results displaying the survival % for the mixed 
monolayer arrangement (top) and the bifunctional linker arrangement (middle) 
with direct comparisons of each (bottom) across both cell lines (PC3: left, 
DU145: right), n=4 
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Linker samples appear to have less toxic effects than the mixed monolayer 
arrangement, this is unexpected, with significant differences being found between 
the mixed monolayer and the negative control (P < 0.05). This is theorized to be a 
combination of the influence of the PBS. PBS is an important buffer 
solution commonly used in biological research. It is a water-based 
salt solution containing disodium hydrogen phosphate, sodium chloride and, in some 
formulations, potassium chloride and potassium dihydrogen phosphate. Literature 
has also reported it to act as an antioxidant in cells, it helps to neutralize (ROS) such 
as free radicals. [147] The increase in cytotoxicity evident by an increase in 
concentration could be a result of the production of Reactive Oxygen Species (ROS), 
ROS are by products of cellular oxidative metabolism, most of which occur in the 
mitochondria. In the mitochondria, ATP is synthesized by the reduction of molecular 
oxygen to water through processes of coupled proton and electron transfer reactions. 
During this process, a small percentage of the oxygen is not completed reduced, 
which results in the formation of superoxide anion radicals and other oxygen 
containing radicals. [289]  The overproduction of ROS can induce oxidative stress 
which results in cells failing to maintain normal physiological redox-regulated 
functions. Generation of ROS induced by nanomaterials is one of several 
mechanisms leading to nano-toxicity. The level of ROS production is determined by 
the chemical properties which arise as a result of their small size, high surface area 
and high surface reactivity which differs greatly from the bulk-size counterpart. The 
physical and chemical properties which contribute to the production of ROS include 
their size and shape and surface bound ligands including coatings, solubility and 
degree of aggregation. [289]   
It is also predicted that the toxicity from the linker may decrease due to the removal 
of the second active functional group by co-functionalization, as the RME linker 
showed only a 55% survival after 7days at 200 µg/ml with working concentrations 
dropping from 92% viability for the linker and 90% for the AuNP SH-PEG-SGA. As 
a trend, the viability seems to be generally lower with the RME peptide. This could 
be a result of the peptide. Overall the general toxicity has decreased with the 
H5WYG peptide with only the mixed monolayer displaying toxicity in comparison 
to the negative control at 25 µg/ml. The cell viability results after 14 days (results 
not shown – see appendix 2, 3 & 4) observed an average % survival of 96% for the 
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citrate capped AuNPs exhibiting that as synthesized AuNPs are not cytotoxic after 
prolonged exposure (up to 14 days). From the DU145 results at day 14, it is observed 
that the mixed monolayer arrangement is increasingly more toxic as the level of 
functionalization increases, with significant difference evident between the AuNP 
SH-PEG (96.6%) and the AuNP SH-PEG & H5 (90.7%). For the linker arrangement, 
while there is significant difference in viability apparent for both the PEGylated and 
linker samples, the degree does not significantly increase with surface 
functionalization remaining at 95% and 96% respectively. However, when directly 
comparing the mixed monolayer to linker the mixed monolayer is significantly more 
toxic than the linker (P number 0.0025), which was not observed at D7. 
Overall, the mixed monolayer displayed the lowest % survival across all samples 
types for both cell lines with only 71% survival for DU145 and 68.4 % for PC3 in 
comparison to the bifunctional linker (81.7% PC3 & 80.8 % DU145). Therefore, it is 
concluded that the initial hypothesizes identified from the literature surrounding the 
effect of a linker on cytotoxicity is void. [222] In effect, from the samples studied in 
this piece of research, it can be concluded that the bifunctional linker has 
demonstrated higher degrees of both colloidal stability and cell viability, which is in 
direct contrast to arguments from the literature regarding an ‘anti-PEG’ effect. 
[217,222] Another result of note includes the little cytotoxicity experienced from the 
samples functionalized using DMSO which corroborates with the literature which 
has reported a cell viability rate of more than 90% observed at 0.1% DMSO. 
However in contrast to that, literature has previous identified  toxicity to  
dramatically increase at DMSO concentrations of 0.5%, which was not seen for the 
AuNP SH-PEG-SGA & H5 across any cell lines at either time points. [277] 
 
5.2.4 Internalization 
The stability and cell viability studies have so far identified significant differences 
between the mixed monolayer and bifunctional linker arrangements when co-
functionalized with H5WYG peptide, this contrasts significantly to the results 
previously obtained in chapter 4. Some literature suggests that vectors should carry 
ligands of a similar length to enable accessibility to the relevant receptors. [157,158,212–
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215,220] Cell internalization studies were investigated to see of the linker ligand would 
elicit an even greater biological response due to direct cell contact. H5WYG peptide 
has previously shown successful internalization in a mixed monolayer arrangement 
through the collaboration with Queen University Belfast, Pharmacy. This area of 
research was implemented to identify if statistically significant cellular result would 
be obtained due to AuNP surface arrangement. Figure 5-9 illustrates the ICP-MS 
results of intracellular AuNP concentration for both mixed monolayer and 
bifunctional linker arrangements following incubation for 24h.  It is observed from 
Figure 5-9 that the uptake for the bifunctional PEGylated AuNPs is minimal, this 
corroborates with the literature, as PEG is commonly reported to hinder uptake. 
However unusually, the AuNP SH-PEG samples have displayed a degree of uptake, 
approximately 0.18pg. For both the PC3 and DU145 cell lines a significant increase 
is evident for the AuNP SH-PEG-SGA & H5 (Bifunctional linker) samples in 
comparison to the PEGylated counterpart (P value of 0.0329 and 0.003 for the PC3 
and the DU145 cell lines respectively) offering an almost 30-fold increase in 
internalization for the DU145 cell lines and a 14-fold increase for the PC3 cell lines. 
The level of uptake for the DU145 linker samples is similar to the level previously 
experienced via the RME peptide peaking at approximately 0.7pg. The DU145 cell 
lines indicate a statistical difference for internalization between the mixed 
monolayer, indicating that the linker has elicited a higher internalization response for 
both cell lines with an overall F value of 181.8 and a P value of 0.0095 (P < 0.05) for 
the DU145 cell lines resulting in over 3 times the amount of gold within the cells. 
Overall the level of internalization is extremely low in comparison to the citrate 
capped AuNPs (approximate average of 10 pg – results not shown), however it 
should be noted that the H5WYG peptide is not an internalization peptide, and 
therefore while the results may not recover the internalization to the level 
experienced by the citrate capped AuNPs, it is still a positive result identifying 
significant difference between the mixed monolayer vs. linker arrangement and 
consequently identifies a niche to be explored potentially utilizing an array of 
targeting peptides and/or internalization ligands. Statistical analysis was performed 
using a one-way ANOVA and Tukey post-test using Graphpad Prism software, with 
a P number <0.05 indicating statistical significance. 
139 
 
 
Figure 5-9 ICP-MS was used to quantify intracellular gold 
content per cell following exposure to a range of modified 
nanoparticles at 25 µg/ml for 24 h in PC3 and DU145 cells. 
Statistical analysis performed using a one-way Anova found  
significant increase evident for the linker samples in 
comparison to the PEGylated counterpart (P value of 0.0329 
and 0.003 for the PC3 and the DU145 cell lines respectively)  (n 
= 4). 
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5.2.5 Clonogenic Survival Assay 
Based on the biocompatibility and elevated uptake apparent, DU145 cell lines were 
chosen to take forward in determining radiosensitivity of both the mixed monolayer 
and bifunctional linker samples. DU145 cells were incubated with 50 μg/ml of both 
AuNP conjugate types for a 24 h period, then removed and cells irradiated with 0-6 
Gy. Figure 5-10 shows the survival fraction of irradiated cells for the clonogenic 
survival assay. The area under the curve (AUC), which represents the mean 
inactivation dose (MID), was calculated using Prism 6.0 (GraphPad software) and 
the sensitizer enhancement ratio (SER) calculated by dividing the MID of untreated 
cells with AuNP conjugate treated cells. The MID is an important measurement as it 
estimates overall radiosensitivity and incorporates all data points, whereas survival 
fraction provides information of a specific dose point on the survival curve which 
can be correlated to clinical tumor.    
The results from the clonogenics demonstrate that ‘as synthesized’ AuNPs resulted 
in a modest 6 % increase in radio sensitivity (SERS 1.06) in comparison to the 
untreated control (P value = 0.04). The functionalization with SH-PEG-SGA and 
SH-PEG-SGA & H5 peptide resulted in SERS of 1.07 and 1.21, demonstrating an 
7% and 21% increase in radiosensitivity respectively, with the Survival fraction of 
the linker at 4 Gy being 48% lower for the linker than the mixed monolayer 
arrangement.  The results have indicated that the synthesis of a linker using a H5 
peptide has resulted in a significant increase in the effectiveness of radiotherapy 
when compared to the control. (P value = 0.01). The mixed monolayer results 
illustrated a 9% decrease in radiosensitivity as the result of irradiation in comparison 
to the negative control. These results correlate to the higher internalization quantities 
previously measured in Figure 5-9 for the linker samples, however the inverse 
relationship between increasing concentrations within the DU145 cells between 
AuNP SH-PEG & AuNP SH-PEG & H5 and decreasing radiosensitivities displayed 
for the mixed monolayer samples indicate that internalization does not necessarily 
automatically correlate to enhanced radiosensitization, and that optimized 
radiosensitization may have been achieved through the linker methodology as a 
result of the enhanced accessibility resultant of the linker arrangement.  
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To ensure radiosensitization at 50 μg/ml was not an effect of long term toxicity 
resultant of the nanoparticles in the absence of radiation, clonogenic controls were 
calculated (± 20 μg/ml AuNP) were and plotted (see appendix 5), showing no 
significant decrease in the ability of the AuNP treated cells to form colonies, and 
thus they don’t affect the cells ability to re-populate and as such are non-toxic. 
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Figure 5-10 Clonogenic survival assay was used to assess the radio sensitizing 
potential of 50 µg/ml AuNPs following a 24 h incubation using DU145 cell lines, 
followed with 0-6 Gy using 160 kVp x-rays. Error bars represent the SEM (n = 4). 
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 Conclusion 
This research has found that despite it being reported that using a PEG linker 
methodology to synthesize an AuNP-BSA-peptide conjugate resulted in frequent 
instabilities; that there is no loss in colloidal stability due to the synthesis of a 
bifunctional linker.  [157,212–215] The results observed in this chapter dispute the initial 
hypothesis outlined above.  
Many researchers have successfully employed AuNPs functionalized using mixed 
monolayers; for example, Kumar et al. successfully utilized a mixed monolayer 
structure to allow for the controlled release of a thiol bound fluorescent dye (as a 
model drug payload) over a period of 2 hours. These authors found that the addition 
of PEG inhibited the initial burst release of the payload as well as preventing particle 
aggregation. [153,182] In 2006 significant progress was made by constructing a novel 
nanomedicine, CYT-6091 by assembling recombinant human tumor necrosis factor 
alpha (rhTNF) to the surface of a 26nm AuNP with thiol PEG in the form of a mixed 
monolayer.  A 7-10-fold increase was seen in the amount of tumor necrosis factor 
(TNF) that was delivered to the tumor compared to the injection of native TNF. It 
was also found that a 7.5 µg/ml injection of CYT-6091 was as effective as 15 µg/ml 
of native TNF, and that the 15 µg-native TNF resulted in a 60% survival rate, 
compared to the 100% survival after treatment with 15 µg of CYT-6091. Thus, the 
formulation is undergoing clinical trial. A Phase I study commenced in 2005, where 
29 patients with solid tumors demonstrated no dose-limiting toxicity up to 600 μg m-
2. The main side effect was reported as controllable grade II fever. One partial 
response and three stable disease states were observed, demonstrating a positive 
outcome in 14% of patients. [59–63,290] 
The results from the internalization study concur with some aspects of the literature 
which concluded that PEG length does not impede peptide function when used in a 
mixed monolayer arrangement. Investigations were previously undertaken to 
determine whether longer PEG molecules would hinder the efficiency of the 
targeting peptides, interestingly, after experiments utilizing three thiol modified 
PEGs of various molecular weights (900MW, 1500MW, 5000MW) it was found that 
the number of PEG5000/RME conjugates in HeLa cell lines were nearly a factor 4 
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larger than that of PEG900/RME conjugates, thus indicating that PEG length did not 
sterically hinder the function of the peptide. [153] This finding has been supported by 
other studies which have observed excellent performance for mixed monolayer 
functionalized AuNPs. [56,61,63,223]  
This chapter has demonstrated that the co-functionalization of AuNPs with RME 
peptide using a NHS ester has resulted a mixed monolayer arrangement due to the 
availability of the cysteine as evident from the PyMol drawing in chapter 5. The 
presence of the ligands along with the method of arrangement of those peptides on 
the AuNP surface has been confirmed by a combination of FTIR, DLS and Texas 
Red. It can also be concluded that while a pre-synthesized NHS ester could offer a 
more efficient means to synthesized a linker, it is heavily dependent on the solvent 
used to synthesize the linker. Changing the solvents gave a wide range of results 
with the parallel loaded and sequentially loaded samples without the cysteine 
showing the successful synthesis of a linker. It was concluded that the NHS ester 
was hydrolyzing and due to the hydrophobicity coupled with the net charge of the 
H5, that it was highly unstable in water.  
Once a linker had been successfully synthesized, a range of mixed monolayer vs. 
linker studies contracted the initial hypothesis both in this Thesis and in the 
literature. It was found that for the H5 peptide that colloidal stability, cell viability 
and internalization were enhanced via the utilization of a bifunctional linker. 
Therefore, having peptide chains longer then the stabilization agent does not have a 
negative effect on colloidal stability or opsonization, and using a linker does enable 
easier accessibility for the peptide to have direct with the cell to elicit a higher 
biological response, with both the PC3 and DU145 cell lines a significant increase 
evident in internalization for the AuNP SH-PEG-SGA & H5 (bifunctional linker) 
samples in comparison to the PEGylated counterpart (P value of 0.03 and 0.003 for 
the PC3 and the DU145 cell lines respectively). The DU145 cell lines indicated a 
statistical difference for internalization between the mixed monolayer (P < 0.05). 
The clonogenic survival assay has also identified significant difference between the 
untreated control and the linker with a P value of 0.02 whereas there was no 
significant difference present for mixed monolayer. 
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Therefore, in spite of recent progress, defining the rules that control the surface 
functionalization of AuNPs with molecular linkers is still a challenge, and while 
clonogenic survival assays observed a significant increase in radio sensitization as a 
result of a linker, future work should re-visit internalization ligands in a linker 
formation as well as the inclusion of a targeting ligand such as RGD peptide. From 
this study, it is now clear that the binding affinity of the conjugating groups should 
be carefully considered prior to functionalization and further characterization 
methods should be employed when utilizing a linker to confirm the co-
functionalization of the ligand on the surface.  
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6. OPTIMIZING ATTACHMENT 
 Introduction 
AuNP synthesis via the Turkevich method produces 10–80 nm diameter, citrate 
capped particles with a zeta potential of approximately -20 to -40 mV. [183]  Co-
functionalization is commonly achieved via electrostatic charge attachment, specific 
affinity immobilization and/or covalent bonding typically by means of thiol, or less 
frequently, amine groups. [290,291] While it has been observed that pH plays an 
important role in controlling ligand attachment, it is not currently possible to predict 
an optimum pH for attaching a particular peptide. Optimizing the ligand attachment 
by altering the pH may have the benefit of being able to maximize the binding 
efficiency with the nanoparticle. [21,185,186,290]  
It is predicted that slightly acidic buffer solutions will elicit a positive charge of the 
peptides and therefore elicit a higher binding affinity towards the negatively charged 
gold nanoparticle. Therefore, this study will focus on tailoring the pH of the AuNP 
solution in relation to the isoelectric point (pI) values of a range of peptides to 
investigate if there is an optimum pH for peptide attachment, and if this varies 
depending upon the peptide characteristics. The attachment of the peptides (RME, 
H5WYG and RGD) to partially PEG capped AuNPs were studied in a range of pH 
buffers above, below and at the isoelectric points of the peptides. The peptides used 
were the receptor mediated endocytosis (RME) sequence 
CKKKKKKSEDEYPYVPN which has an overall net charge of +2.9 and a pI of 9.6 
at a neutral pH. The buffers used for investigation of RME peptide were pH 8, 9, 9.2, 
9.4, 9.6, 9.8, 10 & 11. An endosomal escape pathway H5WYG peptide sequence 
GCGLFHAIAHFIHGGWHGLIHGWYG with a net charge of +0.4 and a pI of 7.75 
(at a pH of 7) was also studied. The buffers used for investigation of H5WYG 
peptide were pH 6, 7, 7.25, 7.5, 7.75, 8, 9, 10 & 12. Finally, the Nrp-1 targeting 
peptide (RGD) labelled with FITC (FITC-Ahx-CRGDK) was investigated which has 
a net charge of +1 and a pI of 8.6 at a neutral pH. The buffers used for investigation 
of the RGD peptide were pH 6, 7, 8, 8.6, 9, & 10.  RME & RGD peptides are both 
terminated with a cysteine residue at the N-terminus for functionalization with the 
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AuNP surface via the thiol, while H5WYG is terminated with a Glycine residue 
alongside the secondary Cysteine residue, which offers the potential attachment via 
the free amine group found on both the N-terminus and C-Terminus.  
All three peptides have been modeled using PyMol, as illustrated in Figure 6-1, 
wherein the yellow spheres indicate the thiol group in each sequence and highlights 
the availability of the cysteine residues for surface interaction.  The dissociation 
constant (Pk) values for the remaining ‘free’ reactive groups found on the amino 
acids for the three chosen peptides were calculated as follows: 
RME pI = 8.7 
H5WYG pI = 6.7 
RGD pI = 7 
Figure 6-1 PyMol Modelling of the a) H5 peptide, b) RGD targeting 
peptide and c&d) the RME peptide taken from Harrison et al. 2017 [308] 
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 Results and Discussion  
The samples synthesized for this chapter are the ‘as synthesized’ AuNPs which will 
be referred to as AuNPs citrate capped, AuNPs functionalized with monofunctional 
(SH-PEG) Polyethylene glycol which will be referred to as AuNP SH-PEG. And 
PEGylated AuNPs co-functionalized with either the receptor mediated endocytosis 
peptide, an endosomal escape pathway (H5WYG) or and Nrp-1 targeting ligand 
(RGD) peptide which will be referred to as AuNP SH-PEG & RME, AuNP SH-PEG 
& H5, AuNP SH-PEG & RGD respectively.  
AuNPs were synthesized using the Turkevich method described in chapter 3, the 
synthesized citrate capped AuNPs and PEGylated AuNPs were characterized using 
TEM and FTIR as described in chapter 3. The citrate capped AuNPs showed an 
average particle size of 13.21nm ± 1.31 by TEM (results not shown). The PEG 
functionalized and co-functionalized samples do not show a significant increase in 
size, as discussed harrison et al. [185]  
The nanoparticles were characterized post synthesis; post PEGylation, post re-
dispersion with the relevant buffer and after co-functionalization with the various 
peptides. The characterization techniques employed for this chapter include FTIR, 
UV/Vis, DLS, Zeta, Photoluminescence and Micro BCA. As synthesized AuNPs 
will be referred to as AuNP citrate capped. AuNP with mono functional PEG is 
AuNP SH-PEG 
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6.2.1 FTIR 
Fourier Transform Infrared Spectroscopy (FTIR) spectra of the washed and dried 
AuNPs, AuNP SH-PEG, AuNP SH-PEG RME, AuNP SH-PEG H5WYG and AuNP 
SH-PEG RGD are shown in Figure 6-2. Prominent differences are visible in the 
spectra for the PEG capped AuNP spectrum compared to that for the citrate capped 
AuNP. The presence of the mono-functional thiol PEG (SH-PEG) on the AuNP SH-
PEG is confirmed by the peaks associated with C=O stretching (1,660 cm-1) and 
bending (1,380 cm-1) and the presence of additional peaks relating to N-H bending 
(1,660 cm-1) and N-H wagging (600-900 cm-1). [185] The characteristic vibrations 
found in ethylene glycol ligands are observed at 1106 cm-1 (C-O-C stretching) and a 
narrowing of the CH2 stretching mode (2850 cm
-1). [61,182,184,202,258] S-Au bonds are 
expected to appear at 1777 or 1545 cm-1. All conjugates present noise at 
approximately 1777 cm-1. While the noise may indicate the presence of Au-S bonds 
Figure 6-2 FTIR Spectra of the washed and dried AuNP citrate capped (black), 
AuNP SH-PEG (green), AuNP  SH-PEG RME (red), AuNP SH-PEG H5WYG  
((H5)blue) and AuNP SH-PEG RGD (wine red) 
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it cannot be confirmed. The successful conjugation of all three peptides to the 
nanoparticle surface was confirmed by the appearance of new amide bonds around 
1670 cm-1and 1550 cm-1 for amide I and II respectively. Amide I bands are mainly 
associated with the C=O stretching vibration relating to the backbone conformation, 
while Amide II bands result from N-H bending and C-N stretching.  Co-
functionalization was further confirmed through the observation of N-H wagging 
peaks (600cm-1 – 900cm-1) on the peptide functionalized samples, with a C-H bend 
at approximately 1376 - 1387 cm-1 and the C-H alkene bend (992 cm-1). [184,259–
261,292–294] Amide III bonds found on the co-functionalized samples (approximately 
1400 – 1300 cm-1 region) are complex bands resulting from a mixture of several 
coordinate displacements. Successful attachment of the PEG was further confirmed 
by an increase in hydrodynamic area, by DLS after co-functionalization, from a size 
of 17.5 nm to approximately 35.4 nm. 
FTIR confirmed the successful attachment of each of the peptides in distilled water, 
therefore to investigate the effect on pH the citrate capped AuNPs were PEGylated 
with SH-PEG, and the AuNP-PEG solutions were then collected and aliquoted 
evenly into 50 ml centrifuge tubes and centrifuged for 90 min at 13,500 RCF. 95% 
of the supernatant was then decanted and discarded leaving the remaining 5% of the 
AuNP as a pellet in the bottom of the centrifuge tube. Each individual centrifuge 
tube was then refilled to the initial volume using the required pH buffer and then 
vortexed to re-disperse. 
Co-functionalization was achieved by continually stirring the re-dispersed AuNP-
PEG samples, 4.45 μg/ml of free RME peptide, 5.86 μg/ml of free H5WYG peptide 
or 2.31 μg/ml of free FITC labelled RGD peptide (dissolved in 1 ml of the relevant 
buffer) were added to the PEGylated AuNPs (see chapter 3). [184]  
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6.2.2 UV/Vis 
For this chapter nanoparticle colloidal stability is defined as the ability to resist 
aggregation as detected by UV/Vis. UV/Vis is commonly used to investigate the 
aggregation states of colloidal gold. The unique optical properties of metal 
nanoparticles, which result from the surface plasmon resonance effect, offers a 
simple means to study size, functionalization and aggregation states with high 
sensitivity. [252,253] AuNP aggregation is accompanied by a red-shift in the plasmon 
peak, as well as broadening of the adsorption peak, and a decrease in absorbance 
which can be easily monitored by UV/Vis spectroscopy. [295] An increase in size 
resulting from aggregation is also evident visually with a change in color of the 
solution from red to blue/purple. [296] Complete aggregation and settling out of the 
AuNP will result in a loss of color and diminution of the characteristic peak in 
UV/Vis. Each sample was measured after synthesis; following PEGylation, after re-
dispersion in the various pH buffer solutions, and after peptide co-functionalization. 
We used the intensity and peak location (λmax) of the plasmon peak in the UV-vis 
spectra as indicators of AuNP aggregation state. Each sample was measured after 
synthesis; following PEGylation, co-functionalization and post re-dispersion in the 
various pH buffer solutions. Intensity, peak width, and peak location (λmax) of the 
Plasmon peak in the UV-Vis spectra was used as an indicator of the AuNP stability.  
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Figure 6-4 UV/Vis absorbance spectra for AuNP SH-PEG re-suspended in each 
pH buffer solution, n=4 
 
Figure 6-3 AuNP SH-PEG in buffer solution prior to peptide attachment visually 
displaying the discoloration of the originally transparent centrifuge tube, stained 
red in varying degrees dependent on the pH buffer solution 
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AuNPs were re-dispersed in the appropriate buffer to obtained the desired solution 
pH. The buffers used were citric acid/sodium hydroxide buffer solution pH 6 
borax/sodium hydroxide buffer solution pH 8 and 10, di-sodium hydrogen 
phosphate/sodium hydroxide buffer solution pH 12. All of these buffer solutions 
were then altered with sodium hydroxide or hydrochloric acid to produce the 
intermediates.  
Figure 6-4 displays the UV/Vis spectra for AuNP SH-PEG which has been re-
suspended in the various buffer solutions compared to the AuNP SH-PEG control. 
No change was found for the peak position and absorbance profiles for the surface 
plasmon band of the sample before modification as a function of pH which displayed 
a wavelength of 520.8 nm with an absorbance value of 0.74. The absorbance values 
for the AuNP SH-PEG in a range of pH is indicative of the surface reactions. Each 
pH change results in a different surface reaction which changes the surface potential, 
this change can result in varying degrees of a loss of stability, which is evident 
through a significant decrease in absorbance intensity as a result of a change in pH. It 
is evident from Figure 6-4 that pH 11 and 9.6 have the greatest loss in absorbance 
intensity. Figure 6-3 observes a change in the color of the centrifuge tube for the 
AuNP SH-PEG samples in each pH buffer solution. From Figure 6-4 it is clear that 
pH 6, 7, 7.25, 7.5, 7.75, 9.2 and11 all discolor the transparent centrifuge tube to 
varying degrees of red. This corroborates with the UV/Vis spectrum in Figure 5-3, as 
each of these samples decrease in Absorbance. The functional groups present on the 
AuNP are pH reactive, and as their buffer changes the pKa of the functional groups 
on the AuNP surface, they ionize to different degrees which affects the colloidal and 
chemical stability in solution. In agreement with a number of publications the 
characteristic peak at 520 nm is clearly visible for all the AuNP samples illustrating a 
degree of stability across the pH range tested. [183,252,255,256] The results show that the 
PEGylated colloidal AuNP solutions have maintained a high degree of colloidal 
stability following centrifugal washing and re-dispersion in the buffer solutions. 
Extremely acidic pH were not measured, as Das et al. (2012) observed that the SPR 
band remained stable except at extreme acidic pH conditions. It was reported that at 
a pH of 1, the characteristic SPR peak was shifted to 537 nm from 527 nm and an 
extra peak at 649.80 nm was observed. [281] Investigations into the colloidal stability 
of nanoparticles in a range of pH buffers also identified a stable range application for 
154 
 
each buffer solution used. Those ranges would show clear plasmonic peaks whereas 
outside of the ranges the nanoparticles would display considerable decreased 
absorbance’s or significant peak shifts. [297] 
 
Table 6-1 Changes in UV/Vis Absorbance Maxima for AuNP SH-PEG and RME 
at each pH 
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Figure 6-5 UV/Vis Absorbance spectra for AuNP SH-PEG mixed 
monolayer & RME after 24h in each buffer solution  
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Figure 6-5 & Figure 6-6 displays the UV/Vis spectra for AuNPs co-functionalized 
with PEG and RME peptide in various buffers 24 h after functionalization or at 
hourly intervals across a 24 h period respectively. Table 5-1 shows the results in 
tabular form listing the peak positions and absorbance values of the samples, both 
before and after co-functionalization with RME peptide. 
The conjugation of these samples was investigated by comparing the UV/Vis spectra 
of each sample to the PEGylated AuNP prior to the peptide addition. Upon 
successful binding of ligands to the gold nanoparticle surface, the SPR spectra will 
red-shift by a few nanometers. This shift is a result of an increase in the local 
refractive index at the gold nanoparticle surface, and is consistent with peptide 
attachment. A very large upshift in peak position and a reduction in absorbance, or 
complete loss of the plasmon peak are indicative of AuNP aggregation (loss of 
colloidal stability).  From Figure 6-5 and Table 5-1, it is apparent from the 
maintenance of a significant peak, that RME co-functionalized AuNPs demonstrated 
significant stability at all pH levels tested. Optimum co-functionalization was 
indicated via a characteristic shift in peak position occurring at a pH of 8, 
accompanied by a modest reduction in absorbance. 
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Figure 6-6 AuNP SH-PEG mixed monolayer & RME peptide monitored for 24 h 
using UV/Vis to identify absorbance maxima at each time point for each pH  
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Table 6-2 Changes in UV/Vis maximum peak position and Absorbance for AuNP 
SH-PEG & H5 at each pH 
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Figure 6-7 AuNP SH-PEG mixed monolayer & H5 peptide monitored for 
24 h using UV/Vis to identify absorbance maxima at each time point for 
each pH 
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Figure 6-7 & Figure 6-8 display the UV/Vis absorbance spectra for AuNP SH-PEG 
& H5WYG at 24h and over a period of 24 h respectively. In the case of the H5WYG 
peptide, it can be seen that many of the buffers tested resulted in a very significant or 
complete loss of the plasmon peak, or a large upshift in peak position indicating 
aggregation. This slight broadening in the long wavelength region as a result of 
surface modification may suggest that a large change of surface charge caused by a 
change in pH affects the surface plasmon oscillation. The lack of a trend is not 
unexpected, as this is a multi-variable interaction, in which some constituents of the 
buffer solutions are not consistent across all the experiments performed and vary in a 
non-linear manner across pH. The constituents of the different pH buffers change 
dramatically with pH in comparison to chemical constituents in a neutral pH. Citric 
is present in the pH 6 buffer solution which may interact with the AuNP surface 
conjugates making a specific change to amount of citrate bound whereas the absence 
of citric in the borax buffer will have a different effect on the remaining AuNP 
surface citrate coverage. These combinations along with the differing pKas make it 
difficult to predict what information can be gathers about surface species and binding 
as multiple parameters are varying between each solution, however does serve to test 
if the AuNP formulation is stable from an impical point of view.  
Figure 6-9 visually represents the aggregation evident from the complete loss of the 
SPR when re-suspended in pH 7.75 (Figure 6-9 b) and also highlights further the 
instabilities noticed during co-functionalization for pH 7 & 7.25 which isn’t clearly 
evident from Figure 6-7. Interestingly the 24 h study displayed in Figure 6-8 identify 
a gradual decrease in absorbance for pH 7 corroborating with the discoloration 
evident in Figure 6-9, along with a loss of absorbance in relation to time for pH 6, 
7.25, 7.5 & 7.75. Only the samples functionalized at pH 6 and 8 displayed a small 
(~2-3 nm) upshift in peak position; however, pH 6 was accompanied via a large 
change in absorbance while pH 8 maintained significant absorbance consistent with 
successful functionalization and colloidal stability. The sample prepared at pH 12 
showed only a small drop in absorbance after peptide addition, but the upshift in 
peak position from 521.6 to 540 suggests a significant degree of aggregation. For 
both peptides, a pH of 8 (see Table 5-1 & 5-2) was concluded to be the optimum pH 
for successful cysteine conjugation of peptides to the nanoparticle surface. The 
reduced colloidal stability observed with the H5WYG peptide may be as a result of 
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the lower net charge of +0.4 compared to 2.9 for the RME peptide. As the AuNPs 
are slightly negatively charged (-5 mV) after PEGylation the higher positive charge 
on the RME will result in more electrostatic attraction between the RME and 
PEGylated AuNPs. The H5WYG will also be less stable in solution as there will be 
little repulsion between the peptide chains due to their low net charge. In addition, 
the H5WYG peptide contains a higher proportion of hydrophobic residues (namely 
A, F, I, L W &Y) than RME rendering the peptide less water soluble.  
Figure 6-10 shows the various RME and H5WYG (labelled H5) co-functionalized 
samples, visually confirming the findings from the UV/Vis analysis. Another trend 
observed from the addition of peptides is that there were higher levels of aggregation 
evident from a reduction in absorbance around the isoelectric point (pI) of the 
H5WYG peptide. The more highly charged nature of the RME peptide may explain 
the colloidal stability of the peptide at the isoelectric point. While the peptide has no 
Figure 6-10 AuNP SH-PEG RME and AuNP SH-PEG H5WYG co-functionalized 
AuNPs in each buffer solution 
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net charge at the isoelectric point, individual units will still be charged offering a 
degree of electrostatic repulsion. This is to be expected given Zwitterions, such as 
the proteins used in this study, have minimum solubility at their isoelectric point (a 
feature that can aid isolation via precipitation at the pI). Figure 6-10 displays this 
phenomenon visually with the sample functionalized with H5WYG at the isoelectric 
point (pH 7.75) showing a shift from red to purple and an almost complete loss of 
color intensity. Figure 6-10 shows the optical images of the co-functionalized 
AuNPs in their respective buffer solutions. Wide range colloidal stability identifies 
the range at which the color will not alter as a result of pH, whereas short range pH 
stability is indicative of a blueish taint once an adjustment has been made to outside 
of the pH range. The images agree with the observations made by UV/Vis.  
6.2.3 DLS 
All samples were characterized using DLS post synthesis and post functionalization. 
Table 6-3 displays the results obtained for the nanoparticle size for PEG prior and 
post RME addition. PEGylation was confirmed for AuNP SH-PEG via the increase 
in nanoparticle diameter from 17.5 d.nm to approximately 35.4 d.nm respectively 
which complements the results observed in chapter 4. After washing and dispersion 
in each buffer solution the nanoparticle diameter measurement was repeated. There 
was no significant difference found between nanoparticle size for AuNP SH-PEG 
prior to buffer and post buffer for all the samples apart from pH 11. The variations 
observed in particle size could be theorized to the use of a normal buffer solution. 
[298] Takashima et al. investigated the approach of surface potential estimation by 
altering the pH of gold nanoparticle solutions using hydrochloric acid and sodium 
hydroxide. The rationale of this approach was to control the potential objective ion 
species by limiting the possibilities to H+, Na+, OH- and Cl-. Limiting the potential 
ionic species minimizes the effect of ion adsorption on the particle surface which 
may disturb the surface charge and avoids inter-ion interaction in bulk solution. [298] 
From Table 6-3 only pH 8, 9, 9.6, 9.8, 10 and 11 displayed an increase in 
nanoparticle size following the addition of RME peptide. Out of those pH, only pH 
8, 9 & 9.6 retained a hydrodynamic diameter close to the AuNP SH-PEG control 
whereas pH 9.6 showed a decrease in particle size in relation to the control. Post co-
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functionalization with RME peptide indicated the most significant increase in size 
for pH 8 in relation to the addition of RME without showing signs of loss of 
colloidal stability by large error bars and/or an unusual decrease in size.   
 
 
 
  
Figure 6-11 SH-PEG DLS Number average and standard error 
prior to peptide addition suspended in each buffer solution (n=9) 
162 
 
Table 6-3 DLS Number average diameter sizes for AuNP SH-PEG with RME 
 
prior to buffer in buffer with RME 
Citrate capped 17.5 ± 1.7   
SH-PEG 35.41 ± 4 
  
pH 8  38.77 ± 4.2 43.33 ± 2.0 
pH 9 
 
38.58 ± 3.2 37.23 ± 7.8 
pH 9.2 
 
39.27 ± 2.4 36.76 ± 13.4 
pH 9.4 
 
40.76 ± 3.2 40.08 ± 2.9 
pH 9.6 
 
32.93± 9 37.6 ± 6.1 
pH 9.8 
 
40.44 ± 2.7 41.06 ± 3.5 
pH 10 
 
27.89 ± 6.3 36.78 ± 14 
pH 11 
 
24.61 ± 5.5 41.07 ± 7.7 
 
 
Table 6-4 DLS Number average diameter sizes for AuNP SH-PEG with H5 
 
prior to buffer in buffer with H5 
Citrate capped 17.5 ± 1.7   
SH-PEG 35.41 ± 4 
  
pH 6 
 
33.07 ± 2 55.58 ± 29.7 
pH 7 
 
33.53 ± 1.9 70.33 ± 26.4 
pH 7.25 
 
31.27 ± 3.2 32 ± 13.4 
pH 7.5 
 
35.96 ± 3.4 42.3 ± 18.7 
pH 7.75 
 
32.53± 5.4 44.7 ± 13.3 
pH 8 
 
38.77 ± 4.5 39.1 ± 2.8 
pH 9 
 
38.58 ± 3.2 36.5 ± 5.6 
pH 12 
 
33.51 ± 4.2 62.7 ± 10.8 
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From Table 6-4 all the samples apart from pH 9 displayed an increase in nanoparticle 
size following the addition of H5WYG peptide. Out of those pH, only pH 7.25 & 8, 
displayed a moderate increase in hydrodynamic diameter however pH 7.25 showed a 
high degree of variability in the error bars. pH 6, 7, and 12 indicated aggregation by 
a large increase in hydrodynamic diameter. This aggregation was highlighted 
previously in Figure 6-8 and by a decrease in absorbance evident for pH 6, a 
decrease in wavelength for pH 7 coupled with a decrease in absorbance over time 
and a large peak shift to approximately 540nm for pH 12 coupled with a loss of 
absorbance (Figure 6-7).  
6.2.4 Zeta 
In solution, if pH < pK then the protonated form of an amino acid side chain 
predominates. This is based upon the Henderson-Hasselbalch equation. If the pH > 
pK then the deprotonated form of the amino acid side chain predominates. This 
relationship however cannot be directly applied as each peptide is bound to a 
negatively charged gold nanoparticle. Instead zeta potential measurements were 
applied to help determine colloidal stability. Ahmed et al. investigated the 
relationship between zeta potential and long term stability when suspended in 
solution. It was found that the zeta potential is predictive of its long-term stability 
and resistance to aggregation at different pH values. [297] AuNPs with a lower 
repulsive potential thus failing to counterbalance Van der Waals attraction, are more 
prone to aggregation; whereas zeta potentials of around -36.1 mV proved to show the 
greatest colloidal stability over a period of time. [297] Investigations into the colloidal 
stability of nanoparticles in a range of pH buffers also identified a stable range 
application for each buffer solution used. Those ranges would show clear plasmonic 
peaks whereas outside of the ranges the nanoparticles would display considerable 
decreased absorbance’s or significant peak shifts. [297]  
Therefore Table 5-1 & 5-2 when cross referenced with Figure 6-5 & Figure 6-7 
identifies the stable ranges for the AuNPs in buffer solutions to be between a pH 8 – 
12 with pH below 8 displaying a decrease in wavelength in comparison to the control 
and pH 7.5 displaying a drastic drop in absorbance.  Once co-functionalized with 
RME peptide, there were no drastic changes in wavelength and/or absorbance, 
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illustrating that RME peptide seems to have good chemical stability in a range of 
buffer solutions. The results for H5WYG however indicate large peptide instability, 
with only pH 8 & 6 having a shift towards the red and pH 6, 7.25, 7.5 & 7.75 having 
drastic decreases in absorbance. 
These observations then cross referenced with Table 6-5 & Table 6-6 are in 
agreement with the relationships investigated by Ahmed et al. [297] with the exception 
of pH 9.8.  
 
Table 6-5 Zeta potential of AuNP SH-PEG mixed monolayer with RME 
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Table 6-6 Zeta Potential of AuNP SH-PEG mixed monolayer with H5  
 
Zeta changes displayed for the RME peptide identify all samples apart from pH 9.8 
to become more negative in surface charge, this coordinates with the literature and 
the UV/Vis spectra for the RME co-functionalized AuNPs which displayed the 
largest drop in absorbance and is the most positive pH explored for this peptide. 
When functionalized with H5WYG, pH 8 and 9 have the most negatively zeta 
potential, with all the remaining pH buffers resulting in more positive zeta with pH 
12 becoming +1.59 mV. Based on the conclusions drawn from the literature, this 
would indicate instability, which is in agreement with the conclusions observed from 
UV/Vis data, with the most drastic change in wavelength via UV/Vis being a result 
of pH 12. Therefore, for both peptides, pH 8 resulted in a more negative zeta 
potential indicating long term colloidal stability.  
6.2.5 Fluorescence 
To confirm the optimum pH for peptide attachment being approximately pH 8; a 
third peptide was investigated. The RGD Nrp-1 targeting peptide (CRGDK) was 
modified with the fluorescent ligand FITC. The AuNP SH-PEG & RGD sample was 
analyzed via UV/Vis in triplicate and the spectra obtained are plotted in Figure 6-12. 
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The UV/Vis spectra for pH 7, 8 & 8.6 display a peak at 495nm corresponding to the 
FITC and the characteristic peak at ~520 – 525 nm, for AuNP. For the remaining 
buffer solutions, due to poor colloidal stability under other pH conditions, the FITC 
peak dominates the spectra. [299,300] 
In previous literature pure FITC has showed a wide absorption band at 480 nm and a 
characteristic emission peak between 495 and 650nm when excited. [299,300] For pH 
ranging between 7- 8.6 a weak peak corresponding to the gold nanoparticles at 
approximately 520 nm is clearly visible, and an adsorption band at approximately 
495 nm corresponding to the FITC, with the pH 8 maintaining the highest absorption 
profile with respect to both AuNP and FITC. For the remaining pH (6, 9-12) there is 
an AuNP shoulder present, however this signal is being almost entirely masked by 
the FITC, overall there is a gradual decrease in the fluorescent intensity of the FITC 
signal observed as the pH drops towards 6.  
Fluorescein has a pKa of 6.4, when the AuNP solution pH is below the pKa of the 
fluorescein, the protonated forms predominate and the proportion of the fluorescein 
molecules bound to AuNP increases. [301] 
The fluorescent strength of some fluorescents appear to be different in alkaline and 
acidic solutions. Fluorescein is almost non-fluorescent at neutral pH and fluoresces 
brightly in acidic environments.[301,302] The fluorescence output per fluorophore is 
proportional to the product of the extinction coefficient and the quantum yield. The 
most important effect on the fluorescent response of fluorescein is the pH, as 
structurally, pH causes a reconfiguration of the fluorophores π-electron system that 
occurs upon protonation. Literature has shown that a change in pH of 7 to 6 can 
result in a 10 % drop in the relative fluorescence response pf fluorescein. [301] In 
acidic environments (< pH 6) the fluorescent response drops to almost 40 %.  
However, there are contradictions in the literature surrounding the effect on 
fluorescein intensity in pH solutions about ph 7. Zhu et al. demonstrated that the 
fluorescent intensity increased as the pH value increased from 6.86 to 8.43, and 
concluded that the stable solution pH range should be 8.43 or higher as fluorescent 
intensity became nearly constant when pH value was 9.10 or greater, whereas 
absorbance studies by Peterson in 2009 have shown that above a pH of 7.5, there 
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was no significant increase in absorbance for increasing pH compared to a neutral 
pH. [301] Diehl et al. found similar results, the UV/Vis absorbance maxima first fell 
rapidly as the pH rises from 0.15, reaching a minimum at pH 3.63, then increases to 
a maximum at pH 5.3, and finally falls to steady value at pH > 8.0.[303]  
Initially, pH 7, 8 & 8.6 maintains the highest absorption profile with respect to both 
AuNP and FITC. For pH values of 6 & 9-12 there is no AuNP signal present, overall 
there is a gradual decrease in the fluorescent intensity due to the absorbed FITC as 
the pH drops towards 6. However, after 24 h the absorption profile for pH 7 greatly 
diminishes with only the sample prepared at a pH of 8 retaining the characteristic 
profile of AuNP at 520 nm. For the remaining samples only the absorption peak at 
approximately 495nm is apparent.  
Therefore, while it can be postulated that the increase in the FITC signal when 
conjugated to AuNPs as the pH drops to pH 6 is due to the unsuccessfully 
conjugated FITC outweighing the absorption signal from the AuNPs, it must be 
considered that this is a direct response of the FITC to the slightly acidic pH. 
However contrary to this, due to the evidence that a of pH 7+ does not adversely 
affect the fluorescent signal from the FITC, it can be concluded that the masked 
signals for pH 9-12 are a result of conjugation to the AuNP surface, and the highest 
absorption profile for the FITC at pH 8 is most likely due to the enhanced binding 
efficiency of the RGD peptide to the AuNP surface (i.e. resulting in more FITC 
present on the AuNP surface), and not a decrease in quantum efficiency (Equation 3-
14).  
It is also noteworthy that a loss of colloidal stability was not observed at the 
isoelectric point of 8.6. This may be due to the high solubility of the peptide. Short 
peptides are inherently highly water soluble and the sequence containing a high 
proportion of hydrophilic residues and no hydrophobic residues. The addition of the 
water soluble FITC tag may also have increased the colloidal stability of the peptide 
at the pI. 
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Figure 6-12 – UV/Vis absorbance spectra of the FITC tag on the AuNP SH-PEG 
& RGD peptide in a range of buffer solutions, pH 6 (pink), pH 7 (dark blue), pH 
8 (red), pH 8.6 (green), pH 9 (purple), pH 10 (light blue), and pH 12 (orange) 
after 1 hour  
 
Figure 6-13 UV/Vis absorbance spectra of the FITC tag on the AuNP SH-PEG & 
RGD peptide in a range of buffer solutions, pH 6 (pink), pH 7 (dark blue), pH 8 
(red), pH 8.6 (green), pH 9 (purple), pH 10 (light blue), and pH 12 (orange)  at 24 
hours after addition 
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Table 6-7 Changes in UV/Vis Absorbance Maxima peak position and Absorbance 
for each pH for RGD peptide 
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Figure 6-14 UV/Vis absorbance spectra of the FITC tag on the AuNP 
SH-PEG & RGD peptide in a range of buffer solutions, pH 6 (pink), 
pH 7 (dark blue), pH 8 (red), pH 8.6 (green), pH 9 (purple), pH 10 
(light blue), and pH 12 (orange) tracking the SPR maximum over 24 h  
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Figure 6-15 Fluorescent emission spectra for the AuNP SH-PEG & RGD (FITC 
tagged) supernatant 
  
171 
 
Figure 6-15 shows the fluorescence spectra of the supernatants after centrifugal 
removal of the FITC labelled RGD and SH-PEG capped AuNPs.  After co-
functionalization with the RGD peptide in a range of buffer solutions, the samples 
were centrifuged in 1.5 ml eppendorf’s at 10,000 RPM for 30min, to remove the co-
functionalized AuNPs. [296] The amount of unbound free FITC labeled RGD peptide 
following centrifugation was determined from the fluorescent intensity of FITC left 
in the supernatant. A clear emission peak was noted around 520nm for all sample 
types. This is typical for green fluorescein FITC. [299,300] At pH 9-12 there were high 
intensities of fluorescing FITC found in the supernatant, consequently indicating 
large amounts of unbound peptide. Whereas pH 6 - 8.6 had significantly lower 
intensities, with pH 7 and 8 having the lowest intensity. These results confirm 
optimal attachment at pH values of 7 & 8 reaffirming the result observed with the 
RME and H5WYG peptides, however due to the instabilities identified previously, 
of the buffers tested, pH 8 has been identified as being the most effective for 
attaching the peptide.   
6.2.6 Protein Concentrations 
Photoluminescence could not be used to confirm binding for the remaining two 
peptides due to the lack of a fluorescent tag, therefore to confirm optimized binding 
efficiency at pH 8; protein estimation was carried out using a Micro BCA Protein 
Assay Kit for the RME and H5WYG peptides at a pH range of 6, 8 & 10. Although 
biuret based protein assays are theoretically applicable to peptide measurement, there 
is a high level of inter-peptide variation, determined largely by peptide 
hydrophobicity. This variation in peptide reactivity can be significantly reduced by 
heat-denaturation of peptides at 95 °C for 5 min in the presence of 0.1M NaOH 
containing 1% (w/v) SDS, therefore prior to incubation with BCA, each peptide was 
denatured at 90°C. [304] 
1 ml of each sample was retained for analysis, each sample was aliquoted into 1.5 ml 
Eppendorf tubes and centrifuged at 10,000 RPM for 30minutes. 900µl of the 
supernatant was then removed and labelled as the supernatant counterpart to be 
measured. The remaining pellet was re-dispersed. 100µl of each peptide ‘as 
synthesized’, after centrifugation, and their respective supernatant, were pipetted into 
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a 96 well plate in quadruplicate. After incubating the assays for the time specified in 
the kit; the absorbance was measured at 562 nm and the OD was converted to 
concentration (µg/ml) using the standard curve generated from BSA. The results for 
both peptides are displayed in Table 6-8. 
 
Table 6-8 Protein estimation via BCA for H5 and RME peptide at pH 6, 8 & 10 
H5 
pH Before (µg/ml) 
Supernatant 
(µg/ml) 
% in supernatant 
6 5.75 1.11 19% 
8 5.82 0.58 10% 
10 5.62 1.03 18% 
RME 
6 5.59 1.6 29% 
8 6.6 1.5 23% 
10 6.57 1.99 30% 
 
The average amount of H5 peptide added was calculated to be ~ 5.73 µg/ml. 
Approximately 19 and 18 % of the peptide added was measured in the supernatant 
for the samples functionalized at a pH of 6 & 10 respectively; whereas only 10% of 
the overall peptide added was found to be present in the supernatant for pH 8. Thus, 
indicating that the remaining 5.24 µg/ml had successfully attached to the AuNPs in 
comparison to the 4.64 µg/ml and 4.59 µg/ml for pH 6 and 10 respectively. A similar 
trend was observed for the RME peptide. Lower attachment percentages were 
observed in general for RME peptide in comparison to the H5WYG, however it was 
still apparent that the most efficient attachment occurred at a pH of 8. This confirms 
that for the pH levels tested, a pH of 8 results in the most efficient attachment for all 
three peptides.   
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6.2.7 Long Term Colloidal Stability 
After a period of 28 days under dark ambient conditions Figure 6-16, the AuNP 
solutions were imaged to monitor long term stability, with changes in solution color 
indicative of aggregation. When compared to the AuNP SH-PEG control with 
varying degrees of aggregation observed at pH values distant from this optimal pH 
across the three peptide types of RME, H5WYG and RGD. It is evident that AuNPs 
co-functionalized at a pH of 8 showed minimal changes in color, consistent with 
other previous measurements investigating initial surface functionalization 
 Discussion 
This chapter investigated the effect of pH on binding efficiency of three peptides to 
SH-PEG functionalized AuNPs using either citric acid/sodium hydroxide buffer 
solution (pH 6), a borax/sodium hydroxide buffer solution (pH 8 or pH 10) and/or a 
di-sodium hydrogen phosphate/sodium hydroxide buffer solution (pH 12). All of 
these buffer solutions were then altered with sodium hydroxide or hydrochloric acid 
to obtain the desired intermediate pH ranges. 
The peptides chosen all contain thiol groups and amine groups for functionalization 
to the AuNP surface, however it is expected that the chosen peptides will all 
coordinate to the AuNP surface through the thiol due to the much higher binding 
Figure 6-16 Images of AuNP SH-PEG (a), AuNP SH-PEG & RME (b), AuNP SH-
PEG & H5 (c) and AuNP SH-PEG & RGD (d) all at pH 6, 8 and 10 (left to right) 
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affinity of thiol groups to Au (40 – 50 kcal/mol-1), than amine groups to gold (8 
kcal/mol-1). [305,306] 
The binding efficiency of a ligand to the AuNP surface is dependent on AuNP size, 
the length of the ligands, the rotational flexibility of the bond, steric effects as well 
as the type of bonding used in the coupling chemistry. [296,298] As previously reported 
there are several strategies for conjugation of peptides and proteins to AuNPs 
resulting in distinct types of binding. Van der Waal forces and hydrogen bridges 
result in weak binding forces between the conjugate and nanoparticle (NP), whereas 
covalent bonding produces stronger conjugation. [296,298] For any of these binding 
modes to occur, repulsion between the AuNP and ligand should be minimized in a 
manner that maintains repulsion between the individual particles – which is essential 
to minimize aggregation. pH may play an important role in this, altering the pH can 
alter the surface charge, therefore by producing a positively charged ligand, opposite 
surface charges will be induced  between the ligand and the negative surface 
potential of the citrate capped AuNP ( - 30 mV), thus enhancing the binding 
efficiency.  
When altering the pH, consideration must be given to the isoelectric point (pI) of the 
peptide. Peptides are composed of a sequence of up to 100 amino residues, all of 
which contain amine groups and carboxyls and some of which contain unique side 
chains. All of these functional groups have the potential to interact with the AuNP 
surface in some form. Therefore the dissociation constant (pK) of the various 
functional groups in each amino acid sequence should be considered. The total pK 
values for the remaining ‘free’ reactive groups found on the amino acids vary 
between 6.7 – 8.7, however the pK values for the individual cysteine residues are 
1.71, 8.33 and 10.78 for the carboxyl, ammonium and thiol group respectively. 
While Glycine has pK values of 2.34 and 9.6 and for the carboxyl and amine groups 
respectively. [269,307] 
The results from the UV/Vis analysis identified optimum co-functionalization for 
both RME and H5WYG peptides at a pH of 8 via a characteristic shift in peak 
position occurring, accompanied by a modest reduction in absorbance. UV/Vis 
analysis of the H5WYG peptide demonstrated that many of the buffers tested 
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resulted in a significant or complete loss of the plasmon peak, or a large upshift in 
peak position indicating aggregation. This slight broadening in the long wavelength 
region as a result of surface modification may suggest that a large change of surface 
zeta potential caused by a change in pH affects the surface plasmon oscillation. DLS 
number averages demonstrated that suspension in pH 8 buffer solutions resulted in 
the largest increase in hydrodynamic diameter in relation to co-functionalization  
with either RME or H5 peptide without showing signs of loss of colloidal stability 
by large error bars, and zeta potential measurements for both peptides resulted in a 
more negative zeta potential at a pH of 8, indicating long term colloidal stability. 
Fluorescent spectra of the supernatants following centrifugal removal of the FITC 
labelled RGD peptide demonstrated the intensity of unbound free FITC A clear 
emission peak was noted around 520nm for all sample types. This is typical for 
green fluorescein FITC. [299,300] Of the buffer solutions testing, a pH of 7 and 8 
having the lowest intensity. The correlates to the least amount of FITC present in the 
supernatant due to the optimum binding resultant of the pH in comparison to the 
remaining samples. While some onsidratio has to be givent o the effect of h on the 
quantum yield of the FITC fluorescent, literature has agreed that fluorescein 
concentration increased with increasing pH, and there was not a significant increase 
in absorbance above pH 7.5, and as such these results confirm optimal attachment at 
pH values of 7 & 8 reaffirming the result observed with the RME and H5WYG 
peptides, however due to the colloidal and chemical instabilities identified 
previously, of the buffers tested, pH 8 has been identified as being the most effective 
for attaching the three peptides chosen for this Thesis. [301,302] [303] 
 
 Conclusions 
pH plays a critical role in controlling peptide binding and subsequent protein 
modified AuNPs colloidal stability; PEG capped AuNPs are stable between pH 
values of ~6 - 12. Citrate capped AuNPs have a zeta potential of approximately -30 
mV, therefore to initiate binding between Au and the ligand required it must be 
oppositely charged. This can be obtained by shifting the solution pH by a buffer to a 
pH value above the pKa value of the gold nanoparticle (6.3 is the pKa of the AuNP 
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functionalized surface with citrate dominating the pKa) but below the pKa value of 
the chosen peptide. Adjusting the pH to ~8 optimizes cysteine binding, but care 
should be taken to avoid the pI of the peptide as this may lead to colloidal instability. 
This method of peptide attachment can be used to synthesize AuNPs capped with 
PEG and one or more peptides, allowing the synthesis of stable AuNPs with the 
desired biological activity. However, it may not always be possible to synthesize 
stable peptide modified AuNPs by selecting a pH in the region of 8. If this pH is 
close to the pI value of the peptide used for surface modification the material may 
show limited colloidal stability under such conditions. The net charge and water 
solubility of the peptide used in surface modification are also crucial factors 
contributing to protein functionalized AuNP stability.  
This chapter therefore suggests that the cysteine – AuNP binding efficiency is 
optimized at a pH of 8 for these three peptides. This chapter builds upon the results 
obtained through chapter 4 that careful consideration must be given to the method of 
binding when using a peptide containing a thiol due to the strength of the thiol bond.  
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7. CONCLUSIONS & RECOMMENDATIONS FOR 
FUTURE WORK 
 Conclusion 
This Thesis has focused on the methods and characterization techniques which must 
be employed to facilitate and confirm the successful synthesis of a AuNP therapeutic 
system utilizing a bifunctional linker. This Thesis also served to address the 
uncertainty in the literature surrounding surface functionalization, on whether a 
chosen surface arrangement could elicit a more favorable biological response, in the 
form of improved colloidal in-vitro stability, potential toxicity, and if one method of 
co-functionalizing a AuNP could result in an enhanced peptide response (improved 
internalization and/or enhanced radiosensitivity).  
 
In a previous publication, the author attempted to directly compare the mixed 
monolayer arrangement to utilizing a PEG linker. In this aforementioned paper, 
AuNPs were functionalized with either mono-functional SH-PEG, or bifunctional 
SH-PEG-SGA, and co-functionalized with RME peptide which had been dissolved 
in distilled water. The resultant nanoparticles were then compared directly to 
investigate the effects on stability, non-specific protein adsorption and cellular 
uptake (emma material science). In this previous publication little differences were 
observed between the two approaches, with both offering similar levels of stability, 
non-specific protein absorption and cellular uptake. However, new analysis which is 
described throughout this Thesis has shown that in the case of the samples 
synthesized using a PEG linker, the thiol containing RME peptide had bound directly 
onto the AuNP surface rather than onto the end of the bifunctional PEG linker. Such 
binding of the peptide directly to the gold surface would lead to the synthesis of 
another mixed monolayer arrangement rather than the utilization of the intended 
PEG linker. As described in chapter 4, it was discovered that the NHS ester end of 
the bifunctional PEG had hydrolyzed in water, and was therefore unavailable for 
peptide attachment. This issue was overcome with the use of DMSO and the 
H5WYG peptide, leading to the successful preparation of functionalized AuNPs 
178 
 
using the bifunctional PEG linker, the published results have since been challenged 
with the recent submission of a paper which addresses the difficulties encountered 
when synthesizing an AuNP using a linker.  
  
The research reported here has sought to investigate the role of surface 
functionalization and to identify peptides which can be utilized to initiate a 
biological response (internalization, radiosensitivity, enhanced stability in vitro, 
ability to resist non-specific protein adsorption) and to challenge to hypothesis 
identified in the literature, the using a linker could potentially result in an ‘anti-PEG’ 
effect. To conclude if one method of AuNP sample preparation would elicit a more 
desirable biological response than the other, AuNPs were capped with either the 
mono-functional SH-PEG or the bifunctional SH-PEG-SGA, and co-functionalized 
sequentially using the endosomal escape peptide, H5WYG ((H5), 
(GLFHAIAHFIHGGWHGLIHGWYG. FTIR, DLS and UV/Vis were the central 
characterization techniques used throughout this Thesis for confirming gold 
nanoparticle functionalization. Thiol sensitive probes became paramount in 
confirming the surface arrangement.  
 
Colloidal stability was investigated by mimicking physiological salt concentrations 
and the biological effect was determined using cell viability assays, cellular 
internalization and clonogenic survival assays to measure the radiosensitizing 
response as a result of AuNP functionalization. The initial ‘anti-PEG’ hypothesis 
was disproved when both the linker and mixed monolayer formation showed 
nanoparticle stability in high ionic strengths; the mixed monolayer was surprisingly 
more prone to non-specific protein adsorption in comparison to using a linker.   
 
Cell internalization studies indicated that for both the PC3 and DU145 cell lines a 
significant increase is evident for the AuNP SH-PEG-SGA & H5 (Bifunctional 
linker) samples in comparison to the PEGylated counterpart (P value of 0.0329 and 
0.003 for the PC3 and the DU145 cell lines respectively). This increase offered an 
almost 30-fold increase in internalization for the DU145 cell lines and a 14-fold 
increase for the PC3 cell lines. The level of uptake for the DU145 linker samples is 
similar to the level previously experienced via the RME peptide in the 
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aforementioned publication, peaking at approximately 0.7pg. The DU145 cell lines 
indicate a statistical difference for internalization between the mixed monolayer, 
indicating that the linker has elicited a higher internalization response for both cell 
lines with an overall F value of 181.8 and a P value of 0.0095 (P < 0.05) for the 
DU145 cell lines resulting in over 3 times the amount of gold within the cells, 
identifying significant difference between the mixed monolayer versus linker 
arrangement. 
 
The results from the clonogenic survival assays demonstrated that functionalization 
with SH-PEG-SGA and SH-PEG-SGA & H5 peptide resulted in SERS of 1.07 and 
1.21, demonstrating an 7% and 21% increase in radiosensitivity respectively, with 
the Survival fraction of the linker at 4 Gy being 48% lower for the linker than the 
mixed monolayer arrangement.  The results have indicated that the synthesis of a 
linker using a H5 peptide has resulted in a significant increase in the effectiveness of 
radiotherapy when compared to the control. (P value = 0.01). 
 
Due to the necessity to dissolve the SH-PEG-SGA and peptide in DMSO to facilitate 
the synthesis of a linker, the mixed monolayer arrangement was brought forward to 
investigate the last phase of this Thesis, which was investigating if there was an 
optimum pH which would improve peptide binding efficiency. pH plays an 
important role in controlling ligand attachment; however it was not possible to 
predict an optimum pH for attaching a particular peptide. The ability to optimize the 
ligand attachment by altering the pH may have the benefit of being able to maximize 
the binding efficiency with the nanoparticle. Functionalization is commonly 
achieved via electrostatic charge attachment, gold has a zeta potential of 
approximately -30 mV therefore an opposite charge is required to initiate binding 
between the Au and the desired ligand. This desired difference in charge was 
hypothesized to be obtained by shifting the solution pH by a buffer to a pH value 
above the pKa value of citrate capped gold (6.3) but below the pKa value of the 
chosen peptide. It was hypothesized that a slightly acidic buffer solution would elicit 
a positive charge of the peptides and therefore synthesize a higher binding affinity 
towards the negatively charged gold nanoparticle.  
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It was concluded that adjusting the pH to ~8 optimizes cysteine binding, but care 
should be taken to avoid the pI of the peptide as this may lead to colloidal instability. 
This method of peptide attachment can be used to synthesize AuNPs capped with 
PEG and one or more peptides, allowing the synthesis of stable AuNPs with the 
desired biological activity.  
 
In terms of a definitive conclusion being drawn as to one surface arrangement over 
another, the data presented in this Thesis has highlighted the difficulty of 
synthesizing an AuNP system using a linker, and the need for an in-depth 
characterization portfolio. The mixed monolayer arrangement offers equal colloidal 
stability to the linker; however the studies in this Thesis have indicated that the 
bifunctional linker resulted in enhanced internalization and radiosensitivity. As such 
it can be concluded that a linker should be used going forward as it offers enhanced 
bioavailability and accessibility to cellular receptors while providing stability 
equivalent to that of the mixed monolayer, and improved resistance to non-specific 
protein adsorption. Optimizing peptide attachment is heavily dependent on the 
peptides chosen, while it has been shown that a pH of 8 satisfies the three cysteine 
containing peptides outlined in this body of work, if an efficient linker methodology 
is to be adopted, then careful thought must be applied to the solvent in which the 
AuNP is to be suspended in. 
 
 Future work 
From the results presented in this Thesis, it is hypothesized that future challenges 
when utilizing the synthesis of a linker will revolve around the addition of peptides 
when one or more ligands are thiol-containing molecules. One of the main choices 
for the use of gold nanoparticles is their ease of functionality; therefore any aversion 
to the utilization of thiols moving forward is not ideal.  As such it is the 
recommendation that future work will focus on synthesizing a sample like the H5 
sample explored, containing the cysteine residue, but one which is stable in water. It 
is also recommended that a linker methodology be employed using an internalization 
peptide (thiol free) for a better determination of the effect of direct cell contact, as 
while the H5 peptide investigated adversely results in internalization, it’s primary 
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function is for endosomal escape, and as such does not give a concrete conclusion on 
the efficiency of uptake by using a linker.  
Other means to synthesize a linker are recommended, such as the using of biotin and 
avidin (or Neutravidin) coupling systems, it is proposed by the author of this Thesis 
that a complex of two targeting mechanisms, primarily the RGD peptide identified 
within this work which targets Nrp-1 receptors found on cancerous cells, and PSMA 
617, a prostate specific membrane antigen when combined, will allow effective 
active targeting. Or as illustrated in Figure 7-1 a complex of a photosensitizer and 
targeting mechanism, as the internalization data throughout this body of work does 
not indicate that internalization correlates to enhanced radiotherapy.   
182 
 
 
Figure 7-1 Illustration of a AuNP active targeting and photosensitizing AuNP 
complex for potential future work 
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